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1 INTRODUCTION TO THE THESIS WORK
What and who we are is determined by numerous factors. Besides hereditary traits, the
experiences we make over the course of our lives affect us in both positive, but sometimes
also negative ways. Stress, defined as the actual or anticipated perception of a threat
to homeostasis or wellbeing (Ulrich-Lai & Herman, 2009), plays an important role in
an organism’s ability to adapt to adverse environmental events. In order to mitigate
the impact of hazardous conditions, it is crucial to show an adequate physiological and
behavioral stress response (Hollon, Burgeno, & Phillips, 2015).
1.1 The perception of danger affects body, cognition, and behav-
ior in multiple ways
Threats to one’s physical or psychological integrity come in different flavors (Bhatnagar,
Vining, Iyer, & Kinni, 2006; Juruena, 2014). Their perception typically leads to certain
alterations of endogenous processes in order to initiate adaptive behavioral actions and
to restore homeostasis (Smith & Vale, 2006). In rodents and humans, the hypothalamic-
pituitary-adrenal (HPA) axis is most relevant in mediating stress responses. As soon as
a potential threat is detected, the paraventricular nucleus of the hypothalamus releases
both corticotropin-releasing hormone and vasopressin, triggering the production and
secretion of adrenocorticotropic hormone by the anterior pituitary gland and, ultimately,
of glucocorticoids as well as mineralocorticoids by the adrenal cortex (Aguilera, 2011;
Joseph & Whirledge, 2017; Smith & Vale, 2006). This endocrinological cascade is associated
with many changes in the peripheral and central nervous system in order to prepare for
autonomous and behavioral responses (Ulrich-Lai & Herman, 2009).
During the stress responses, to increase chances of survival, important body functions,
such as the cardiovascular activity, respiration, or metabolic rate, are enhanced, while other,
less critical functions are inhibited (Joseph & Whirledge, 2017). Furthermore, to prevent
the risk of lethal blood loss, autonomous nervous system (ANS)-regulated vasoresponses
change the volume of arterial blood vessels, typically decreasing blood flow to peripheral
body parts (Engert et al., 2014). Physiological research takes advantage of such alterations
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in ANS activity to gain insight into the organism’s stress response (Cardone & Merla, 2017;
Ermatinger, Brugger, & Burkart, 2019). Moreover, levels of hormones that are released via
the HPA axis can be analyzed to determine the intensity of perceived stress. In particular
glucocorticoids, as the downstream product of the HPA axis (i.e., cortisol in humans,
corticosterone in mice and rats), are commonly employed as biological stress markers
(Boehringer et al., 2015; Hellhammer, Wust, & Kudielka, 2009).
1.2 Stress can have severe implications on medical and psycho-
logical wellbeing
While stress is commonly perceived as unpleasant and adverse, it fulfills an evolutionary
purpose and can enhance our physical and psychological functionality (Hollon et al., 2015;
McEwen, 2007). However, intense or long-lasting periods of stress may have a negative
impact on, or may even be the cause of, somatic diseases as well as psychological and
cognitive states (Hollon et al., 2015; Yaribeygi, Panahi, Sahraei, Johnston, & Sahebkar,
2017). Stress is further linked to dysfunctional behavioral patterns and unfavorable coping
mechanisms, such as substance abuse (Piazza & Le Moal, 1998). With regard to psychiatric
conditions, stressful experiences have an at least modulating impact on the development
and course of many, if not all, psychiatric syndromes, including posttraumatic stress
disorder (PTSD), major depression, and schizophrenia (Agid, Kohn, & Lerer, 2000).
1.3 Aggression is a natural behavioral response to stressful events
Stress typically leads to characteristic physiological and behavioral responses. One impor-
tant possible reaction to a threat is aggression, exhibited by many different species, with
humans being no exception (Veroude et al., 2016; Waltes, Chiocchetti, & Freitag, 2016). In
general, aggression can be defined as an overt behavior that has the intention of inflicting
physical damage or harm to other living beings (Miczek, Fish, De Bold, & De Almeida,
2002; Nelson & Trainor, 2007). However, former work suggests distinct subgroups of
aggression (e.g., reactive versus proactive; overt versus covert; physical versus relational),
with variations in the incidence of these subtypes in relation to context, age, and gender
(Björkqvist, 2018; Österman et al., 1998; Veroude et al., 2016). While adaptive in certain
situations, when exhibited repeatedly, over longer phases, or out of context aggression
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constitutes a serious problem for society as a whole, both due to individual consequences
and economical costs (Blair, 2016). Thus, a closer look at factors modulating the expression
of aggressive responses to stress is desirable.
1.4 Aggression is a consequence of the interplay between genet-
ics and the environment
Over the last decades, genetic and environmental factors that may cause or modulate
aggression have extensively been investigated. For instance, twin and adoption studies
emphasize that, besides a strong hereditary impact, the relevance of environmental factors
should not be underestimated. In particular, the non-shared environment plays an at least
moderate role in aggressive behavior. However, due to differences in age and gender of
the investigated individuals as well as operationalization of aggression phenotypes over
studies, the amount of estimated genetic and environmental influence varies (Veroude
et al., 2016). Accordingly, genome-wide association studies (GWAS), which aimed to
identify gene variants relevant for aggressive phenotypes, could not achieve genome-wide
significances (Mick et al., 2014; Tiihonen et al., 2015; Waltes et al., 2016). Approaches of can-
didate gene association studies (CGAS), on the other hand, targeted and identified several
genes possibly connected to aggression. In particular, genes that influence monoaminergic
neurotransmission (Veroude et al., 2016; Waltes et al., 2016) seem to be of importance.
Research genuinely relying on genetic readouts neglects the interplay between genes and
the environment, which seems to serve as an important modulator of the development of
aggressive behavior and related disorders. In an influential study, Caspi and colleagues
(2002) prospectively examined the impact of a variant number tandem repeat (VNTR)
polymorphism in the promoter region of the monoamine oxidase A (MAOA) gene on the oc-
currence of antisocial problems in men. The MAOA gene is located on the X chromosome
and expresses an enzyme that metabolizes monoamines, such as serotonin, dopamine, or
noradrenaline. These neurotransmitters have been linked to aggression (Brunner, Nelen,
Breakefield, Ropers, & van Oost, 1993). In 2002, Caspi et al. reported that low MAOA
activity, due to the VNTR polymorphism, is linked to a higher risk of antisocial behavior.
However, this higher risk could only be observed in individuals who additionally suffered
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from maltreatment during childhood, highlighting the importance of both genes and
adverse environmental factors in the explanation of problematic behavior patterns (Caspi
et al., 2002). Their findings have been replicated multiple times (Byrd & Manuck, 2014;
Kim-Cohen et al., 2006), suggesting a robust gene × environment interaction effect on
aggression. Epigenetic analyses try to combine both genetic and environmental research
by investigating the effects of environmental factors on the expression of genes via, besides
others, DNA methylation, chromatin modification, or histone acetylation and deacetyla-
tion (Palumbo, Mariotti, Iofrida, & Pellegrini, 2018).
Studies examined a huge number of potentially relevant environmental risk factors with
respect to aggressive behavior. However, such work often focuses on not clearly defined
environmental experiences (e.g., childhood maltreatment). More importantly, risk factors
are often assessed in an isolated manner, ignoring possible additive effects (Raine, 2002).
Furthermore, several other parameters moderate aggressive behavior, such as age and
gender (Björkqvist, 2018; Österman et al., 1998). Moreover, an altered state of mind,
typically found in psychiatric conditions, such as schizophrenia, is prominently linked to
increased aggressive potential. In fact, aggression does occur more frequently in patients
with schizophrenia compared to individuals without. Yet, just a minority of patients
actually exhibits aggressive behavior, often moderated by additional factors (Fazel, Gulati,
Linsell, Geddes, & Grann, 2009; Sariaslan, Lichtenstein, Larsson, & Fazel, 2016).
1.5 Schizophrenia is a severe psychiatric condition associated
with stress and aggression
Schizophrenia is a chronic mental disease, which usually starts in early adulthood and
severely impairs cognitive functions, affect, and behavior of patients. It is characterized by
both positive symptoms, like sensory hallucinations, delusions, and disordered thoughts
as well as negative symptoms, such as poverty of speech (alogia), reduction of emotions
and motivation, and social withdrawal (American Psychological Association, 2013; Howes
& Murray, 2014). With a lifetime prevalence of approximately 1%, schizophrenia is one
of the very common psychiatric disorders, with highly heterogeneous interindividual
disease patterns (Howes & Murray, 2014). Schizophrenia negatively affects an individual’s
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ability of daily living and quality of life in manifold ways. Moreover, due to high direct
and indirect costs, schizophrenia is not only a burden for patients and their personal
environment but also for society (Knapp, Mangalore, & Simon, 2004; van Os & Kapur,
2009).
Both genetic and environmental risk factors have been associated with schizophrenia
(Belbasis et al., 2018; Schizophrenia Working Group of the Psychiatric Genomics Con-
sortium, 2014; Brown, 2011; van Os & Kapur, 2009), but our knowledge concerning its
development is limited. As an approach to overcome weaknesses of many genetic and
environmental studies, our group established the Göttingen Research Association for
Schizophrenia (GRAS) data collection as a multicenter assessment of patients suffering
from schizophrenia or schizoaffective disorder (Begemann et al., 2010; Ribbe et al., 2010).
In a recent study, our group used the potential of the GRAS data collection to investigate
the impact of well-defined environmental risk factors on the age of disease onset in a
sample of 750 male patients with schizophrenia (Stepniak et al., 2014). We reported that
the amount of adverse risk factors experienced before adulthood is strongly related to
the age of onset of schizophrenia. Moreover, extreme group comparisons revealed a 10
years earlier disease onset in patients with a high, in relation to those with a low, risk load.
Contrary to the remarkable effects of the environment on disease onset, polygenic risk
scores did not reveal notable results. Having these large additive environmental effects
on the development of schizophrenia in mind, we were wondering whether models of
accumulated environmental risk factors, experienced in critical phases of development
(i.e., before adulthood) could improve our understanding of the relationship between
environmental stressors and aggression in both individuals from the general population
and patients suffering from schizophrenia.
1.6 Stress leads to autonomous responses in animals and humans
As discussed before, autonomic responses to negative environmental experiences are
an important readout of stress, not only in animal studies but also in human research
(Ulrich-Lai & Herman, 2009). Stress is not only relevant when it occurs in an intense way
or in critical stages of development. Chronic mild stress can influence our somatic and
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psychological wellbeing and daily life functioning (Won & Kim, 2016; Yaribeygi et al.,
2017). Therefore, it is worthwhile to take a closer look at the physiological and behavioral
responses to more subtle forms of stress.
Animal models of stress commonly rely on the assessment of behavioral reactions within
stress-inducing settings. Depending on the experimental scenario, different behavior can
be observed, including fight-or-flight reactions, freezing, or situational avoidance (Benus,
Koolhaas, & van Oortmerssen, 1992; de Boer, 2018; Harro, 2018; Toth & Neumann, 2013).
In addition, to get deeper insights into endogenous processes, techniques to investigate
physiological reactions to stress are available. The latter range from blood corticosterone
levels and core body temperature, often measured via a surgically introduced probe, to
posthumous analyses of hypothalamic Fos expression (Bhatnagar et al., 2006; Keeney,
Hogg, & Marsden, 2001; Martinez, Carvalho-Netto, Amaral, Nunes-de Souza, & Canteras,
2008). Such measures, however, are very invasive or distress animals even further, lead-
ing to unnatural testing conditions and thus likely biasing the outcome of experiments
(Cardone & Merla, 2017). Moreover, invasive assessment techniques raise ethical concerns
regarding animal welfare (Gjendal, Franco, Ottesen, Sorensen, & Olsson, 2018; Meyer,
Ootsuka, & Romanovsky, 2017).
Compared to animals, human research provides the great advantage to get insight into
psychological states by simply asking. Assuming proper usage, psychometric tools, such
as psychological questionnaires or interviews, are known to be capable of collecting valid
information on an individual’s internal processes. However, subjective self-descriptions
may not always be the best choice to investigate stress. For instance, the administration
of psychometric instruments is not always feasible over the course of an experiment.
Furthermore, given answers are commonly biased and are not necessarily in line with data
derived from physiological instruments. Therefore, an accompanying implementation of
more objective approaches is indicated.
Human body responses to ANS activity are typically measured via a variety of instru-
ments. Modern techniques are capable of accurately capturing a wide spectrum of basal
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physiological functions, such as the heart rate, arterial blood pressure, respiration rate,
muscle tone, or electrodermal activity (Cardone & Merla, 2017; Engert et al., 2014). Al-
though these valuable tools are important in both neuroscientific research and clinical
practice, they all have certain limitations (Ermatinger et al., 2019). Many of these tech-
niques require participants to remain as motionless as possible to prevent measurement
artifacts and errors, or they need to apply sensors on the test subjects’ bodies (Cardone &
Merla, 2017). Such intrusive conditions typically result in an uncomfortable and artificial
testing environment. Moreover, certain investigations, such as an exploration of social
interactions, are often considerably limited (Cardone & Merla, 2017; Ioannou, Morris,
Baker, Reddy, & Gallese, 2017). Furthermore, the application of those techniques is highly
challenging in individuals who are not able or willing to follow standard measurement
protocols, such as patients suffering from psychiatric conditions (Engert et al., 2014).
In summary, methods commonly used in both animal and human stress studies suffer
from limitations that weaken and question the validity of reported outcomes. There-
fore, besides others, this field of research could substantially benefit from non-invasive,
contact-free techniques to reliably measure ANS activity. Modern infrared thermography
recording has the potential to fill this gap.
1.7 Infrared thermography is a non-invasive, contact-free tech-
nique to measure body surface temperature
Infrared thermography (IRT) was first discovered in 1800 by astronomer William Herschel
under the term ’Calorific Rays’ while investigating specific radiation emitted by the sun
(Herschel, 1800; Rogalski, 2012). In order to quantify the physical property commonly
perceived as ’heat’, IRT utilizes electromagnetic radiation of a characteristic wavelength
outside our visible spectrum of light, namely within a bandwidth of 0.75 to 1000 µm
(Lahiri, Bagavathiappan, Jayakumar, & Philip, 2012). Every living being, as well as inani-
mate objects with a temperature higher than 0 ◦K, emit radiation within this spectrum,
where higher wavelengths are linked to lower temperatures (Tattersall, 2016). As an exam-
ple, mammals’, including humans, body surface constantly emits heat, peaking between 8
and 12 µm. Thus, IRT specialized in recording living beings mostly relies on sensors made
of materials sensitive to long-wavelength infrared (Lahiri et al., 2012; Tattersall, 2016).
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Today, infrared radiation technology commonly used to detect thermal alterations relies
on either cooled (quantum) or uncooled (thermal) detectors (Usamentiaga et al., 2014).
Quantum IRT systems utilize the interaction of semiconductors with changes in the energy
distribution of electrons due to the stimulation of thermal photons (Cardone & Merla,
2017; Rogalski, 2012). They depend on selective wavelengths and achieve very high mea-
surement precision. Given the high demand for constant cooling, this type of detectors are
characterized by high costs, a bulky and heavy design, and a complicated way of usage
(Rogalski, 2002). Conversely, cameras with uncooled thermal detectors are calibrated to a
certain temperature (e.g., ambient temperature) and are typically independent of photonic
wavelength (Rogalski, 2012). In order to translate electromagnetic radiation to electricity
and, subsequently, to thermal images, special materials that do not block infrared radiation
are employed (Cardone & Merla, 2017; Rogalski, 2002, 2012). When detector parts are hit
by thermal radiation, they heat up and alter their electrical properties. In order to create a
visible representation of this process, changes in electrical properties can be translated to
corresponding pixels. This results in the creation of a monochromatic image with pixel
intensities correlating with the respectively detected thermal energy. For a better visual
interpretation, monochromatic images can then be converted into false-color images using
different color palettes (Alpar & Krejcar, 2017; Ring & Ammer, 2012; Tattersall, 2016). An
example of the recording and data quantification process can be found in Figure 1.
In relation to cooled systems, uncooled IRT cameras are characterized by lower thermal
sensitivity. Nevertheless, modern cameras still achieve a relatively high spatial (up to 1280
× 1024 pixels) and temporal resolution (≥200 frames per second) and combine a satisfying
thermal sensitivity (Noise-Equivalent Temperature Difference of not more than 30 mK at 30
◦C ambient temperature) with a sufficiently high testing accuracy (Cardone & Merla, 2017).
At present, IRT plays an important role in different fields, such as the military, law
enforcement, search and rescue missions, material sciences, and many more (Jarlier et
al., 2011; Rogalski, 2012; Tattersall, 2016; Usamentiaga et al., 2014). In medicine, IRT had
its first appearance already in the 1960s. However, technical limitations led scientists
and physicians to favor more applicable tools (Lahiri et al., 2012; Ring, 2010). In recent
years, technological and manufactural advancements resulted in a comeback of IRT in
both medical research and diagnostic applications. Nowadays, modern IRT presents
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itself as a valid, relatively inexpensive and easy-to-use measuring method that is already
implemented in diverse areas of medicine, including oncology, dentistry, dermatology,
endocrinology, epidemiology, or infectiology (Lahiri et al., 2012; Ring & Ammer, 2012;
Usamentiaga et al., 2014).
FIGURE 1.1: Example of the process of IRT recording and following data extraction.
A: Grayscale image derived from a mouse performing an Open Field paradigm. B: Pseudo-colors
application makes differences in surface temperature easily visible. C: Peripheral (blue) and core
(red) body regions are defined for the following data extraction. D: Thermal curve of the index of
core body divided by periphery (centralization) over the course of 500 seconds. E: To reduce noise
thermal curve can then be smoothed.
Recently, IRT has found its way into neuroscientific research, including both animal and
human subjects (Cardone & Merla, 2017; Ermatinger et al., 2019; Gjendal et al., 2018;
Herborn, Jerem, Nager, McKeegan, & McCafferty, 2018; Ioannou, Gallese, & Merla, 2014;
Moline et al., 2017; Mufford et al., 2016; Tattersall, 2016). Mammals are endothermic
organisms and therefore in need of maintaining stable body temperature by internal regu-
lation processes, including muscular activity (e.g., shivering) to increase body heat and
perspiration (i.e., activation of sweat glands) in order to cool down (Mufford et al., 2016;
Ring, 2010). But body temperature does not only alter in response to physical parameters
like ambient temperature changes. Autonomous activity, for instance, as a response to
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stressful experiences, leads to alterations in volumes of blood vessels (i.e., vasoconstriction
and vasodilation) in both peripheral and core body regions, culminating in changes in
blood flow (flushing; Gjendal et al., 2018; Meyer et al., 2017; Mufford et al., 2016; Yoshihara
et al., 2016). Autonomous responses prepare animals for defensive actions in the eye of a
physical or predatory threat (e.g., fight-or-flight). Moreover, they provide protection from
blood loss due to injury and hence increase the chances of survival (Herborn et al., 2018;
Ioannou et al., 2014; Vianna & Carrive, 2005). As a side effect, such highly adaptive physi-
ological alterations concur with changes in temperature of core and peripheral body parts.
Remarkably, IRT is capable of quantifying these changes by recording heat emissions from
the body surface.
Accordingly, in humans, associations between physiological processes, detectable via
measurements of thermal alterations, and psychological or behavioral reactions have long
been reported. For instance, already Darwin (1872) described the relationship between
facial flushing and emotions, such as anger. Subsequently, other authors reported vaso-
constriction or vasodilation as a result of autonomous activity that is strongly linked to
thermal changes in both acral and central body parts as well as facial regions (Ioannou et
al., 2014, 2017). Notably, in a series of studies Kistler and colleagues (Kistler et al., 1996;
Kistler, Mariauzouls, & von Berlepsch, 1998a, 1998b) used Laser Doppler Flowmetry and
photoplethysmography techniques to associate sympathetic vasoconstriction and temper-
ature alterations in the fingertips during sympathetically activating procedures, such as
watching horror movies, chewing cotton swaps, or receiving an acupuncture treatment.
The authors showed that with a delay of approximately 15 seconds, temperature changes
reliably occurred in more than 90% of the time. Similarly, Drummond and colleagues
used Laser Doppler Flowmetry in order to explore the relationship between blood vessel
volume and anger induction in female (Drummond, 1999), and during an embarrassment
task in male and female, participants (Drummond & Su, 2012).
The human face is of particular interest for thermal studies. Due to a complex network
of blood vessels under its surface, alterations in ANS activity have strong effects on
subcutaneous blood flow and, consequently, temperature in different facial regions (Figure
2; Ioannou et al., 2017). Engert et al. (2014) investigated thermal alterations of various
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areas of the face in response to physical and social stress, revealing large differences in
thermal patterns in relation to the type of stressor experienced. Changes in flushing, due
to negative or positive social stimuli, combined with different intensity levels also lead
to alteration in surface temperature, with, in particular, the nose consistently reported as
highly reactive to affective and social cues (Cardone & Merla, 2017; Engert et al., 2014;
Ioannou et al., 2017; Kosonogov et al., 2017).
FIGURE 1.2: Facial areas exhibit different thermal patterns over the course of IRT.
A: False-color image of a participant reveals area-specific face surface temperatures. Ellipses
denote defined regions of interest for subsequent data extraction, namely nose (1), lower (2),
middle (3), and upper (4) cheek, and periorbital area (5). B: Quantification of these regions shows
different temperatures and also thermal curves during a cognition task with social components,
with the nose exhibiting most reactivity.
1.8 IRT has several advantages over ’conventional’ physiologi-
cal measurement techniques
IRT has been proven to have a satisfactorily high accuracy in measuring physiological
parameters, such as cardiac pulse, respiratory rate, and cutaneous blood perfusion rate, as
compared to state-of-the-art techniques in humans (Cardone & Merla, 2017; Cardone, Pinti,
& Merla, 2015; Ermatinger et al., 2019; Ioannou et al., 2014). Additionally, former work
showed that IRT is a valid readout of ANS activity in mice (Gjendal et al., 2018). Further,
it displays several advantages over other established physiological measuring techniques.
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Most importantly, IRT offers an easy to use, non-invasive, and contact-free application
mode. This renders it feasible to conduct experiments with almost no restriction in
the movements of test subjects, leading to a more naturalistic and ecological testing
environment (Ioannou et al., 2014, 2017). Moreover, IRT can record and analyze multiple
test subjects simultaneously, remarkably facilitating research of social contexts, deeming
IRT as the most suitable method in this research field (Cardone & Merla, 2017). IRT is
fully functional even in complete darkness (i.e., in absence of visible light). Accordingly,
enhanced measurements under conditions with light as a limiting factor, for instance in
testings of nocturnal animals, is possible. Recent work successfully introduced IRT into
the assessment of psychiatric patients, making it possible to investigate individuals who
have difficulties with the restrictive standard measuring procedures of other methods
(Di Giacinto, Brunetti, Sepede, Ferretti, & Merla, 2014; Jian, Chen, Chu, & Huang, 2017;
Perpetuini et al., 2019). Taken together, IRT can be seen as a valuable, non-invasive,
economical tool to conduct psychophysiological research in more naturalistic contexts.
1.9 Limitations of modern IRT in research context
Even though IRT’s validity in displaying surface temperature is generally accepted, its
testing reliability depends on controlling of numerous environmental, personal, and tech-
nological factors (Fernández-Cuevas et al., 2015). Physical parameters, including ambient
temperature and humidity, direct sunlight, or emission from other sources of heat, in-
terfere with IRT. To obtain proper recordings, IRT cameras also need a clear and direct
focus on the relevant body surfaces. Moreover, multiple personal factors, comprising
gender, age, amount of body fat, diurnal or menstrual cycle, food intake or consumption
of psychoactive substances, besides others, display potentially confounding effects and,
therefore, have to be taken into account.
Unfortunately, many former studies did not sufficiently control for these issues. Moreover,
no overall accepted gold standard in IRT testing has been introduced yet. Hence, numerous
different experimental designs, test stimuli, and examined facial regions as well as ways
of data extraction and analysis have been utilized (Ermatinger et al., 2019; Ioannou et al.,
2014; Ring & Ammer, 2012). Rather small and heterogeneous sample groups further limit
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explanatory power. The majority of previous work relies on the analysis of single or short
series of IRT images (e.g., before versus after experimental manipulation), examinations
of thermal dynamics over the course of longer-lasting time intervals are scarce. Thus, the
interpretation of IRT alterations is often limited to unidirectional statements.
14 INTRODUCTION TO THE THESIS WORK
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2 SCOPE OF THE PRESENT WORK
As discussed in the Introduction, stress is long known to be an internal reaction in the face
of danger or threat to physiological or psychological integrity. Typically, stress results in
adaptive physiological and behavioral responses, aiming at reducing the impact of per-
ceived threats and, ultimately, to re-establish and maintain homeostasis. Apart from that,
chronic or intensive stress experiences, particularly in critical periods of development, can
have a negative impact on an individual’s physical and psychological health. Furthermore,
stress commonly accounts for a broad spectrum of dysfunctional behaviors. Aggression,
due to its impact on individuals and society, is a very prominent target of respective
investigations. Different models have been postulated to explain the association between
stressors and aggression, still, most work focuses on individual risk factors. This weakens
power in explaining or predicting aggressive behavior. Likewise, a range of measurement
techniques can utilize autonomous responses to stressful experiences. These techniques
are invasive, demand applications of body sensors, or require test subjects to remain
unnaturally motionless. Such limitations, besides others, may greatly bias the context of
measurements. Infrared thermography (IRT) can overcome these issues. However, due
to differing quality in controlling for external and personal confounding factors as well
as study designs, findings reported from former IRT studies have to be interpreted with
caution.
This work seeks to address the discussed issues of former research, using two innovative
methodological approaches. Within the first research project, we create a robust model
of accumulated environmental risk to predict violent aggression in large groups of both
schizophrenia patients and individuals from the general population in several independent
samples. The second project aims to enhance the methodological quality of IRT as a
reliable tool in both mice and humans to measure autonomic responses to stress and
arousal by utilizing novel approaches in IRT data acquisition, preprocessing, and analyses.
16 SCOPE OF THE PRESENT WORK
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3 PROJECT I: VIOLENT AGGRESSION PREDICTED BY
MULTIPLE PRE-ADULT ENVIRONMENTAL HITS
3.1 Overview of project I
Aggression is of great concern for individuals and society as a whole. The identification of
factors playing a vital role in its manifestation is useful with respect to the prevention of
aggression. Unfortunately, previous research lacks empirically confirmed models capable
of predicting aggressive behavior. Notable work highlights the substantial impact of
the environment in the development of aggression and antisocial behavior (Caspi et al.,
2002; Nelson & Trainor, 2007; Palumbo et al., 2018; Veroude et al., 2016; Waltes et al.,
2016). However, studies focusing solely on genetic data (e.g., classical GWAS) neglect
the important contribution of the environment to the occurrence of aggressive behavior.
Conversely, phenotypical studies attempt to elucidate the role of the environment in
aggression. However, such research commonly investigates specific, individual factors
instead of assessing a possible additive effect (Raine, 2002).
Aggressive behavior is commonly attributed to patients suffering from mental disorders,
such as schizophrenia (Fazel et al., 2009; Sariaslan et al., 2016). Albeit the fact that aggres-
sion occurs more often in patients with this disorder, compared to individuals without
(Fazel et al., 2009; Sariaslan et al., 2016), the relevance of moderating factors remains
rather obscure. Our study was conducted to improve our knowledge about negative
environmental influences on violent aggression.
In a follow-up to the study by Stepniak et al. (2014), we planned to compare male
schizophrenia patients with low and high amounts of adverse environmental experiences
before adulthood in a highly matched discovery sample. In doing so, we realized that
high-risk patients had a great chance of a record of past or current aggressive behaviors.
Thus, we were wondering about a possible connection between adverse environmental
risks and the likelihood of displaying aggressive behavior.
18 PROJECT I
As a first approach, we carefully screened all information on the discovery sample patients,
collected during GRAS examinations (Begemann et al., 2010; Ribbe et al., 2010), with re-
spect to any aggressive behavior. Based on these data, we created the Violent Aggression
Severity Score (VASS) as a highly sensitive readout of any kind of aggressive behavior
over the course of the patients’ lifetime. Next, we defined environmental risk factors and
assessed their relationship with the VASS. In particular, six factors, namely urbanicity
(being raised in a big city), migration, physical abuse, sexual abuse, problematic alcohol
use, and lifetime consumption of cannabis, revealed effects on aggressive behavior. This
observation was consistently reproduced in three independent schizophrenia samples,
using a proxy of violent behavior as the target readout. Consequently, we created a model
of accumulated risk including the above-mentioned six factors.
We found that, although single risk factors already had a moderate impact on violent ag-
gression readouts, our accumulation models revealed strong associations between violent
behavior in relation to the number of risk factors. Interestingly, the described risk was
only observed in patients who suffered from such negative experiences before adulthood
(i.e., before 18 years of age), indicating that environmental experiences have a harmful
impact, especially during the critical developmental period of childhood to adolescence.
Our results suggest that the environment has a strong effect on the manifestation of violent
behavior that may be rather independent of patients’ mental condition. To investigate this
hypothesis, we associated accumulated environmental risk and psychometrically collected
aggression trait scores in two general population samples. Again, we found highly
significant associations between risk and aggression traits. These findings emphasize
not only the environment’s influence on violent behavior, but also that our model of
accumulated environmental risk can be used to predict aggressive behavior and identify
individuals at risk.
Contrary to the large effects attributable to the environment, epigenetic analyses using epi-
genome-wide association scans remained behind our expectations; patients with different
risk loads (low versus high) revealed comparable blood-derived DNA methylation levels.
However, peripheral histone deacetylase 1 (HDAC1) mRNA levels, a gene encoding an
important epigenetic modulator, were significantly higher in individuals who suffered
from a high risk load.
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3.2 Original publication
Mitjans, M.*, Seidel, J.*, Begemann, M.*, Bockhop, F., Moya-Higueras, J., Bansal, V.,
Wesolowski, J., Seelbach, A., Ibáñez, M. I., Kovacevic, F., Duvar, O., Fañanás, L., Wolf, H.-
U., Ortet, G., Zwanzger, P., Klein, V., Lange, I., Tänzer, A., Dudeck, M., Penke, L., Tebartz
van Elst, L., Bittner, R. A., Schmidmeier, R., Freese, R., Müller-Isberner, R., Wiltfang, J.,
Bliesener, T., Bonn, S., Poustka, L., Müller, J. L., Arias, B., Ehrenreich, H. (2018). Violent




I was involved in the ongoing process of GRAS patient examinations, thoroughly as-
sessing more than 100 patients suffering from schizophrenia or schizoaffective disorder,
and collecting, besides others, detailed information about negative environmental factors
experienced before adulthood and aggressive behavior. I updated and organized our
phenotypical databases with information while additionally supervising students in the
process of data entry. Together with my first author colleagues and under the supervision
of Prof. Hannelore Ehrenreich I created variables to investigate both potential environ-
mental risk factors and aggressive behavior of different intensity. I was responsible for
the creation and the validation of the Violent Aggression Severity Score (VASS) and for
the design of our model of accumulated risk factors of violent aggression. Furthermore, I
conducted extensive statistical analyses of all the phenotypical data in addition to com-
paring HDAC1 methylation levels in different risk accumulation groups. Moreover, I was
responsible for creating Figure 1 as well as Tables 1-3 of the final manuscript. Together
with my first author colleagues and Prof. Hannelore Ehrenreich I contributed to the
Introduction, Methods, and Results sections of the manuscript and interpreted our findings
for the Discussion section. Finally, I answered questions and requests from editors and
reviewers during the process of submission and publication and read and corrected the
final version of the manuscript.
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Abstract
Early exposure to negative environmental impact shapes individual behavior and potentially contributes to any mental disease.
We reported previously that accumulated environmental risk markedly decreases age at schizophrenia onset. Follow-up of
matched extreme group individuals (≤1 vs. ≥3 risks) unexpectedly revealed that high-risk subjects had >5 times greater
probability of forensic hospitalization. In line with longstanding sociological theories, we hypothesized that risk accumulation
before adulthood induces violent aggression and criminal conduct, independent of mental illness. We determined in 6
independent cohorts (4 schizophrenia and 2 general population samples) pre-adult risk exposure, comprising urbanicity,
migration, physical and sexual abuse as primary, and cannabis or alcohol as secondary hits. All single hits by themselves were
marginally associated with higher violent aggression. Most strikingly, however, their accumulation strongly predicted violent
aggression (odds ratio 10.5). An epigenome-wide association scan to detect differential methylation of blood-derived DNA of
selected extreme group individuals yielded overall negative results. Conversely, determination in peripheral blood mononuclear
cells of histone-deacetylase1 mRNA as ‘umbrella mediator’ of epigenetic processes revealed an increase in the high-risk group,
suggesting lasting epigenetic alterations. Together, we provide sound evidence of a disease-independent unfortunate
relationship between well-defined pre-adult environmental hits and violent aggression, calling for more efficient prevention.
Introduction
Early exposure to external risk factors like childhood mal-
treatment, sexual abuse or head trauma, but also living in
urban environment or migration from other countries and
cultures, have long been known or suspected to exert
adverse effects on individual development and
socioeconomic functioning. Moreover, these environmental
risk factors seem to contribute to abnormal behavior and to
severity and onset of mental illness [1–11], even though
different risk factors may have different impact, dependent
on the particular neuropsychiatric disease in focus. On top
of these ‘primary’ factors, that are rather inevitable for the
affected, ‘secondary’, avoidable risks add to the negative
individual and societal outcome, namely cannabis and
alcohol abuse [1, 11–16].
Adverse experiences in adulthood, like exposure to
violence, traumatic brain injury, or substance intoxication,
can act as single triggers to increase the short-term risk of
violence in mentally ill individuals as much as in control
subjects [16, 17]. However, comprehensive studies,
including large numbers of individuals and replication
cohorts, on pre-adult accumulation of environmental risk
factors and their long-term consequences on human beha-
vior do not exist. In a recent report, we showed that















accumulation of environmental risks leads to a nearly 10-
year earlier schizophrenia onset, demonstrating the sub-
stantial impact of the environment on mental disease, which
by far outlasted any common genetic effects [18]. To search
for epigenetic signatures in blood of carefully matched
extreme group subjects of this previous study (with ≤1 vs.
≥3 risk factors) we had to re-contact them. This re-contact
led to the unforeseen observation that high-risk subjects
had > 5 times higher probability to be hospitalized in for-
ensic units compared to low-risk subjects.
This finding stimulated the present work: Having the
longstanding concepts of sociologists and criminologists in
mind, we hypothesized that early accumulation of envir-
onmental risk factors would lead to increased violent
aggression and social rule-breaking in affected individuals,
independent of any mental illness. To test this
hypothesis, we explored environmental risk before
the age of 18 years in 4 schizophrenia samples of the
GRAS (Göttingen Research Association for Schizophrenia)
data collection [19, 20]. Likewise, risk factors were
assessed as available in 2 general population samples. In all
cohorts, accumulation of pre-adult environmental
hits was highly significantly associated with lifetime con-
viction for violent acts or high psychopathy and aggression-
hostility scores as proxies of violent aggression and rule-
breaking. As a first small hint of epigenetic alterations in
our high-risk subjects, histone-deacetylase1 (HDAC1)





Ethics Committees of Georg-August-University, Göttingen,
and participating centers across Germany approved the
GRAS study, complying with the Helsinki Declaration. All
patients (and/or legal representatives) gave written informed
consent. GRAS data collection-I (2005–2010) [19, 20] and
-II (2013–2016) consist of schizophrenic and schizoaffec-
tive subjects, assigned to: (1) male discovery sample (N=
134 extreme group individuals with ≤1 or ≥3 risk factors,
selected/matched from our previous study [18]); (2) male
GRAS-I (N= 606); (3) male GRAS-II (N= 320); (4)
female GRAS-I and -II cohorts (N= 503).
General population
Replication samples IV (N= 336) and V (N= 229) consist
of individuals from the Spanish general population,
recruited from the Jaume I University in Castelló and drawn
from the third wave of an ongoing follow-up study
which recruited students from a variety of urban
and rural, public and private high schools from Castelló.
Ethical approval was obtained from University Ethics
Committees; participants provided written informed consent
[21, 22].
Sociodemographic and disease-related parameters
The GRAS data collection contains comprehensive infor-
mation regarding sociodemographic and disease-related
parameters, acquired through detailed examination, semi-
structured interviews, telephone consultations, ques-
tionnaires, and complete collection of hospitalization letters,
allowing meticulous double-checking of patients’ self-
reports [19, 20]. Chlorpromazine equivalents as indi-
cator of present medication/disease severity and past sui-
cide attempts as measure of severe self-aggression were
employed for sample characterization and group compar-
ison. Premorbid intelligence was estimated using MWT-B
(Mehrfachwahl-Wortschatz-Intelligenztest-B), and for cur-
rent cognitive symptoms, a cognitive composite score was
calculated, based on reasoning (Leistungsprüfsystem-
subtest-3), executive function (Trail-Making-B) and verbal
learning and memory (VLMT) [18, 19].
Environmental risk exposure
Schizophrenia subjects
Specific information was derived from history-taking and
semi-structured interviews with patients and relatives/care-
takers (GRAS-Manual) [19, 20] and from SCID-I. Each
patient was dichotomously classified as having/not having
been exposed premorbid and until age 18 years to severe
physical abuse (comprising unpredictability of violence,
injury due to physical reprimand or objects for corporal
punishment), sexual abuse (forced touches, kissing,
attempted or real rape), migration (subjects immigrating to
Germany), neurotrauma (traumatic brain injury of all
severity grades), perinatal complications (pregnancy,
delivery, early postnatal life), any cannabis consumption
and alcohol abuse [23]. To operationalize urbanicity until
age 18, information on place of residence and relocation
was collected from discharge letters, social history, tele-
phone interviews/return mail (questionnaire). Total urbani-
city score was dichotomously divided into rural vs. urban
residence [18]. In case of contradictory or missing infor-
mation, patients were excluded from respective analyses.
Single risk factors with highest impact over all samples
were accumulated to investigate combined influence on
aggression.
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General population subjects
Physical and sexual abuse was assessed by the shortened
version of Childhood Trauma Questionnaire (CTQ) [24]
and dichotomously recorded (never/any), as was migration
(not born in Spain), alcohol (Alcohol Use Disorders Iden-
tification Test - AUDIT ≥ 4) [25] and any cannabis con-
sumption. Data regarding perinatal complications,
neurotrauma and urbanicity were unavailable.
Measures of violent aggression and criminal
conduct
Schizophrenia subjects
History of forensic hospitalization or conviction for bat-
tery, sexual assault, manslaughter, murder (at least once in
life time) was used as violent aggression proxy. For cross-
validation of this dichotomous variable, a continuous
measure, the violent aggression severity score (VASS),
based on questionnaires, interviews and charts, was gener-
ated and applied to the discovery sample. The VASS in turn
was cross-validated by an intra-sample ranking of relative
aggression severity by 2 independent raters (Fig. 1).
General population subjects
Secondary psychopathy of the Levenson Self-Report Psy-
chopathy Scale (LSRP) [26], measuring antisocial aspects of
psychopathy (rule-breaking; lack of effort towards socially
rewarded behavior), and aggression-hostility factor of the
Zuckerman–Kuhlman Personality Questionnaire, shortened
form (ZKPQ-50-CC) [27], were used as proxies of violent
aggression.
Statistical analysis of environmental risk
Group differences for continuous variables were assessed
using Mann-Whitney-U or Kruskal-Wallis-H test for com-
parison of > 2 groups. Frequency differences between
groups were assessed using χ2-test or Fisher’s exact test. As
trend tests, Jonckheere-Terpstra or Cochran-Armitage tests
were applied. Covariates are explained in display items.
Bonferroni correction accounted for multiple testing (p
values withstanding correction denoted). Statistical analyses
were performed using SPSS (v17.0; IBM-Deutschland
GmbH, Munich, Germany), or R (v3.3.2; R-Foundation
for Statistical Computing, Vienna, Austria).
Methylation Array
Whole blood-derived DNA of extreme group individuals
(N= 134) was analyzed by Infinium-HumanMethylation450K
(Illumina Inc, CA, USA). Raw intensity data was pre-
processed and SWAN (Subset-quantile Within Array Nor-
malization) performed using Bioconductor package Minfi
(v1.18.6) [28]. Probes with annotated single-nucleotide
polymorphisms (SNPs) in CpG site or at single base
extension sites were removed, leaving 467,971 probes total.
To identify differentially methylated positions, a linear
regression model using limma (v3.28.17) Bioconductor
package [29] was fit. Covariates were age, medication and
estimated cell proportions (monocytes, granulocytes, CD4T,
CD8T, natural killer, and B-cells), calculated using Cell
Counts Function in Minfi package [30]. A total of N= 129
individuals were finally included for the analyses since two
samples were dropped based on separate clustering in prin-
cipal component analysis and information regarding medi-
cation was not available for three samples. All analyses were
performed in R.
PBMC isolation and HDAC1 assay
PBMC were isolated from morning blood, collected into
CPDA-vials (Citrate-Phosphate-Dextrose-Adenine, Sar-
stedt, Germany), applying standard Ficoll-Paque-Plus iso-
lation (GE-Healthcare, Munich, Germany). Total RNA
extraction was done using miRNeasy Mini-kit (Qiagen,
Hilden, Germany). For reverse transcription, 200ng RNA
was applied using a mixture of oligo(dT)/hexamers, dNTPs,
DTT and 200U SuperscriptIII (Life Technologies GmbH,
Darmstadt, Germany). HDAC1 expression was measured
using quantitative real-time PCR. The cDNA was diluted
1:12.5 in 10 µl reaction-mix, containing 5 µl of SYBR-green





Technical triplicates were run on LightCycler480
(Roche-Diagnostics GmbH, Mannheim, Germany). Rela-
tive HDAC1 expression was calculated by the threshold-
cycle method (LightCycler480 Software1.5.0SP3-Roche)
and normalization to the housekeeping gene GAPDH was
performed. After examination for outliers, Student’s t test
was used to compare groups using Prism4 (GraphPad-
Software; San Diego, CA, USA).
Results
The environmental risk factors evaluated in this study
comprise urbanicity, migration, perinatal complications,
physical maltreatment, sexual abuse, traumatic brain injury,
cannabis consumption and alcohol abuse. Contacting male
extreme group subjects of GRAS (with low vs. high
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environmental risk before age 18; discovery sample; N=
134) [18] for a planned epigenetic follow-up, we found 27%
of high-risk individuals in forensic units in contrast to only
6% of low-risk subjects (p < 0.001; χ2-test, two-sided). This
finding was replicated in the remaining GRAS-I sample
(GRAS-I males and females minus extreme group subjects),
where a stepwise increase in lifetime prevalence of forensic
hospitalization was seen upon risk accumulation (Fig. 1a).
This observation made us wonder whether we would find
a strong intercorrelation between the here investigated
environmental risks. To test for multicollinearity between
the risk factors included in the accumulation models, we
calculated the variance inflation factor (VIF) for each
sample. Our results suggest that none of the included factors
significantly collinears with any other (for each sample
VIF ≤ 1.28), allowing us to include them in our models.
We hypothesized that forensic hospitalization reflects
violent aggression. To quantify this trait, and in absence of
established instruments for comprehensive retrospective
analysis of violent aggression, we generated the VASS
Fig. 1 Multiple environmental hits before adulthood predict vio-
lent aggression in mentally ill subjects as well as in the general
population – Results from 6 independent samples. a Distribution of
forensic hospitalization in the discovery sample (see results) suggested
a substantial impact of environmental risk accumulation on violent
aggression, a finding replicated in the remaining GRAS sample
(GRAS-I males and females minus extreme group subjects of the
discovery sample). Note the ‘stair pattern’ upon stepwise increase in
risk factors; stacked-charts illustrate risk factor composition in the
respective groups (including all risk factors of each individual in the
respective risk group). Each color represents a particular risk (same
legend for d–g and j–k); χ2 test (two-sided). b Brief presentation of the
violent aggression severity score, VASS, ranging from no documented
aggression to lethal consequences of violent aggression with relative
weight given to severity of aggression and number of registered re-
occurrences. c Highly significant intercorrelation of violent aggression
measures used in the present paper. d Application of VASS to risk
accumulation in the discovery sample; Kruskal-Wallis-H test (two-
sided). e–g Schizophrenia replication cohorts I–III: ‘stair pattern’ of
aggression proxy in risk accumulation groups; all χ2 test (one-sided). h
Comparative presentation of subjects (%) with violent aggression in
risk accumulation groups across schizophrenia cohorts. i Comparative
presentation of subjects (%) with violent aggression before (pre-
morbid, ‘early’) or after schizophrenia onset (‘late’) vs. individuals
without evidence of aggression (‘no’) in risk accumulation groups of
the discovery sample. j–k General population replication cohorts IV
and V: ‘stair pattern’ of aggression proxies, LSRP secondary psy-
chopathy score (j) and aggression-hostility factor of ZKPQ-50-CC (k)
in risk accumulation groups; Kruskal-Wallis-H test (one-sided). l
HDAC1 mRNA levels in PBMC of male extreme group subjects as
available for analysis; Student’s t test (one-sided)
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(Fig. 1b). Information for VASS was extracted for all dis-
covery individuals (N= 134) from detailed history, avail-
able in the GRAS database [19, 20], and additional
extensive chart study based on original medical documents
over lifetime. VASS ranges from no documented aggression
to lethal consequences of violent aggression. Relative
weight is given to severity of aggression and number of
registered re-occurrences. For first cross-validation of this
new tool, an intra-sample expert ranking of relative
aggression severity in the discovery sample was performed
by 2 independent psychologists (unaware of environmental
risk status of subjects under study), yielding Spearman’s
rho= 0.97 for interrater reliability and rho= 0.96 for
intercorrelation with VASS (Fig. 1c). Inspection of VASS
values in the discovery sample upon risk accumulation
again demonstrates the ‘stair pattern’ (Fig. 1d).
Since not all information was available as detailed for the
schizophrenia replication samples of GRAS-I and -II as for
the discovery sample, we introduced a dichotomous
aggression proxy, including history of forensic hospitali-
zation and/or conviction for battery, sexual assault, man-
slaughter or murder (at least once in lifetime).
Intercorrelation with VASS and expert ranking, respectively,
resulted in rpb= 0.63 (point-biserial) and rrb= 0.62 (rank-
biserial) (Fig. 1c). Applying this proxy to replication sam-
ples I-III (GRAS-I males without discovery sample, GRAS-
II males, GRAS-I&II females), consistently yielded the
‘stair pattern’ upon risk accumulation, even though at
slightly lower level in females (Fig. 1e–g). The percentage
of subjects with documented aggression increases with the
number of risk factors, strikingly similar in all schizo-
phrenia cohorts (Fig. 1h). Important for future preventive
measures in at-risk subjects is the observation that a single
risk factor (independent of its kind) is still compensated for
(Fig. 1h). When comparing subjects with 0 vs. ≥3 envir-
onmental factors over all schizophrenia samples, the odds
ratio for violent aggression (based on aggression proxy)
amounts to 10.5. Details on sociodemographic and disease-
related variables, as well as on the various highly inter-
correlating measures of violent aggression in the environ-
mental risk accumulation groups in discovery and
replication samples are given in Tables 1 and 2. Whereas no
consistent differences in premorbid intelligence, present
cognition (cognitive composite), and chlorpromazine
equivalents (relative amount of antipsychotics) emerge
among groups, age tends to be lower and suicidality to
occur more frequently with increasing pre-adult environ-
mental risk exposure in the schizophrenia cohorts, which is
not unexpected considering our previous report [18]
(Table 1). A remarkable increase in all available measures
of violent aggression becomes obvious upon accumulation
of environmental risk (final model consisting of urbanicity,
migration, physical and sexual abuse, alcohol and
cannabis), reflected by highly significant p values in group
and trend statistics throughout samples (Table 2).
For analyzing onset of aggressive behavior, the extensive
information on aggression available in the discovery sample
was exploited. Early aggression (any aggression docu-
mented before age 18 years and well before schizophrenia
onset) clearly increased upon ≥2 risk factors, whereas
aggression seen only later in life seemed independent of
early environmental risk (Fig. 1i). Therefore, we hypothe-
sized that violent aggression upon risk accumulation may be
unrelated to mental disease.
To test this hypothesis, we had the chance to analyze 2
well-characterized independent samples (replication IV and
V; Tables 1 and 2) of young individuals from the Spanish
general population. Since data on criminal conduct could
not be obtained in these cohorts, we had to use alternative,
psychometrically validated instruments as aggression
proxies, namely LSRP secondary psychopathy score [26],
measuring rule-breaking and lack of effort towards socially
rewarded behavior, and the aggression-hostility factor of
ZKPQ-50-CC [27]. Urbanicity as risk factor was unavail-
able in these samples (reducing the model to 5 of the 6 risk
factors explored in schizophrenia, that is migration, physical
maltreatment, sexual abuse, alcohol and cannabis). We also
note that subjects were younger and as academics probably
higher educated as compared to the disease cohorts. Despite
these mitigating facts, and despite employing individuals of
another country, the expected ‘stair pattern’ still emerged
clearly for both proxies, likely suggesting generalizability of
these findings (Fig. 1j,k; Tables 1 and 2). Data given here
for the general population samples (replications IV and V)
are based on both males and females. In addition, evaluating
men and women separately (taking both general population
cohorts together) yielded significant results for both genders
(Table 2 bottom).
Addressing the composition of risk factors among groups
across cohorts, we obtained a comparable pattern through-
out schizophrenia samples (stacked-charts; Fig. 1a,d-g). In
the general population subjects, particularly alcohol and
cannabis consumption (classified as ‘secondary hits’) pre-
dominated (Fig. 1j,k) which also seem to play an appreci-
able role in schizophrenia cohorts. Therefore, we wondered
whether separate analysis of risk accumulation, integrating
only primary vs. only secondary hits, would still result in
significant effects on aggression. For all schizophrenia
samples individually, group difference and trend remained
highly significant (not shown). Taking all schizophrenia
subjects together (N > 1200), the aggression proxy yields
for the accumulation model, built on primary risks only
(urbanicity, migration, physical and sexual abuse), p=
4.5 × 10−17 (χ2= 75.28) and p < 2.2 × 10−16 (χ2= 68.28),
for group differences and trend, respectively. The corre-
sponding results for secondary risk factors (alcohol,
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Table 1 Presentation of environmental risk groups in discovery and replication samples: sociodemographic and disease-related measures
No risk factors 1 risk factor 2 risk factors ≥3 risk factors p value (H/χ2)
Discovery samplea (N= 121–134)
Male schizophrenic subjects n= 30–33 n= 32–36 n= 24–26 n= 35–39
Age (years)b 33.09 (10.24) 35.68 (11.23) 31.47 (8.27) 32.46 (8.66) p= 0.630 (H= 1.73)
Premorbid intelligence MWT-Bc 103.23 (16.57) 101.09 (11.80) 104.48 (14.36) 97.42 (14.91) p= 0.172 (H= 5.00)
Cognitive composite scored −0.05 (1.13) −0.49 (1.07) 0.22 (0.72) 0.03 (1.00) p= 0.651 (H= 1.64)
Chlorpromazine equivalents 751.09 (696.52) 771.87 (1227.51) 674.28 (508.49) 648.83 (569.38) p= 0.769 (H= 1.13)
Suicidalitye 11 (33.3%) 8 (23.5%) 9 (34.6%) 14 (36.8%) p= 0.651 (χ2= 1.64)
Replication sample I (N= 392–411)
GRAS I male schizophrenic subjects n= 91–98 n= 156–166 n= 91–92 n= 53–59
Age (years)b 46.94 (12.26) 39.65 (12.50) 34.51 (10.18) 32.85 (8.38) p= 1.6 x 10−5 (H= 24.87)
Premorbid intelligence MWT-Bc 105.35 (17.09) 103.32 (15.87) 101.00 (14.26) 99.23 (15.10) p= 0.085 (H= 6.61)
Cognitive composite scored 0.15 (1.12) 0.75 (1.01) 0.10 (0.93) −0.01 (0.89) p= 0.873 (H= 0.70)
Chlorpromazine equivalents 611.92 (571.29) 703.38 (585.70) 686.03 (608.01) 836.07 (622.14) p= 0.059 (H= 7.43)
Suicidalitye 23 (24.2%) 57 (34.5%) 33 (36.6%) 33 (55.9%) p= 0.001 (χ2= 16.11)
Replication sample II (N= 238–290)
GRAS II male schizophrenic subjects n= 36–46 n= 68–84 n= 67–82 n= 67–78
Age (years)b 45.57 (15.02) 42.17 (13.83) 38.50 (14.08) 35.75 (10.52) p= 0.011 (H= 11.20)
Premorbid intelligence MWT-Bc 98.09 (14.46) 102.29 (16.03) 100.48 (13.36) 96.39 (9.29) p= 0.184 (H= 4.84)
Cognitive composite scored −0.23 (1.24) −0.08 (1.03) −0.01 (0.84) −0.08 (0.96) p= 0.816 (H= 0.94)
Chlorpromazine equivalents 629.15 (513.31) 747.35 (629.02) 689.31 (717.18) 713.84 (532.66) p= 0.629 (H= 1.74)
Suicidalitye 8 (20.5%) 12 (14.6%) 25 (31.6%) 25 (34.2%) p= 0.018 (χ2= 10.08)
Replication sample III (N= 345–386)
GRAS I-II female schizophrenic subjects n= 125–140 n= 118–130 n= 65–71 n= 37–43
Age (years)b 43.44 (11.75) 46.67 (12.90) 40.84 (12.71) 36.53 (11.31) p= 0.003 (H= 13.83)
Premorbid intelligence MWT-Bc 103.53 (14.19) 104.04 (14.28) 102.96 (15.84) 99.10 (15.41) p= 0.147 (H= 5.37)
Cognitive composite scored 0.03 (0.96) 0.09 (0.99) 0.24 (0.99) −0.21 (1.00) p= 0.164 (H= 5.11)
Chlorpromazine equivalents 536.52 (579.61) 564.04 (506.21) 620.48 (628.30) 650.87 (477.23) p= 0.167 (H= 5.07)
Suicidalitye 45 (33.6%) 59 (46.5%) 33 (46.5%) 22 (53.7%) p= 0.052 (χ2= 7.72)
Replication sample IV (N= 299)
General population n= 39 n= 83 n= 133 n= 44
Age (years) 26.44 (4.81) 25.93 (2.46) 25.56 (3.50) 25.25 (3.64) p= 0.117 (H= 5.89)
Gender, female/male (% male) 29/10 (25.6%) 51/32 (38.6%) 78/55 (41.4%) 18/26 (59.1%)
Replication sample V (N= 177–183)
General population n= 13 n= 54–56 n= 86–89 n= 24–25
Age (years) 20.54 (0.88) 20.63 (0.98) 20.85 (1.12) 20.88 (1.15) p= 0.696 (H= 1.44)
Gender, female/male (% male) 7/6 (46.2%) 41/15 (26.8%) 56/33 (37.1%) 20/5 (20.0%)
Data are uncorrected means (SD) or n (%); for statistical analysis, Kruskal-Wallis-H, χ2, or Fisher’s exact test was used, all p values two-sided;
Bonferroni-corrected p values <0.01 are considered significant and underlined; because of missing data, sample sizes vary;
anote regarding discovery sample: extreme groups of our previous study [18] differ slightly due to elimination of birth complications and
neurotrauma, but inclusion of alcohol in the present study;
bcorrected for age at disease onset;
cMWT-B=Mehrfachwahl-Wortschatz-Intelligenztest-B;
dcognitive composite score consists of reasoning (Leistungsprüfsystem-subtest-3), executive function (Trail-Making Test B), verbal learning &
memory test (VLMT) [18]; corrected for age, PANSS negative score, and chlorpromazine equivalents (standardized residuals after linear
regression);
esuicidality=individuals with past suicide attempts
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cannabis) in schizophrenia are p= 6.6 × 10−19 (χ2= 83.71)
and p < 2.2 × 10−16 (χ2= 83.40). Analogously, taking all
general population subjects together (N > 530), we obtain
for LSRP with primary risks (urbanicity not available) p=
0.002 (H= 12.65) and p= 0.0003 (J= 33774.5), and with
secondary risks p= 1.3 × 10−4 (H= 17.92) and p= 5.3 ×
10−5 (J= 42412.5) for group differences and trend. Also
here, significance was already reached with separate ana-
lysis of both cohorts (not shown).
For deciding on the accumulation model, we had initially
screened all individual risk factors of our ‘primary plus
secondary risk factor model’ separately in both schizo-
phrenia and general population cohorts to get an estimation
of their relative impact (Tables 3a,3b,3c). Perinatal com-
plications and neurotrauma before the age of 18 years were
unavailable for general population subjects. Since these
risks showed the lowest overall impact on aggression
proxies in schizophrenia, we decided not to include them in
our present accumulation model.
Finally, we performed an epigenome-wide association
scan to detect differential methylation of blood-derived
DNA of selected extreme group individuals (discovery
sample; N= 134; Fig. 1a), originally planned as epigenetic
follow-up study [18]. This scan turned out to be negative. In
fact, contrasting subjects either with high vs. low number of
environmental hits or according to VASS median split
yielded a single methylation difference upon lowering the
Bonferroni threshold to 10−6 (Table 4). Similarly, when
looking in an exploratory fashion (small/unbalanced group
sizes) at individual risk factors separately, results were
essentially negative (Table 4). Hits associated with migra-
tion were likely related to ethnicity rather than environ-
mental risk, as reported recently [31]. The power of our
sample size - even though in the range of suggestions [32]
and despite extreme group comparison - may not have been
sufficient to detect differences, also due to a vast underlying
heterogeneity of individual methylation sites. Even the
search for methylation differences of aggression-related
candidate genes [33–35] turned out negative (not shown),
putting the relative weight of phenotypical consequences
(here violent aggression) vs. common methylation results in
humans into perspective. In contrast, determining HDAC1
mRNA levels in PBMC available from male extreme group
subjects (≤1 vs. ≥3 risks) revealed a highly significant dif-
ference (p= 0.001), with higher levels in the high-risk (N
= 33) compared to the low-risk group (N= 109) (Fig. 1l).
This transcript encodes an enzyme of the histone deacety-
lase complex which serves as an overarching regulator of
epigenetic processes. Indeed, peripheral HDAC1 mRNA
levels seem to be a more robust readout of epigenetic
modifications in small sample sizes [36] as compared to
specific methylation sites in the epigenome-wide associa-
tion scan, and suggest lasting epigenetic alterations.
Discussion
The present work was initiated based on the observation in a
schizophrenia cohort that accumulation of environmental
risk factors before adulthood promotes the likelihood of
later forensic hospitalization, interpreted as indicator of
violent aggression. This interpretation and the effect of risk
accumulation were consolidated using direct scoring of
aggression over lifetime or, as aggression proxies, forensic
hospitalization and conviction for battery, sexual assault,
manslaughter or murder, or respective psychopathology
measures in 4 independent schizophrenia cohorts and 2
general population samples. Importantly, our data support
the concept of a disease-independent development of vio-
lent aggression in subjects exposed to multiple pre-adult
environmental risk factors.
Whereas a vast amount of literature on single environ-
mental risk factors reports consequences for abnormal
behavior and mental illness, publications on pre-adult risk
accumulation are scarce and mostly based on closely
interrelated social/familial risk factors. Also, risk and con-
sequence are often not clearly defined. Studies including
larger, comprehensively characterized datasets and replica-
tion samples do not exist. The present work is the first to
provide sound evidence, based on 6 separate cohorts, of a
disease-independent relationship between accumulation of
multifaceted pre-adult environmental hits and violent
aggression. The overall societal damage is enormous, and
we note that mentally ill individuals who re-enter the
community from prison are even more at risk for unem-
ployment, homelessness, and criminal recidivism [37].
These results should encourage better precautionary mea-
sures, including intensified research on protective factors
which is still underrepresented [2, 38–40].
In the psychosociological literature, the so-called exter-
nalizing behavior in childhood includes hostile and
aggressive physical behavior toward others, impulsivity,
hyperactivity, and noncompliance with limit-setting
[41, 42]. The respective risk factors are all highly plau-
sible, yet often theoretical, and derived from 4 broad
domains: child risk factors (e.g., adverse temperament,
genetic and gender risk), sociocultural risks (e.g., poverty,
stressful life events), parenting and caregiving (e.g., conflict
and violence at home, physical abuse), and children’s peer
experiences (e.g., instable relationships, social rejection). A
full model of the development of conduct problems has
been suggested to include at least these 4 domains [41, 43,
44]. The risk factors analyzed in the present study are
perhaps somewhat clearer defined but partially related to
and overlapping across these domains. Urbanicity, migra-
tion, cannabis and alcohol reflect sociocultural input but
also peer experience, and physical or sexual abuse belong to
the parenting/caregiver aspect.
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Certainly, there are many more, still undiscovered risk
and numerous protective factors, potentially explaining why
‘only’ 40–50% of high-risk individuals in our schizophrenia
samples fulfill criteria of violent aggression. We note that
this study does not include genetic data analysis or cor-
rection for any genetic impact. The genetic influence on
aggression, however, may be of considerable relevance for
the individual [45–49], even though highly heterogeneous
as for essentially all behavioral traits. Heritability of
aggression, estimated from twin studies, reaches > 60%
[50, 51]. In fact, 50% of individuals with violent aggression
upon pre-adult risk accumulation in the present study
means another 50% without detectable aggression. This
consistent finding across samples likely indicates that
genetic predisposition is prerequisite for whichever beha-
vioral consequence. Individuals without genetic predis-
position and/or with more protective factors (genetic and
environmental) may not react with violent aggression to
accumulated environmental risk. Importantly, the obvious
gender effect may be a matter of degree rather than of
pattern. In fact, the etiology of externalizing behavior pro-
blems is similar for girls and boys [41, 52], as is the con-
sequence of risk accumulation in the present study for males
and females.
The risk factors of the sociological domains seem to be
stable predictors over time, to some degree interchangeable,
pointing to many pathways leading to the same outcome
(principle of equifinality) [41]. The interchangeability is
highly interesting also with respect to potential biological
mechanisms. It appears that any of the here investigated hits
alone, independent of its kind, can be compensated for but
that higher risk load increases the probability of violent
aggression. Also for that reason, we are weighing risk fators
equally in the present study. This could theoretically create
some bias. However, to be able to estimate the true effect
size of each specific factor separately on violent aggression
and subsequently weigh all factors in a more proper way,
much larger samples sizes would be needed that are pre-
sently not available anywhere in the world.
In contrast to the marginal influence of genome-wide
association data on mental disease in GRAS [18, 53], the
accumulated environmental impact on development of
violent aggression is huge, reflected by odds ratios of > 10.
When striking at a vulnerable time of brain development,
namely around/before puberty, the environmental input may
‘non-specifically’ affect any predisposed individual. The
hypothetical biological mechanisms underlying this accu-
mulation effect in humans may range from alterations in
neuroendocrine and neurotransmitter systems, neuronal/
synaptic plasticity and neurogenesis to changes in the
adaptive immune system and interference with develop-
mental myelination, affecting brain connectivity and net-
work function [9, 10, 54, 55].
Our approach to detect methylation changes in blood
using an epigenome-wide association scan was unsuccess-
ful despite matched extreme group comparison, likely due
to the small sample size (although in the suggested range
[32]), and perhaps the etiological/pathogenetic complexity
of accumulated risks. Changes in brain, not accessible here
for analysis, can certainly not be excluded. Interestingly,
however, HDAC1 mRNA levels in PBMC of male extreme
group subjects were increased in the high-risk compared to
the low-risk group. This finding confirms peripheral
HDAC1 mRNA levels as a more robust readout of epige-
netic alterations in relatively small sample sizes [36], as
compared to specific methylation sites in epigenome-wide
association scans or even in candidate genes. To gain fur-
ther mechanistic insight and thereby develop - in addition to
prevention measures - novel individualized treatment con-
cepts [36], animal studies modeling risk accumulation seem
unavoidable.
To conclude, this study should motivate sociopolitical
actions, aiming at identifying individuals-at-risk and
improving precautionary measures. Effective violence pre-
vention strategies start early and include family-focused and
school-based programs [2, 16, 38]. Additional risk factors,
interchangeable in their long-term consequences, like
urbanicity, migration, and substance abuse, should be
increasingly considered. Health care providers are essential
for all of these prevention concepts. More research on
protective factors and resilience should be launched. Ani-
mal studies need to be supported that model risk accumu-
lation for mechanistic insight into brain alterations leading
to aggression, and for developing new treatment approa-
ches, also those targeting reversal of epigenetic alterations.
As a novel concept, scientific efforts on ‘phenotyping of the
environment’ [11] should be promoted to achieve more
fundamental risk estimation and more effective prevention
in the future.
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4 PROJECT II: VASCULAR RESPONSE TO SOCIAL
COGNITIVE PERFORMANCE MEASURED BY INFRARED
THERMOGRAPHY: A TRANSLATIONAL STUDY FROM
MOUSE TO MAN
4.1 Overview of project II
Physiological measurements play an important role in psychological and neuroscientific
research. Recently, advances in the field of infrared thermography (IRT) resulted in in-
creased implementation attempts of this technology in studies investigating stress and
arousal (Ermatinger et al., 2019; Gjendal et al., 2018; Herborn et al., 2018; Ioannou et al.,
2014). Modern IRT is characterized by both high spatial and temporal resolution (Cardone
& Merla, 2017; Ioannou et al., 2014; Jarlier et al., 2011) and, due to its non-invasive and
contact-free application method, can be employed where other ’conventional’ techniques
reach their limits (Ermatinger et al., 2019; Ioannou et al., 2014). However, various IRT stud-
ies suffer from diverse weaknesses, due to small and heterogeneous samples, insufficient
control of the many environmental and personal confounding factors (Fernández-Cuevas
et al., 2015), or suboptimal data extraction methods (Ioannou et al., 2014). Consequently,
this leads to inconsistencies in findings (Ermatinger et al., 2019), limiting explanatory
power.
This project seeks to enhance our knowledge of modern IRT technology and its potential
in the assessment of stress, both in mice and men. We developed novel approaches to
explore alterations in body surface temperature at defined regions of interest as readout of
autonomous activity. Importantly, we took great effort to avoid the numerous pitfalls that
typically occur in experimental IRT research (Cardone & Merla, 2017; Fernández-Cuevas
et al., 2015; Ioannou et al., 2014). This way, we intended to enhance the quality of collected
data and analyses, ensuring robust study conclusions.
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The starting point of this work was the rather unexpected observation that mice exhibited
abnormal social behavior during a modified Y-maze sociability test (Brimberg et al., 2016;
Lai & Johnston, 2002) four weeks after completing the SocioBox test of complex social
recognition (Krueger-Burg et al., 2016). Intrigued by that finding we conducted more
experiments, using mice, separated by sex, under two different conditions. While the
experimental groups underwent the normal SocioBox paradigm, control groups stayed
in the empty box. Four weeks afterward, all mice performed the Y-maze sociability test.
As we were wondering whether groups differ regarding their autonomous activity, in
addition to potentially distinct sociability behavior, we recorded body surface temperature
via IRT. As hypothesized, experimental mice, in contrast to control animals, exhibited
higher central body, compared to tail, temperatures over the course of the SocioBox exper-
iment. Further, during the experimental test condition, thermal readouts were negatively
associated with time spent interacting with the unfamiliar stimulus mouse, indicating
that increased physiological arousal, as determined via IRT, interferes with recognition
abilities.
In accordance with our initial findings, the Y-maze sociability test revealed both differ-
ent behavioral as well as thermal readouts between experimental and control animals:
While control mice showed a high motivation to interact with an unfamiliar conspecific,
compared to a lifeless object, experimental group mice demonstrated a reduced social
engagement. Moreover, experimental mice displayed higher body, compared to tail, tem-
peratures. The evaluation of a possible relationship between thermal readouts during
SocioBox and sociability during Y-maze showed that experimental mice with a higher
thermal centralization during SocioBox spent less time interacting with a conspecific. Our
findings suggest that the amount of physiological arousal experienced during the SocioBox
is associated with a reduced motivation for social engagement, possibly inducing social
avoidance behavior, which is maintained for at least four weeks.
In order to clarify whether the SocioBox is associated with overall behavioral changes, after
the Y-maze sociability test all mice performed a paradigm of novelty-induced freezing.
Importantly, comparisons in the degree of freezing behavior over time uncovered similar
patterns between experimental and control mice. Based on these findings, we assume
that the SocioBox is not only a promising instrument to assess complex social recognition
memory in mice, it also seems to have a negative effect on social interaction behavior,
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indicating a potential value as a novel model of isolated social anxiety (Toth & Neumann,
2013). IRT can be used to reliably record body temperature as an additional readout of
physiological arousal, not revealed by conventional behavioral tests alone.
Subsequently, we evaluated the applicability of IRT in a human study, translating our
findings from mice to man. Therefore, we created the Face Recognition Test (FRT), a social
memory task using neutral male faces as stimuli (Kulke, Janßen, Demel, & Schacht, 2017),
that resembles, in its design, the SocioBox paradigm. We then employed IRT to explore
temperature alterations between the FRT and the Wisconsin Card Sorting Test (WCST), a
widely used test of executive functioning that employs abstract symbols (Heaton, Chelune,
Talley, Kay, & Curtiss, 2003), in a homogenous group of healthy men. In order to acquire
solid data, novel approaches of automated extraction were employed. The analyses of
thermal alterations over time in defined areas of the face revealed that the majority of
participants showed a characteristic thermal pattern during the FRT but not in the WCST.
Interestingly, salivary cortisol level changes were not different between the two tests and
correlated rather mildly with thermal values. This suggests that IRT provides higher
sensitivity than an established readout of physiological stress (Engert et al., 2014), at least
within the context of the conducted social experiment.
4.2 Original publication
Seidel, J.*, Bockhop, F.*, Mitkovski, M.*, Martin, S., Ronnenberg, A., Krueger-Burg, D.,
Schneider, K., Röhse, H., Wüstefeld, L., Cosi, F., Bröking, K., Schacht, A., Ehrenreich, H.
(2020). Vascular response to social cognitive performance measured by infrared thermog-
raphy: A translational study from mouse to man. FASEB BioAdvances, 2, 18-32.
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Abstract
To assess complex social recognition in mice, we previously developed the SocioBox 
paradigm. Unexpectedly, 4 weeks after performing in the SocioBox, mice displayed 
robust social avoidance during Y-maze sociability testing. This unique “sociophobia” 
acquisition could be documented in independent cohorts. We therefore employed in-
frared thermography as a non-invasive method of stress-monitoring during SocioBox 
testing (presentation of five other mice) versus empty box. A higher Centralization 
Index (body/tail temperature) in the SocioBox correlated negatively with social rec-
ognition memory and, after 4 weeks, with social preference in the Y-maze. Assuming 
that social stimuli might be associated with characteristic thermo-responses, we ex-
posed healthy men (N = 103) with a comparably high intelligence level to a standard-
ized test session including two cognitive tests with or without social component (face 
versus pattern recognition). In some analogy to the Centralization Index (within-
subject measure) used in mice, the Reference Index (ratio nose/malar cheek tem-
perature) was introduced to determine the autonomic facial response/flushing during 
social recognition testing. Whereas cognitive performance and salivary cortisol were 
comparable across human subjects and tests, the Face Recognition Test was associ-
ated with a characteristic Reference Index profile. Infrared thermography may have 
potential for discriminating disturbed social behaviors.
K E Y W O R D S
flushing, IRT, social stimulus, stress, temperature, vasoactivity
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1 |  INTRODUCTION
An association of emotions during unaccustomed social in-
teractions with facial flushing in humans has long been rec-
ognized.1-3 The autonomic nervous system response during 
such social interactions—highly conserved across mammals 
and perceived like “stress”—leads to altered vasoactivity in 
peripheral and core body regions. The resulting blood flow 
changes via vasoconstriction and vasodilation, respectively, 
affect local body temperature.4-10 Exposure to an embarrass-
ment task, for instance, led to an increase in facial blood flow 
in both male and female participants, measured via Laser 
Doppler Flowmetry.11 Using this technique, temperature 
changes upon sympathetic vasoconstriction, occurring with 
a delay of 5-15 s,12-14 can be reliably detected. Negative as 
well as positive social stimuli provoke alterations in surface 
temperature of various facial areas, with the nose consistently 
reported as highly reactive to affective and social cues.12,15-18
These observations advocate infrared thermography (IRT) 
as a highly attractive method of contact-free and non-invasive 
measurement of naturally emitted electromagnetic radiation 
with a wavelength between 0.75-1000 µm, commonly inter-
preted as “heat”.19 Modern IRT recording systems are char-
acterized by high spatial and temporal resolutions and require 
almost no restrictions in movement of test subjects, allowing 
a more natural/ecological testing environment.9,15,20 Because 
of its high accuracy, relative ease of use, and minimal incon-
venience for the subjects, IRT has already been implemented 
in different fields of medical research and practice.19,21
While the validity of IRT for assessing surface tempera-
ture is generally accepted and has led to several pivotal pub-
lications,4,6,7,16,22-28 its broader applicability in the future will 
depend on controlling environmental, subject-related, and 
technological factors29 as well as improved reliability and re-
producibility. So far, no overall accepted, dependable state-of-
the-art procedure for IRT testing in social behavior diagnostics 
has been introduced. Numerous different experimental designs, 
test stimuli, facial/body target regions, and data extraction/
analysis procedures have been reported.9,21 Often, single or 
short series of IRT images (before versus after experimental 
condition) are described, based on rather small and heteroge-
neous samples, whereas data on thermal dynamics over longer 
time intervals are scarce. Interpretation of thermal alterations 
is frequently limited to single directional statements, for in-
stance increase or decrease or unaltered temperature.
In the present translational study, we employ and adapt 
IRT for more reliable, internally controlled measurement of 
a social stimulus-related autonomic vaso-response. We start 
with an unexpected discovery in mice, namely induction of 
“sociophobia” upon inescapable interaction in a social rec-
ognition test, where the Centralization Index (ratio body/
tail temperature) serves as continuous “whole body stress 
readout”. We then extend these findings to human subjects, 
exposed to social versus non-social cognitive tasks in a 
highly standardized fashion. Here, the Reference Index (ratio 
nose/malar cheek temperature) is introduced to determine the 
autonomic facial response/flushing during social recognition 
testing. We report a novel non-invasive “sociophobia” model 
in mice, characterized by a pronounced thermo-reaction 
during induction and on retrieval, and a typical facial ther-
mo-response in men under cognitive challenge containing a 
social component.
2 |  MATERIALS AND METHODS
2.1 | Mouse studies
2.1.1 | Mice
All experiments were approved by and conducted in ac-
cordance with the regulations of the local Animal Care 
and Use Committee (Niedersächsisches Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit, LAVES). 
C57BL/6JRj mice were used as experimental mice, C3H/
HeNCrl as stimulus mice (Charles River). Animals were 
group-housed in standard cages (36.5 × 20.7 × 14 cm, 4-5 
mice per cage of the same gender and strain), in rooms sepa-
rated by gender and strain (to avoid olfactory contact), and 
kept on a 12 h light-dark cycle (lights off at 7 pm) at 20-22°C. 
Food and water were provided ad libitum.
2.1.2 | SocioBox test for complex social 
recognition memory and recording
A detailed description of the SocioBox as a multiple social 
recognition task is provided elsewhere30 (see also Figure 1). 
Experiments were conducted during light phase of the day 
(10-15 lux, 23.5°C room temperature), with male or female 
C57BL/6JRj experimental mice (N = 45 in total) and gender-
matched C3H/HeNCrl as stimulus mice (Figure 1A). Male 
mice were 13-15, female 20-22 weeks old. Prior to test ses-
sion, experimental and stimulus mice had been habituated 
separately (in absence of any other mice) to the SocioBox for 
3 consecutive days. The following test sessions consisted of 
three phases, namely exposure 1, exposure 2, and recognition 
test.30 At beginning of test session, the experimental mouse 
was placed into the central arena inside a white Plexiglas cir-
cular partition, spatially and visually separated from stimulus 
mice. After 5  minutes of recovery (“Initiation stage”), the 
circular partition was lifted, and the mouse allowed to freely 
explore the arena, including the stimulus mice in their inserts, 
for 5 additional minutes (“Interaction stage”). At the end of 
exposure 1, the mouse was removed and placed back in its 
transport cage. The arena was cleaned and the mouse then 
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again placed in the SocioBox center. Exposure 2 followed the 
same procedure. At the end of exposure 2, one of the five 
stimulus mice was randomly exchanged for a new, unfamil-
iar conspecific. Next, the mouse was reintroduced and the 
recognition test conducted accordingly. During the course of 
the experiment, a black body-calibrated A655sc IRT camera 
with a 13.1 mm focal length lens was used. The system has 
a noise equivalent thermal difference (NETD) <30 mK and 
resolution of 640 × 480 pixels (FLIR ResearchIR Max soft-
ware v4.40.2.1, TOPA, Hohenpeissenberg, Germany) and 
was mounted 110 cm above the arena, recording at a frame-
rate of 25 Hz. Care was taken that no direct or indirect heat 
F I G U R E  1  Mouse IRT study: SocioBox recognition testing induces lasting social avoidance in mice. A, SocioBox arena30 with experimental 
mouse in center (gray), unfamiliar “stranger” (“Test”) and familiar stimulus mice (all brown). Time spent in zones close to each stimulus mouse 
(circles) is recorded to determine interaction/recognition. B, Y-maze sociability test:31 Test mouse starts in center of Y-maze with one arm empty, 
one containing an object and the third another mouse (C3H). Time spent in each arm is measured. A normal naïve mouse spends most of the time 
with the other mouse (stair pattern of controls in panel K and L). C, Unexpectedly, 4 weeks after SocioBox testing, experimental mice display 
social avoidance behavior in 2 independent samples: Discovery I and II; repeated-measure ANOVA; quadratic-trend analysis (below; italics). D, 
IRT image of SocioBox test with experimental mouse (arrowhead) and stimulus mice (asterisks); white arrow: experimental mouse left trace of 
urine (evaporation cooling). Magnification on the right illustrates temperature differences in body parts. Compare video S1. E, Zone preference of 
male mice during SocioBox recognition testing. Mice with normal recognition memory spend most time with the “stranger” (unfamiliar stimulus 
mouse). F, Control mice tested in empty SocioBox do not show appreciable zone preference; repeated-measure ANOVA. G, Average interaction 
time with all familiar mice versus time with unfamiliar mouse (stranger); paired Student's t tests (one-sided). H, Both genders exhibit in SocioBox 
an increase in Centralization Index (body/tail temperature), compared to controls in empty box; unpaired Student's t tests (two-sided). Note that 
due to difficulties in tracking tail ROI (≥25% missing values), 3 animals (1 male, 2 female controls) had to be excluded from thermal analyses. I, 
Centralization Index is negatively correlated with social recognition performance; Spearman's rho (one-sided). J, Representative IRT image during 
Y-maze sociability. K-L, Both genders show robust social avoidance 4 weeks after SocioBox compared to the expected stair pattern of control 
animals; repeated-measure ANOVA; quadratic-trend analysis (below; italics). Due to atypical hypoactive behavior during testing, two female 
control animals were excluded prior to analyses. M, Social aversion priming: Negative correlation between Centralization Index in SocioBox and 
time spent with C3H conspecific in Y-maze 4 weeks later; Spearman's rho (one-sided)
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emissions from external sources affected recordings. The 
IRT camera was connected to a computer located in a sepa-
rate room. Readouts were temperature changes of the mouse, 
duration of interaction with stimulus mice/recognition of the 
stranger mouse, and distance traveled (video S1). To ensure 
that sociability changes are not triggered by the SocioBox 
arena itself, the same procedure was conducted with control 
mice exposed to an empty SocioBox (without stimulus mice).
2.1.3 | Y-maze sociability testing  
and recording
Y-maze testing was performed as described with slight modi-
fications.31 Mice were tested 4 weeks after SocioBox/empty 
box performance on 2 consecutive days at light intensities 
of 60-70 lux. Day 1 included three habituation trials with an 
inter-trial-interval of 60 min. The mouse was placed in one of 
the arms and allowed to explore the empty maze for 10 min 
per trial. The starting point was rotated through all three arms 
(dimensions of each arm 46.1 × 8.3 × 13.7 cm). On day 2, an 
object (6 cm chess piece) and a C3H-stranger mouse, same 
gender and age, were each presented in an insert, preventing 
direct access, and positioned at the end of two randomly cho-
sen Y-maze arms while the third arm remained empty (Figure 
1B). The mouse was then placed in the empty arm, facing the 
center, and allowed to explore freely for 10 minutes. All mice 
underwent the same test procedure. The IRT camera was po-
sitioned 130 cm above the maze, readouts were changes in 
temperature, distance traveled and, to estimate social prefer-
ence, time spent in each arm (Figure 1J).
2.1.4 | Data extraction and preprocessing
Mouse location and stress readouts during SocioBox recogni-
tion and Y-maze sociability tests were assessed through an 
image analysis workflow implementing the software pack-
ages Ilastik v.1.3.3b232 and FIJI,33 as well as the TrackMate34 
FIJI plugin. Thermal readouts of both, body and tail, were 
extracted by first using the pixel classification workflow 
of Ilastik. Pixel groups delineating “background”, “body”, 
and “tail” were annotated to train a Random Forest classi-
fier32 that was used to produce probabilities for the respec-
tive classes for each image sequence of the recorded mice. 
Resulting body and tail probabilities were binarized with 
FIJI to generate masks, which were then applied to the corre-
sponding, original IRT image sequence as regions of interest 
(ROI), from which the relative mean body and tail tempera-
tures were obtained.
For the SocioBox, five zones were defined in close prox-
imity to each stimulus mouse/empty inset (Figure 1A). 
Number of frames the respective mouse spent in each zone 
was summed up to obtain total interaction time with stimulus 
mice. Interaction with stranger (unfamiliar mouse) served as 
readout of social recognition.30 To exclude zone preferences 
not attributable to experimental setup (eg, room features) 
during empty SocioBox condition, control mouse zone orien-
tations were randomly matched to experimental mouse zones. 
A similar procedure was employed during Y-maze sociability, 
counting number of frames in each arm (empty, object, C3H).
After down-sampling (1 Hz) to increase computational 
speed during following preprocessing steps, frames with miss-
ing information (eg, hidden tail) were replaced by the mean 
of the remaining data points for each mouse. Mice with ≥25% 
missing values were excluded from respective thermographic 
analysis. To reduce random noise effects we smoothed data 
sequences of both body and tail separately, using locally esti-
mated scatterplot smoothing (LOESS). By dividing the rela-
tive mean temperature of the body ROI by its corresponding 
tail ROI relative mean temperature at each time point, we 
created an intraindividually adjusted measure of endogenous 
arousal: the Centralization Index. To evaluate whether poten-
tial thermal differences were independent of higher physical 
activity, we additionally calculated the distance mice traveled 
in 500 ms intervals for SocioBox and Y-maze.
2.2 | Statistical analyses
Both male and female experimental (SocioBox) versus control 
(empty box) mice were analyzed. To reduce the impact of ex-
treme values in statistical analyses while avoiding exclusion, 
data for each group (empty SocioBox, SocioBox with stimuli) 
were winsorized: extreme values <5th and >95th percentiles 
were set to 5th and 95th percentiles, respectively.35 Total time 
spent in SocioBox zones was analyzed using repeated meas-
ure analyses of variance (ANOVA).30 Additionally, for ex-
perimental groups, average time spent in zones with familiar 
mice was compared with time spent with stranger (unfamil-
iar zone). Due to expected outcome (more time spent with 
unfamiliar mouse),30 one-sided paired Student's t tests were 
calculated. Differences in mean Centralization Index and 
total distance traveled were compared between conditions via 
two-sided unpaired Student's t tests. Exploring the relation-
ship between Centralization Index as readout of physiological 
reactivity (stress) and recognition performance, Spearman's 
rho was calculated for all experimental mice. Because of ini-
tial orientation and adaption to the situation with potentially 
interfering effects on recognition performance, we used only 
the second half of SocioBox test (minutes 4-5). Hypothesizing 
that a higher Centralization Index is associated with worse 
performance, analysis was one-sided. For Y-maze sociability, 
differences in time spent in each arm was tested via repeated-
measure ANOVA with following linear and quadratic trend 
analyses using polynomial contrasts. Both differences in 
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mean Centralization Index and total sum of distances trave-
led were analyzed with two-sided unpaired Student's t tests. 
Hypothesizing that the Centralization Index in Y-maze cor-
relates negatively with sociability, one-sided Spearman's rho 
was calculated, including all test mice. Additionally, to inves-
tigate the relationship between severity of experience during 
SocioBox (assumed priming of social aversion) and sociability 
in Y-maze, we calculated Spearman's rho for Centralization 
Index in SocioBox and time spent in C3H-arm during Y-maze, 
again with test mice from all conditions. Expecting a negative 
correlation, a one-sided test was applied. All statistical analy-
ses were performed using R v3.5.236 with RStudio v1.1.463 
(RStudio Inc, Boston, United States) and significance level 
of alpha = 0.05. Welch-corrected Student's t tests were used, 
and, in cases of violations of sphericity, Greenhouse-Geisser 
corrections were applied to repeated-measure ANOVA.
2.3 | Human studies
2.3.1 | Participants
The study was conducted in accordance with the Declaration 
of Helsinki and approved by the ethics committee of the 
Georg-Elias-Müller-Institute of Psychology, University of 
Göttingen. Online screening was set up to attract and assess 
eligibility of potential participants. Besides providing demo-
graphic information and answering questions regarding their 
ability to identify and memorize faces, interested individuals 
completed the German versions of Brief Symptom Inventory 
(BSI)37 and complementary social phobia instruments Social 
Phobia Scale (SPS) and Social Interaction Anxiety Scale 
(SIAS)38. As additional readout of personality structure, 
NEO-Five-Factor Inventory (NEO-FFI)39 was filled out. 
Those with questionnaire scores within normal limits were 
invited to the experimental session, aiming to include only 
mentally healthy individuals without indication of (sub)clini-
cal symptoms. Based upon results of this online screening, 
a total number of N = 111 subjects were invited. However, 
due to psychiatric conditions, illicit substance consumption 
shortly before study onset, or technical difficulties during re-
cording, N = 8 had to be excluded, leaving a final sample of 
N = 103 participants (see Figure 2A for inclusion process). 
All subjects were heterosexual, native German men between 
18 and 34 years of age with normal or contact lens-corrected 
vision, no facial piercings or beard, and without history of 
neuropsychiatric or somatic diseases.
2.3.2 | Experimental procedure
To reduce impact of external factors during IRT re-
cordings9,15,29 participants were asked to avoid alcohol 
consumption (24 h), physical activity (12 h), and intake of 
food or activating substances (eg, caffeine, nicotine; 2 h) be-
fore test session (Figure 2 and Figure 3). Additionally, they 
were instructed not to shave or apply facial lotion at testing 
day. Study participation was compensated with 35€ or course 
credit. Completing the online screening offered the chance 
to win 1 of 3 gift cards (10€). All test subjects gave writ-
ten informed consent and could withdraw participation at 
any time. Main experiments took place in a 5 × 3 m2-sized 
testing room without direct sunlight or ventilation and with 
normal ambient temperature (M = 22.94°C, SD = 1.14) and 
humidity (M = 59.62%, SD = 7.34). Trained experimenters 
(JS, FB) ensured standardized test conditions during ses-
sions,29 which consisted of an initial assessment, habituation, 
two IRT-recorded computer tests of cognitive abilities, and a 
closing assessment (Figure 2B). Individual sessions consist-
ently started at either 09:00 am or 11:00 am, total test dura-
tion did not exceed 120 minutes. During initial assessment, 
the participant was welcomed and informed about study 
procedure, followed by an examination of state-trait anxiety 
(German version of State-Trait Anxiety Inventory, STAI)40 
and, thereafter, general face perception abilities via a short 
prosopagnosia test. IRT-recorded cognitive testing was per-
formed in a 3 × 2 m2-sized chamber within the experimen-
tal room (Figure 3A). One chamber side was not completely 
closed to allow fresh air supply and communication between 
subject and experimenters. The participant was seated in 
a specialized comfortable chair which adapted to his body 
size and shape, effectively avoiding pressure points (McLean 
REHAtechnik, Duderstadt, Germany). The implemented 
headrest enabled relaxation of head and neck muscles, while 
gently minimizing head movements (Figure 3A). The entire 
setup was highly adaptable to the differing subject shapes and 
sizes preventing irritation of the vascular system, while en-
suring an unobstructed view of the relevant facial features for 
the IRT camera. Prior to testing, subjects stayed in a relaxed 
position for 15 minutes to acclimatize to setup (habituation 
phase).15,29 Each participant performed computerized tests of 
both executive functioning and social cognition in counter-
balanced order, separated by a 2 min break. The IRT camera 
was mounted above the monitor and recorded whole-face im-
ages of the participant at 25 Hz from approximately 32 cm 
distance while the subject performed the tasks.
Executive functioning
Executive functioning as a process of general cognitive 
abilities was measured via Wisconsin Card Sorting Test, 
Computer Version 4 (WCST).41 Subjects are required to 
virtually classify cards regarding different features (symbol, 
number, color) via button press to 1 of 4 target decks. No addi-
tional instructions are provided. Instead, subjects have to infer 
sorting strategies from a feedback (“correct”/”incorrect”) fol-
lowing each sorting decision. After a series of correct answers 
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of certain length, sorting criteria shift, prompting subjects to 
adapt.
Social cognition
Social cognition in humans was assessed based on face mem-
ory tasks.42-44 Analogous to the SocioBox recognition test in 
mice, we created the Face Recognition Test (FRT), a com-
puterized measure of social cognitive abilities (face perception, 
face memory based on internal features, perception of social 
evaluation). The FRT consists of a learning phase, followed by 
two test blocks, each separated by a negative feedback or, al-
ternatively, neutral statement (Figure 2C). The test is presented 
via PsychoPy v1.85.445 for Python v2.7.46 During the learning 
phase, 50 male faces from the Göttingen Faces Database47 with 
neutral valence, standardized visual features, luminance, and 
resolution are sequentially presented in random order. Test sub-
jects are instructed to stay calm, focus and memorize the stimu-
lus on screen. Each face is shown once for 10 s at the center of 
the screen, followed by fixation cross (500 ms). Learning phase 
lasts 560 s in total. For test-block 1, of the previous 50 stimulus 
faces, two are randomly replaced with unfamiliar ones. This 
new set of images is then given in 10 trials. Each trial includes 
5 stimuli, randomly presented in a circular order (Figure 2C). 
Participants indicate via keyboard button press within 20 s if 
F I G U R E  2  IRT of social recognition versus executive function testing in men: Study logistics. A, Recruitment process: To ensure sample 
homogeneity, pre-experimental online screenings were implemented. A total of 111 individuals completed experimental session, starting at either 
09:00 am or 11:00 am. After post-session exclusion, 103 subjects remained as final sample. B, Study design: During initial assessment, participants 
were welcomed and provided with study information, followed by state-trait anxiety and prosopagnosia examinations. Then, IRT-recorded test 
phase was conducted, starting with habituation and 2 computerized cognition tests (in counterbalanced order: FRT, WCST). At closing assessment, 
intelligence was measured, and an interview concerning mental and physical health as well as debriefing (explanation of feedback) and, finally, 
compensation for participation took place. Over the course of experimental session saliva samples for cortisol analysis were collected at 5 different 
time points in 15-35 min intervals. C, Sketch of the novel, brief Face Recognition Test (FRT): Participants are first asked to memorize 50 male 
stimulus faces (learning phase). Subsequently, test trials containing 5 stimulus faces each are presented; subjects decide whether all are familiar 
or not, respectively (test-block 1). After 10 trials either a fabricated, negative feedback or an alternative, neutral statement is presented, before 
concluding with 10 more trials (test-block 2), analogous to test-block 1
(A) (C)
(B)
:ngiseDwolftnemtiurceR Face Recognion Test (FRT)
Study design
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all faces are familiar or not. Each stimulus face is shown only 
once and trials never contain more than one unfamiliar face. 
Additionally, after each trial, participants rate confidence in 
their response on a 5-point Likert scale. Then, after a break of 
10 s, either an unprompted, fabricated negative feedback or a 
neutral statement is included, each lasting for 10 s. Negative 
feedback is shown graphically and as text ("your perfor-
mance is below average"), the non-threatening alternative is 
displayed as text (“you may now take a break - the second part 
of the test will start automatically”). Immediately thereafter, 
test-block 2 is initiated with the two unfamiliar faces of test-
block 1 again exchanged for two new faces and participants 
perform the same task with confidence judgments, analogous 
to test-block 1. Closing assessments covered a structured clini-
cal interview on mental and somatic conditions, a nonverbal 
intelligence assessment (performance test system subtest-3; 
F I G U R E  3  Human IRT study during social recognition versus executive function testing: Social cognition stimulus induces a distinct 
thermo-pattern. A, Illustration of test setup: Participant sits as still as possible in a comfortable orthopedic armchair, with headrest to minimize head 
movements, and performs FRT (Face Recognition Test) while IRT camera (above screen) records facial regions of interest (ROI). B, IRT images of 
two sample test subjects with nose and right malar cheek ROI (circled in red) used to calculate Reference Index (RI). Images taken from early and 
late FRT session phase, respectively. Compare video S2. C-D, Overlays of all participants' normalized Reference Index differences from baseline 
in both tests indicate a sinusoid-shaped thermo-pattern over the course of FRT but not WCST (Wisconsin Card Sorting Test). E, Consensus ratings 
by three examiners (blinded to any test/subject information) revealed that the majority of test subjects exhibited a characteristic Reference Index 
sinusoid pattern during FRT (left example curve) but not WCST (right example curve); χ2-test. F, Comparison of Reference Index course between 
tests over time using M ± 95% confidence intervals. Groups' thermo-patterns differ significantly where confidence intervals do not overlap. G, 
Over each test quartile, accumulated absolute changes in Reference Index showed differences during second test halves, with higher temperature 
dynamics in FRT compared to WCST; repeated-measure ANOVA, Bonferroni-adjusted multiple-comparison tests (two-sided). H, Contrary to 
Reference Index, salivary cortisol reactivity was similar between tests, suggesting IRT as a more sensitive tool for measurement of physiological 
responses in social tasks. Cortisol levels were log10-transformed and normalized to the first sample (baseline); then cortisol delta values were 
calculated between sample time points; paired Student's t test (two-sided). I, Pearson correlation coefficient revealed mild-to-moderate positive 
relationship between log10- and z-transformed time-adjusted integrals of Reference Index and z-transformed salivary cortisol delta values during 
FRT. Only participants with characteristic sinusoid thermal curve and z-score ± 2.58 included (N = 78)
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“Leistungsprüfsystem Untertest-3”),48 monetary compensa-
tion and, lastly, a debriefing on the aims of the study. As an 
additional, biological readout, saliva was collected to measure 
cortisol levels at five different time points in intervals of around 
15-35 min (Figure 2B).
2.3.3 | Data extraction & preprocessing
Tracking information of facial ROI in human subjects was 
obtained with the DeepLabCut software package49 and imple-
mented into a FIJI-based image analysis workflow, allowing 
for corrections of small head movements not prevented by the 
headrest. Labels delineating either nose or right cheek (malar 
region) coordinates (Figure 3B; video S2) in up to 600 images 
were used to train the DeepLabCut network. Facial regions 
were selected regarding reactivity to social stimuli, with nose 
reacting strongly while malar cheek does not. After 106 itera-
tions, the resulting network had converged sufficiently to be 
evaluated for accuracy and then applied to human IRT record-
ings in FIJI in order to track and extract relative mean tempera-
tures of the two facial ROI at their respective position and time. 
The resulting series of temperature values (25 per second) were 
subsequently down-sampled (1 Hz) for following process-
ing steps. In order to replace missing values we calculated the 
sequence (ascending/descending) between the last valid data 
points before and after the missing. Then both ROI frame se-
quences were smoothed separately using LOESS fitting.
By dividing mean nose ROI temperature of each frame 
with its corresponding malar cheek ROI, we calculated the 
Reference Index, analogous to the Centralization Index in 
mice. Due to initial temperature differences in respective ROI, 
Reference Index was normalized as percentage change from the 
very first frame (baseline), and, due to varying individual test 
length of participants, duration of both tests was normalized 
to 1000 arbitrary units, both for FRT (Figure 3C) and WCST 
(Figure 3D). To investigate differences in thermal curve charac-
teristics, two independent evaluators rated in a blinded manner 
over both tests whether the normalized Reference Index curve 
was initially decreasing and then increasing (sinusoid curve), 
or was differently shaped (Cohens' kappa = 0.63). In case of 
dissent, a third evaluator made a final decision on the rating.
2.3.4 | Saliva cortisol determination
Saliva was collected at five different time points in intervals 
of 15-35 minutes (Figure 2B) and stored at −80°C until fur-
ther use. ELISA was used to detect cortisol levels in saliva 
samples, according to manufacturer's instruction (Demeditec, 
Kiel, Germany). To account for circadian cortisol profile 
differences (ie, cortisol awakening response50-52) due to ex-
perimental starting points (09.00  am versus 11.00  am), we 
calculated normalized delta values (∆) between sample col-
lection time points: First, all samples were log10-transformed 
and normalized to percentage alteration from first sample 
(baseline). Next, differences between consecutive samples 
were calculated. This way we received adjusted cortisol 
changes for habituation, FRT, WCST, and closing assessment.
2.3.5 | Statistical analyses
Differences in frequency of sinusoid-curve ratings between 
FRT and WCST were analyzed using Yates'-corrected chi-
squared test. To display averaged group differences over 
total test course, normalized Reference Index means and 95% 
confidence intervals were calculated, highlighting significant 
differences where confidence intervals do not touch. To ad-
ditionally investigate thermal dynamics over test quarters, 
mixed-design ANOVA was calculated, with quarter-sums of 
absolute Reference Index changes per arbitrary unit as de-
pendent variable, test quarters as within- and test as between-
factor. Bonferroni-adjusted post-hoc multiple comparison 
tests were calculated to compare differences between indi-
vidual test quarters. Cortisol reactivity changes between FRT 
and WCST were analyzed by comparing cortisol-∆ group 
values via two-sided paired Student's t test. All statistical 
tests were conducted in R using RStudio, with significance 
levels set to alpha = 0.05. Welch-corrected Student's t tests 
were used, and, in cases of violations of sphericity, Huyn-
Feldt corrections were applied to repeated-measure ANOVA.
3 |  RESULTS
3.1 | Unexpected discovery: SocioBox 
recognition testing induces lasting social 
avoidance in mice
To evaluate the social Y-maze test31,50 for suitability as rou-
tine sociability readout in our mouse behavioral test battery, 
we used mice which had previously undergone SocioBox30 
experiments. By serendipity, we this way discovered that 
4 weeks after passing through the SocioBox paradigm, these 
mice displayed social avoidance. This unexpected result 
was fully replicated in a second, independent cohort of for-
mer SocioBox completers (Figure 1A-C), leading to two first 
conclusions: (I) By chance, we may have developed a mouse 
model of social aversion priming/sociophobia, arising from 
a situation of inescapable social contacts. (II) The SocioBox 
test, even though superior to all other presently available so-
cial recognition tests and the first that successfully addresses 
multiple social contacts in parallel, will have to be treated as a 
final test in future behavioral test batteries (similar to eg, fear 
conditioning).
48
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3.2 | IRT as non-invasive tool to 
measure the vascular response to social 
cognitive performance in a “sociophobia” 
inducing setup
To further explore the novel “mouse model of sociophobia”, 
we employed IRT as a non-invasive method to continu-
ously approximate experienced stress during these inescap-
able social contacts in the SocioBox (Figure 1D-I; video S1). 
Conveniently, IRT additionally provides monitoring of spa-
tiotemporal dynamics, and thus location information needed 
for tracking. As expected, in the SocioBox recognition test, 
male mice spent significantly more time in the zone close to 
the stranger compared to already acquainted stimulus mice 
(F(4,36) = 3.58; P = .015; Figure 1E), while control mice (empty 
SocioBox) did not exhibit any zone preference (F(4,32) = 0.86; 
P = .499; Figure 1F). These findings were reproduced in fe-
male mice (SocioBox: F(4,32) = 3.03; P =  .032; empty box: 
F(4,64)  =  1.21; P  =  .314). Comparison of mean time spent 
with stranger versus all known mice yielded equivalent re-
sults (male t(9) = 2.38; P = .021; female: t(8) = 2.20; P = .030; 
Figure 1G). Screening the obtained IRT readouts in a few 
males first, we observed that mice changed their temperature 
over time in the SocioBox in a typical way, namely displayed 
an increase in body and a decrease in tail temperature (video 
S1). We therefore introduced a novel descriptive measure, 
integrating an internal control (within-subject) aspect, the 
Centralization Index. This measure, likely approximating 
the experienced stress during the task, clearly demonstrates 
an increase in SocioBox mice versus controls for both males 
(t(10.23) = −4.44; P  =  .001) and females (t(10.66) = −2.27; 
P  =  .045; Figure 1H). Importantly, enhanced movement 
and thus physical activity cannot account for this difference 
since control mice even had a tendency to move more than 
SocioBox performers (t(36.18) = 1.90; P = .066). Interestingly, 
the Centralization Index correlated negatively with the time 
spent with the stranger in the SocioBox (Spearman's rho = 
−0.51; P = .017; Figure 1I), indicating that mice with a higher 
Centralization Index (likely reflecting their stress level) per-
form worse in this social recognition task.
3.3 | Robust induction of social avoidance 
in the Y-maze sociability test following 
SocioBox recognition testing
Around 4 weeks after SocioBox testing, mice were exposed 
to Y-maze sociability testing, including IRT (Figure 1J). 
While male control mice exhibited normal social preference 
(F(2,16) = 7.88; P = .004; linear trend: b = 128.32; t(16)  = 4.85; 
P = .0004; quadratic trend: b = 6.44; t(16)  = 0.24; P = .811), 
the prior SocioBox performers displayed social avoidance 
behavior, similar to the discovery samples (F(2,18)  = 4.55; 
P  =  .025; linear trend: b  =  25.86; t(18)  =  0.99; P  =  .334; 
quadratic trend: b = −92.48; t(18) = −3.55; P = .002; Figure 
1K). Comparable effects were found for female mice in both 
control (F(2,28)  =  4.89; P  =  .015; linear trend: b  =  57.70; 
t(28) = 3.80; P = .0007; quadratic trend: b = 0.23; t(28) = 0.02; 
P  =  .988) and post-SocioBox condition (F(2,16)  =  9.56; 
P = .002; linear trend: b = 44.67; t(20) = 2.16; P = .046; quad-
ratic trend: b = −100.52; t(16) = −4.87; P =  .0002; Figure 
1L). These results, together with those of the two discovery 
samples, point to a robust induction of “sociophobia” by the 
SocioBox recognition test.
After Y-maze sociability testing, we controlled for poten-
tial differences in basic anxiety-related conduct. As a simple, 
non-invasive readout, spatial novelty-induced freezing in the 
fear-conditioning chamber (without shock) was evaluated. 
Importantly, neither male nor female SocioBox performers 
differed from empty box controls regarding duration of freez-
ing (males: F(2,36) = 0.09; P = .910; females: F(2,28) = 2.96; 
P = .068, tendency in the opposite direction), excluding an 
“unspecific global fear behavior” underlying their “sociopho-
bia” phenotype.
The next crucial question was whether we would see a 
correlation between stress, experienced in the SocioBox, as 
measured by the Centralization Index, and the degree of so-
ciability evaluated 4  weeks later in the Y-maze. Indeed, a 
higher Centralization Index was associated with lower so-
ciability (Spearman's rho = −0.27; P = .049) (Figure 1M). 
Together, these results support our hypothesis that inescap-
able social encounters can induce sociophobia/social aver-
sion in mice.
The Centralization Index during Y-maze sociability test-
ing also tended to be increased in SocioBox mice (M = 1.23, 
SD = 0.03) versus empty box controls (M = 1.21, SD = 0.02; 
both genders included; two-sided unpaired Student's t 
test, t(34.47)  =  −1.88, P  =  .068). Once again, these higher 
Centralization Index values could not be explained by higher 
physical activity; control animals traveled more than their 
SocioBox counterparts (both genders included; t(36.07) = 2.81; 
P = .008).
3.4 | Translational study: IRT as sensitive 
measure of the vascular response to social 
cognitive performance in humans
In our mouse experiments, we unexpectedly discovered that 
stress experienced during an inescapable social encounter 
(SocioBox) likely acts as a “primer” of sociophobia/social 
aversion. We thus started an IRT study in men, investigat-
ing in a translational fashion, whether a simple social com-
ponent in a cognitive task (face recognition) would already 
yield thermographic results differing from a “non-social” 
cognitive test (pattern recognition) (Figure 2A-C; Figure 
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3A-I; Table 1; video S2). Of a total of N = 228 men screened 
for participation, N  =  111 were tested, and N  =  103 fi-
nally analyzed. Recruitment flow, study design and Face 
Recognition Test (FRT) are shown in Figure 2A-C.
All 103 subjects displayed high accuracy of face rec-
ognition in the prosopagnosia test (part of initial assess-
ment; M = 97.67%, SD = 6.45) as prerequisite to perform 
the study. To ensure that subjects whose session started 
with FRT did not differ systematically from those with 
Wisconsin Card Sorting Test (WCST) first, we compared 
sociodemographic, psychopathological, and cognitive data 
between the two samples (Table 1). Since none of these 
variables showed any group differences, we combined both 
samples for the now following analyses of IRT readouts. 
First, we screened several facial IRT videos of participat-
ing subjects, allowing us to determine our regions of in-
terest (ROI), namely nose (highly variable and seemingly 
responsive, as also described before)15,18 and malar region 
of the cheek (obviously quite stable; compare video S2). 
We then calculated the Reference Index, in some analogy 
to the Centralization Index in mice, by dividing mean nose 
ROI temperature of each frame with its corresponding 
malar cheek ROI. Comparing the Reference Index course 
of all individuals during FRT, we noticed a sinusoid pat-
tern predominating in most subjects (initial decrease, 
followed by increase) (Figure 3C). In contrast, only a mi-
nority of participants seemed to show such pattern during 
WCST (Figure 3D). To consolidate this first visual im-
pression, independent raters estimated in a blinded fashion 
all individual thermal curves of both FRT and WCST to 
determine whether they resembled the characteristic sinu-
soid shape or not, with high interrater reliability (Cohen's 
kappa  =  0.63 between first two raters). Comparisons of 
pattern frequency (sinusoid versus not) yielded highly 
significant differences, with 77.7% of participants show-
ing the sinusoid curve during FRT but only 30.1% during 
WCST (OR = 7.98; Figure 3C-E). Interestingly, comparing 
participants with sinusoid-shaped Reference Index curve 
to those without revealed younger age and less time spent 
in the educational system together with higher scores in 
Social Phobia Scale (SPS) and Social Interaction Anxiety 
Scale (SIAS)38 as well as lower answer security in FRT 
(Table 2).
Presentation of the normalized Reference Index total 
course of all subjects for each test (M ± 95% confidence in-
terval) illustrates the sinusoid pattern during FRT versus the 







Neutral statement in FRT 23 (22.33%) 12 (23.08%) 11 (21.57%) 0.03 .854
Years of age 24.58 (3.34) 24.76 (3.49) 24.40 (3.20) 0.55 .584
Years of education 16.83 (2.67) 17.02 (2.86) 16.65 (2.51) 0.65 .520
BMI 24.15 (2.97) 23.75 (1.95) 24.53 (3.67) −1.25 .216
LPS-3 (T) 61.52 (5.53) 61.58 (6.20) 61.46 (4.81) 0.10 .918
STAI state 32.41 (5.08) 32.90 (5.62) 31.90 (4.45) 1.00 .318
STAI trait 32.85 (6.94) 33.79 (7.47) 31.90 (6.27) 1.39 .168
SPS sum 6.22 (4.51) 5.75 (4.35) 6.71 (4.67) −1.08 .285
SIAS sum 15.95 (8.05) 15.38 (7.88) 16.53 (8.25) −0.72 .473
BSI sum (T) 45.81 (9.07) 46.21 (9.58) 45.39 (8.59) 0.46 .649
NEO-Openness 32.20 (6.50) 33.06 (6.68) 31.33 (6.25) 1.35 .179
NEO-Conscientiousness 32.31 (7.21) 33.38 (7.09) 31.22 (7.23) 1.54 .127
NEO-Extraversion 29.21 (6.61) 29.15 (6.06) 29.27 (7.19) −0.09 .927
NEO-Agreeableness 31.21 (6.93) 31.08 (7.44) 31.35 (6.45) −0.20 .841
NEO-Neuroticism 15.61 (7.45) 16.12 (8.01) 15.10 (6.87) 0.69 .490
FRT error percentage 42.28 (12.04) 41.06 (12.58) 43.53 (11.46) −1.04 .300
FRT duration (s) 969.12 (64.88) 975.24 (68.86) 962.74 (60.48) 0.98 .332
FRT confidence 3.40 (0.52) 3.44 (0.47) 3.36 (0.57) 0.78 .437
WCST error percentage 18.35 (9.43) 17.29 (9.01) 19.43 (9.82) −1.15 .251
WCST duration (s) 621.15 (161.36) 612.04 (146.99) 630.44 (175.80) −0.58 .566
Note: Data represent uncorrected means (SD) or N (%). Student's t tests and Pearson's chi-squared tests for independent comparisons were employed for analyses. 
Abbreviations: BMI, Body Mass Index; BSI, Brief Symptom Inventory; FRT, Face Recognition Test; LPS-3, Leistungsprüfsystem-3 (performance test system sub-
test-3); SIAS, Social Interaction Anxiety Scale; SPS, Social Phobia Scale; STAI, State-Trait Anxiety Inventory; WCST, Wisconsin Card Sorting Test.
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continuous decrease followed by a plateau during WCST 
(Figure 3F). Mean temperature changes over test quartiles 
as another readout of thermal dynamics were likewise found 
significantly different, with greater fluctuations in the second 
half of FRT (quartile × condition-interaction: F(3,612) = 30.17; 
P = 2.28 × 10−15; Figure 3G). Taken together, these data may 
point to an association of the sinusoid pattern with the emo-
tional perception of the social task component.
Somewhat surprisingly, salivary cortisol alterations as 
“classical stress measures” did not differ during FRT and 
WCST (t(101)  =  −0.06; P  =  .952; Figure 3H). This may 
question the validity of cortisol measurements for deter-
mining the specific stress caused by a social test component 
which can be sensitively detected by IRT. Nevertheless, 
cortisol reactivity during FRT correlated mildly positively 
with the time-adjusted integrals of Reference Index during 
FRT (Pearson correlation coefficient; r = 0.255; P = .026; 
Figure 3I), indicating at least a slight “typical” stress reac-
tion during FRT.
Contrary to our expectations, no differences were found 
upon presentation of negative feedback versus neutral state-
ment during FRT, neither in Reference Index curve ratings 
(χ2(1) < 0.01; P > .999), nor average Reference Index curve 
shape, nor post-feedback temperature dynamics (fluctuations 
during 3rd and 4th test quartile, repeated-measure ANOVA 
interaction effect: F(1,101) = 2.38; P =  .126), nor any other 
variable (two-sided unpaired Student's t tests; all P >  .05). 
This suggests that the negative feedback did not have any rel-
evant impact on these measures.
4 |  DISCUSSION
The present translational study demonstrates that IRT can 
be applied as a convenient, easy-to-apply, non-invasive 
technology to sensitively and reliably assess physiologi-
cal reactivity (“flushing”) in social contexts in humans and 
mice.







Neutral statement in FRT 23 (22.33%) 5 (21.74%) 18 (22.50%) <0.01 >.999
Presenting FRT first 52 (50.49%) 12 (52.17%) 40 (50.00%) <0.01 >.999
Starting at 09:00 am 56 (54.37%) 9 (39.13%) 47 (58.75%) 2.04 .154
Years of age 24.58 (3.34) 26.16 (3.90) 24.13 (3.03) 2.31 .028
Years of education 16.83 (2.67) 18.24 (2.99) 16.43 (2.46) 2.41 .024
BMI 24.15 (2.97) 24.92 (4.72) 23.92 (2.21) 0.92 .366
LPS-3 (T) 61.52 (5.53) 62.41 (4.24) 61.26 (5.84) 1.04 .302
STAI state 32.41 (5.08) 31.57 (6.27) 32.65 (4.70) −0.77 .447
STAI trait 32.85 (6.94) 30.17 (7.35) 33.63 (6.66) −2.03 .051
SPS sum 6.22 (4.51) 4.09 (3.41) 6.84 (4.62) −3.13 .003
SIAS sum 15.95 (8.05) 12.91 (5.85) 16.83 (8.40) −2.54 .014
BSI sum (T) 45.81 (9.07) 44.04 (9.48) 46.31 (8.94) 1.02 .313
NEO-Openness 32.20 (6.50) 33.00 (5.90) 31.98 (6.68) 0.71 .481
NEO-Conscientiousness 32.31 (7.21) 33.35 (8.05) 32.01 (6.97) 0.72 .476
NEO-Extraversion 29.21 (6.61) 30.57 (6.40) 28.83 (6.66) 1.14 .262
NEO-Agreeableness 31.21 (6.93) 31.13 (6.77) 31.24 (7.02) −0.07 .948
NEO-Neuroticism 15.61 (7.45) 14.26 (8.25) 16.00 (7.21) −0.92 .367
FRT error percentage 42.28 (12.04) 40.22 (12.20) 42.88 (12.01) −0.92 .362
FRT duration (s) 969.12 (64.88) 951.94 (69.46) 975.79 (62.48) −1.49 .147
FRT confidence 3.40 (0.52) 3.65 (0.55) 3.33 (0.49) 2.48 .018
WCST error percentage 18.35 (9.43) 16.96 (6.72) 18.75 (10.08) −1.00 .323
WCST duration (s) 621.15 (161.36) 594.41 (139.00) 636.83 (169.32) −1.23 .225
Note: Data represent uncorrected means (SD) or N (%). Student's t tests or Pearson's chi-squared tests for independent comparisons were employed for analyses.
P values < .05 are indicated in bold.
Abbreviations: BMI, Body Mass Index; FRT, Face Recognition Test; WCST, Wisconsin Card Sorting Test; LPS-3, Leistungsprüfsystem-3 (performance test system 
subtest-3); STAI, State-Trait Anxiety Inventory; SPS, Social Phobia Scale; SIAS, Social Interaction Anxiety Scale; BSI, Brief Symptom Inventory. Because of the 
exploratory nature of the study, no P-value adjustments were conducted.
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By implementing IRT within the SocioBox paradigm, we 
replicated and extended our previous findings that normal 
mice are able to easily recognize an unfamiliar stranger out 
of five stimulus mice. Strikingly, 4 weeks after performing 
this challenging social cognitive task, mice displayed abnor-
mal social interaction in the Y-maze sociability test, namely 
distinct social avoidance. This unforeseen “sociophobia” 
following inescapable exposure to five conspecifics in the 
relatively narrow environment of the SocioBox was robustly 
reproduced several times in both genders. Control mice in 
the same narrow box without conspecifics (“empty”) did not 
acquire this phenotype nor show any appreciable change in 
their basal anxiety behavior, as evaluated by spatial novel-
ty-induced spontaneous freezing. Importantly, performance 
in the SocioBox as inducer of sociophobia was characterized 
by a higher overall Centralization Index, that is, higher tem-
perature in central compared to peripheral body parts (tail), 
suggesting an increase in the experienced stress. Eye, body, 
or tail have previously been reported as stress-responsive 
IRT zones in mice.4 Considering body and tail temperature 
of mice in IRT simultaneously, as introduced here with the 
Centralization Index, seems to constitute a promising robust 
measure of autonomous responses/social stress. Interestingly, 
the Centralization Index during SocioBox correlated nega-
tively with the time spent with the stranger mouse in the so-
cial recognition task as well as the succeeding sociability test, 
indicating that the degree of stress influences cognitive per-
formance (SocioBox) as well as severity of social avoidance 
(Y-maze). Hence, the SocioBox paradigm may serve not only 
as a superior test of complex social recognition memory,30 but 
also as a reliable inducer of social avoidance, thereby deliv-
ering a novel non-invasive animal model of “sociophobia”.51 
As a consequence, the SocioBox test has to be used as a final 
test in a behavioral battery, similar to fear conditioning.
This unexpectedly strong relation between social cog-
nition testing and IRT readouts in mice raised the obvious 
translational question whether the addition of a social com-
ponent to a cognitive task would yield characteristic IRT data 
also in human individuals that differ from those obtained 
during a non-social test. In human IRT, thermo-patterns de-
pend strongly on stimuli used and facial ROI targeted.9,16,20,29 
We focused on the nose because of its high reactivity to social 
cues.9,12,15-17,20 Since the introduction of the Centralization 
Index in mice had proven to be a reproducible, sensitive and 
widely environment-independent measure, we established 
a similar readout in human subjects. The Reference Index, 
again providing an “internal” (ie, within-subject) control by 
relating the responsive facial area (nose) to a rather tempera-
ture-stable zone (malar cheek) turned out to be a suitable tool 
to adjust for sources of IRT readout noise (eg, slight differ-
ences in ambient temperature, humidity, camera accuracy).9,29
Indeed, in the translational human study, we saw a char-
acteristic sinusoid-shaped thermal curve with initial decrease 
in the majority of test subjects during the social FRT. In 
contrast, over the course of WCST, as non-social pattern rec-
ognition test, this typical curve was widely absent, with the 
temperature overall decreasing. However, not all participants 
responded with this characteristic social thermo-pattern, in 
the following referred to as “non-responders”. Contrasting 
participants that exhibited the typical sinusoid-shaped ther-
mo-pattern in FRT with the “non-responders” revealed in-
teresting and plausible differences: younger age, less time 
spent in the educational system, higher scores in social pho-
bia questionnaires (though still within the normal range), and 
less secure feedback-answers regarding their perceived own 
performance during FRT. Together, these differing items 
may point to lower experienced stress,15 that is, to a more 
“relaxed attitude” toward social test settings.
Whereas IRT analyses revealed differences between so-
cial/non-social tests, salivary cortisol levels, an established 
standard measure of the hypothalamus-pituitary-adrenal 
(HPA) stress response, did not. To exclude potential bias 
due to different starting times of our test sessions (9.00 am 
or 11.00 am), falling into the cortisol diurnal profile/awaken-
ing response,52-54 we employed normalized cortisol changes 
(delta values) between time points of sample collection. 
Comparing subject groups separated by starting time or 
order of test presentation (FRT or WCST first) did not reveal 
differences in delta cortisol values. These negative cortisol 
findings are in agreement with previous investigations on the 
potential of IRT in physical and social stress paradigms, com-
pared to recognized stress markers.16 While thermal readouts 
in various facial regions were sensitive to stress-induced 
mood changes, conventional stress markers, such as cortisol, 
were not,16 suggesting a different origin (less HPA-related, 
more autonomic/catecholaminergic) and time course (fast 
versus delayed) of the experienced stress. Taken together, 
IRT seems to have a higher discriminative power for assess-
ment of social cognition-related stress than cortisol.
Somewhat surprising, the fabricated negative feedback 
within FRT (“your performance is below average”), com-
pared to the neutral statement (“you may now take a break—
second part of test will start automatically”) did not induce 
any measurable differences in thermograms. This may be due 
to a lower than expected socially threatening/embarrassing 
impact, the shortness of presentation (only 10 s each)13 with 
test-block 2 following immediately thereafter, or doubts of 
subjects regarding feedback authenticity. Finally, temperature 
alterations in connection with such ultra-brief negative feed-
back may belong to different underlying processes.20 Neither 
nose nor malar cheek may be optimal for exploring respective 
facial thermo-reactions.
In recent years, the potential of IRT as a valid research 
tool alongside traditional physiological approaches has been 
increasingly explored.9,15,17 However, IRT did not instan-
taneously turn out as a straightforward and easy-to-apply 
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method. IRT is sensitive to numerous interfering factors, 
arising from environmental (eg, ambient temperature, humid-
ity, room size, radiation) and individual sources (eg, gender, 
age, amount of brown adipose tissue, physical activity, food 
or substance intake). Further inconsistencies and reliability 
problems were caused by suboptimal study design, such as 
small or heterogeneous samples, artifacts due to manual ROI 
definition or quantification, or camera signal noise.9,29 Many 
studies did not sufficiently control for these methodological 
issues, leading to weak internal consistencies.9,29
In the present study, considerable effort was made to limit 
the impact of such interfering factors. As for the animal part, 
inbred mice were housed under controlled conditions and 
tested under standardized settings. In the human part, healthy 
male individuals with highly comparable sociodemographic 
characteristics were included. Large enough (N = 45 mice, 
N = 103 humans) test samples and standardized testing and 
recording procedures under constant ambient conditions were 
used as suggested by Fernández-Cuevas and colleagues.29 
While various studies analyzed single or short series of im-
ages due to technological or memory-storage limitations,9 we 
used relatively long IRT video recordings (5-10 minutes for 
mice; >15 minutes per human participant and test) with high 
spatial and temporal resolution, and novel methods of data 
extraction and analysis. Centralization Index and Reference 
Index were introduced here as sensitive and widely environ-
ment-independent measures, providing internal (within-sub-
ject) control in the assessment of thermo-reactions in social 
contexts. Automated tracking and preprocessing algorithms 
delivered examiner-independent, objective and clean data ex-
traction and organization, while imputations, smoothing, and 
winsorizing of data were conducted to reduce the impact of 
IRT camera inaccuracy, noise, and missing data.
Recently, IRT has also been employed for subjects diag-
nosed with mild posttraumatic stress disorder, Alzheimer's 
disease, or schizophrenia,55-57 underlining that psycholog-
ical/psychiatric research might profit from the contact-free, 
non-invasive IRT of freely moving and interacting subjects. 
In fact, deficits in social interaction/cognition of various ori-
gins are frequently seen in neuropsychiatry and often difficult 
to diagnose cross-sectionally. The current study on healthy 
individuals may stimulate future standardized social interac-
tion testing using IRT in disease states, thereby opening new 
avenues for differential diagnostic approaches.
To summarize, based on a unique translational IRT study 
from mouse to man, we suggest that inclusion of a social 
component in a cognitive task specifically alters local body 
or face temperature, indicating a defined vascular response to 
this particular category of stress. These rather clear-cut find-
ings were only possible on the ground of highly standard-
ized and innovative experimental conditions, including IRT 
videos over an extended period to long-term monitor tem-
perature alterations, unusually large, homogeneous subject 
samples, novel measures of internally (within-subject) con-
trolled temperature over time, that is, Centralization and 
Reference Index and, finally, novel approaches to data acqui-
sition, preprocessing, and analyses.
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5 SUMMARY AND CONCLUSIONS
As discussed and reported, we found strong associations between the amount of defined
adverse environmental risk factors experienced before adulthood and violent aggression
in patients suffering from schizophrenia. Environmental risk accumulation is further
linked to aggression severity scores in two general population samples. Moreover, while
we could not find epigenome-wide differences in DNA methylation, an examination
of HDAC1 mRNA expression levels revealed significant group differences in relation
to environmental risk load (high versus low). These results explicitly suggest that an
accumulation of negative environmental experiences during childhood and adolescence
has a substantial influence on aggression, which may be even more relevant with respect
to the exhibition of aggressive behavior than a person’s mental condition.
It is important to note that we do not report a direct, causal relation between these risk
factors and aggression; neither living in a large city, migrating to another country, nor
consuming cannabis once in life will transform anybody into a threat to others. How-
ever, these factors constitute valid predictors in the complex interplay of genetics and
environmental experiences, with the ultimate outcome of aggressive phenotypes. Against
this backdrop, the reported model lets us predict the likelihood of aggressive behavior
manifestation and makes the identification of individuals at risk possible. Some of the
reported risk factors are easily avoidable, such as consumption of certain substances,
whereas negative effects of others may be possible to mitigate.
Future research should aim to replicate our findings and extend them to different contexts.
It is yet not clear whether our model’s large effects are specific to aggression phenotypes
or if it has more general implications. Possibly, there are other, equally or even more
important, factors not included in our current model. Similarly, some of the identified
risk factors could be characterized more clearly, to improve its accuracy even further. For
instance, concerning the risk factor Migration, our model does not distinguish between
individuals seeking refuge and those who migrated due to educational or occupational
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reasons. Likewise, it might be beneficial to differentiate the risk factor Lifetime cannabis
consumption further with respect to the severity of consumption or used cannabis type
(Schoeler et al., 2016). However, the standard model revealed already large and solid
effects over all examined groups.
Notably, model modifications for more specific research questions seem to be feasible and
can easily be achieved. Currently, we are working on modifications of the standard model
in order to apply it in different contexts. For example, we investigate the relationship
between environmental risk and psychopathology in a group of young asylum seekers.
In this approach, the standard model is modified to take the special, detrimental expe-
riences commonly reported by persons fleeing their countries due to war or expulsion,
into account. Within a second project, we assess the relationship of our model with the
consumption of multiple illicit drugs (i.e., polytoxicomania). In both cases, the model of
accumulated environmental risk exhibits promising results (in preparation).
Our work on the utilization of infrared thermography (IRT), on the other hand, resulted
not only in the development of a new model of social avoidance (’social phobia’) in mice
but also improved our knowledge about the potentials of IRT recordings in both animal
and human experiments. By introducing new thermal readouts as well as innovative
routines of automated data acquisition, processing, and analysis we were able to deepen
our insight into socially-induced temperature alterations over longer time periods. In this
context, the many confounders that can undermine the reliability of thermal assessments
have been considerably taken into account. The number of studies employing IRT in
psychophysiological or neuroscientific context is growing fast, rendering reliable and
state-of-the-art recording and quantification techniques more and more important.
IRT offers great prospects for research and applications, in particular when the usage of
other measurement techniques is limited. This involves, besides others, settings where
assessed individuals are not able to act in accordance with application protocols of other
techniques or are not willing to cooperate. In such situations, IRT can increase our range
of possibilities, due to its contact-free and non-invasive application mode.
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In particular, physiological research involving patients suffering from mental conditions
can benefit greatly from IRT research. As shown by several recent studies, IRT can be
successfully utilized in experiments with patient groups (Di Giacinto et al., 2014; Jian
et al., 2017; Perpetuini et al., 2019). Additionally, IRT may prove itself to be a valuable
supporting tool in diagnostical approaches of different psychiatric conditions exhibiting
similar phenotypes. IRT may detect distinct thermal patterns and enable a more reliable
discrimination of patients in regard to psychiatric diseases as well as individuals from the
general population. Accordingly, IRT can potentially be used in therapeutical contexts,
for example as a contact-free, more flexible measure of physiological states during the
treatment of disorders that are associated with stress and arousal.
Taken together, this work aimed at improving our knowledge on behavioral and au-
tonomous reactions to stressful experiences. The robust findings we reported along with
our methodological suggestions have implications both for research and society.
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Schizophrenia is a complex disabling disorder that occurs in all populations, with a lifetime morbidity risk of around 0.7–0.8%1 and a higher incidence in males compared with females2. The 
high heritability of the disorder indicates a major role for genetic 
variants in its etiology3,4; however, non-genetic influences involving 
the intra-uterine environment have been repeatedly implicated in 
explaining at least part of the non-shared environmental contribu-
tion to the disorder4–6.
Animal studies have shown that exposure to environmental 
insults in utero leads to altered response to stress postnatally, with 
effects on brain development and behavior that are partly medi-
ated by gene expression changes in placenta7–9, a key environmen-
tally sensitive organ during development9,10. Studies in animals 
also reveal that males are more vulnerable than females to prenatal 
adversities8,9.
An important role for the intra-uterine environment in 
the etiology of schizophrenia is consistent with the disorder’s 
putative neurodevelopmental origins11 and is also supported 
by many epidemiological studies. For example, the prevalence 
of schizophrenia increases in offspring of mothers who were in 
the second trimester during influenza epidemics; in a prospective 
study, maternal respiratory infection during pregnancy increased 
the risk for schizophrenia in the offspring threefold to seven-
fold5,12. More generally, schizophrenia has been associated with 
a number of early-life complications (ELCs), that is, potentially 
adverse events that occur during pregnancy and labor, at deliv-
ery, and early in neonatal life5,12,13. Meta-analyses of this body of 
literature have found that ELCs increase risk by 1.5- to 2-fold13, a 
greater effect than any common genetic variant. Studies of ELCs 
in high-risk individuals (that is, offspring of parents affected 
with schizophrenia) suggest an interactive role for genetic 
background13, which is consistent with preliminary evidence of 
a relationship between ELCs, hypoxia-related genes, and risk 
for schizophrenia13–15.
Convergence of placenta biology and genetic risk 
for schizophrenia
Gianluca Ursini1,2,3, Giovanna Punzi1,2, Qiang Chen1, Stefano Marenco4,5, Joshua F. Robinson6, 
Annamaria Porcelli2, Emily G. Hamilton6, Marina Mitjans7, Giancarlo Maddalena2, Martin Begemann7, 
Jan Seidel7, Hidenaga Yanamori8, Andrew E. Jaffe   1,9, Karen F. Berman4, Michael F. Egan10,  
Richard E. Straub1, Carlo Colantuoni11,12,13, Giuseppe Blasi   2, Ryota Hashimoto   8,14, Dan Rujescu15, 
Hannelore Ehrenreich7, Alessandro Bertolino2 and Daniel R. Weinberger1,3,11,12,13,16*
Defining the environmental context in which genes enhance disease susceptibility can provide insight into the pathogenesis of 
complex disorders. We report that the intra-uterine environment modulates the association of schizophrenia with genomic risk 
(in this study, genome-wide association study–derived polygenic risk scores (PRSs)). In independent samples from the United 
States, Italy, and Germany, the liability of schizophrenia explained by PRS is more than five times greater in the presence of 
early-life complications (ELCs) compared with their absence. Patients with ELC histories have significantly higher PRS than 
patients without ELC histories, which is confirmed in additional samples from Germany and Japan. The gene set composed of 
schizophrenia loci that interact with ELCs is highly expressed in placenta, is differentially expressed in placentae from compli-
cated in comparison with normal pregnancies, and is differentially upregulated in placentae from male compared with female 
offspring. Pathway analyses reveal that genes driving the PRS-ELC interaction are involved in cellular stress response; genes 
that do not drive such interaction implicate orthogonal biological processes (for example, synaptic function). We conclude that 
a subset of the most significant genetic variants associated with schizophrenia converge on a developmental trajectory sensi-
tive to events that affect the placental response to stress, which may offer insights into sex biases and primary prevention.
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Genome-wide association studies (GWASs) indicate that genetic 
risk for schizophrenia across heterogeneous samples is conferred 
by many small-effect alleles throughout the genome16. Studies of 
rare chromosomal defects showing greater penetrance also imply 
a myriad of susceptibility genes17–19, indicating that the genetic 
architecture of the disorder is heterogeneous, consistent with poly-
genic mechanisms16,20. Although current GWASs are not designed 
to detect complex genetic and environmental heterogeneity16, we 
hypothesized that the most significant GWAS associations might 
achieve their statistical status by converging on early developmental 
mechanisms sensitive to environmental factors that are also rela-
tively common among patients. In this article, we analyze the role 
played by the intra-uterine and perinatal environment in modu-
lating the association of schizophrenia with genomic risk, with 
emphasis on the placental transcriptome.
Results
Interaction of polygenic risk score and early-life complications 
history on case–control status. We first investigated whether the 
intra-uterine and perinatal environment modulates the association 
of schizophrenia with genomic risk. Specifically, we explored the 
interaction between genomic risk for schizophrenia and history 
of ELCs on the likelihood that a subject is a patient or a control, 
that is, case–control status. Genomic risk for schizophrenia was 
measured as the polygenic risk score (PRS)21 based on GWAS sig-
nificant alleles (P < 5 × 10–8, PRS1; single nucleotide polymor-
phisms (SNPs) in Supplementary Table 1)16, whereas ELC history 
was assessed with the McNeil–Sjöström scale22,23, defining a posi-
tive or negative ELC history based on the presence or absence of 
at least one potentially serious complication (that is, presence or 
absence of ELCs with McNeil–Sjöström scale severity level ≥ 4) as 
in previous reports22,24,25. In the discovery sample of 501 individu-
als from the United States (scz_lie_eur: 267 healthy subjects and 
234 patients with schizophrenia, all Caucasian; see Table 1 and 
Supplementary Table 2 for sample information), the polygenic risk 
profile score constructed from alleles showing significant (P < 5 × 
10–8) association with schizophrenia (PRS1) in a meta-analy-
sis of Psychiatric Genetic Consortium (PGC) GWAS datasets, 
after excluding the scz_lie_eur sample, was positively associ-
ated with case–control status (N = 501, t = 5.347, P = 2 × 10–7), 
so that patients had greater genetic risk compared with con-
trols; PRS1 accounted for approximately 6% of risk prediction 
(Nagelkerke’s pseudo R2 = 0.060; Fig. 1a and Supplementary Table 3). 
In this sample, ELCs were not significantly different among 
healthy subjects and patients with schizophrenia (z = − 0.38, 
P = 0.704). However, multiple logistic regression revealed a sig-
nificant interaction between PRS1 and severe ELCs on case–
control status (t = 2.87, P = 0.004; Fig. 1b and Table 1); results 
of the multiple regression also indicated that the ELC history 
was associated with schizophrenia when covarying for genetic 
risk score (t = 2.11, P = 0.03), whereas PRS1 was not associated 
with schizophrenia when covarying for ELCs (t = 1.18, P = 0.24). 
This result suggests that the association between genetic risk and 
schizophrenia was affected by ELC history. Indeed, when analyz-
ing the relationship between PRS1 and case–control status in the 
absence and in the presence of ELCs, we found that the liability 
of schizophrenia explained by the genetic risk score was highly 
significant in the context of ELCs (N = 334, Nagelkerke’s pseudo 
R2 = 0.112, t = 5.97, P = 5.02 × 10–9), but not in the absence of 
them (N = 167, Nagelkerke’s pseudo R2 = 0.008, t = 1.07, P = 0.28; 
Fig. 1b). We evaluated the same relationship in the context of 
each severity level of ELCs; strikingly, whereas in the absence of 
potentially serious ELCs (weights 0–3) cases and controls were 
not different in PRS1, the two groups became clearly differen-
tiated as the severity of ELCs increased (Fig. 1c). These results 
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significant variant in the extended major histocompatibility com-
plex (MHC) region (chr6: 25–34 Mb; Supplementary Table 4).
We then grouped individuals in quintiles based on their PRS1 
levels, and we determined odds ratios (ORs) of being affected with 
schizophrenia associated with being in each PRS1 quintile, com-
pared with the lowest PRS1 quintile. We also stratified our sample 
by ELC history to further represent the capacity of PRS1 to predict 
risk for schizophrenia in the context of ELCs. The OR increased with 
higher PRS1 quintiles only in the sample with ELCs, so that hav-
ing the highest PRS1 quintile corresponded to an OR of 8.36 (95% 
confidence interval [CI]: 3.79–18.47, P = 3.22 × 10–8) in the presence 
of ELCs, and only 1.55 (95% CI: 0.59–4.07, P = 0.37) in the absence 
of ELCs (Fig. 2a), compared with having the lowest PRS1 quintile.
We further analyzed whether the interaction between genomic 
risk and ELCs was specific for the PRS constructed with GWAS 
significant alleles (PRS1) or was also found with other PRS levels 
(that is, PRS2–10) constructed from alleles showing association 
with schizophrenia at lesser statistical thresholds (that is, not GWAS 
significant). Interestingly, the ELC-dependent change in schizo-
phrenia risk variance, explained by PRS, gradually decreased when 
considering different PRSs constructed from variants showing asso-
ciation with schizophrenia at the lower thresholds of significance 
(Fig. 2b). Specifically, only the first two scores, constructed from the 
alleles showing the strongest clinical association with schizophrenia 
(PRS1: P < 5 × 10–8; PRS2: P < 1 × 10–6), interact with ELCs on case–
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Fig. 1 | PRS1, ELC history, and schizophrenia in the scz_lie_eur sample (N = 501). a, Association between genomic risk score (PRS1), constructed from 
alleles showing significant association with schizophrenia (with GWAS P <  5 × 10–8), and case–control status. b, Interaction between PRS1 and ELCs on 
case–control status: shown are genomic risk scores (PRS1) of controls (CONT) and patients with schizophrenia (SCZ), in the absence of ELCs (left) and 
in the presence of ELC history (right). c, Relation between PRS1 and case–control status in the context of ELCs with different severity levels; ELCs with 
severity scores ≥  4 (in red) are considered harmful or relevant factors in fetal stress, whereas ELCs with severity scores of 0, 1, 2, and 3 (in black) are not. 
All of the statistics were generated using multiple logistic regression, adjusting for population stratification (ten PCs) (see also main text and Table 1 for 
detailed statistics). Boxplot centers depict median; lower and upper hinges correspond to 25th and 75th percentiles; whiskers extend from hinges to the 
smallest and larger values no further than 1.5*IQR from the 25th and 75th percentiles. Results in the other clinical samples are shown in Supplementary 






















































































(70,18,52) (59,18,41) (52,20,32) (50,18,32) (35,13,22)
(48,14,34) (50,14,36) (65,19,46)(41,16,25)(30,17,13)
Fig. 2 | Liability of schizophrenia explained by genomic risk in the context of ELC history, in the scz_lie_eur sample (N = 501). a, OR for schizophrenia 
by PRS1 quintile and ELC history: the PRSs constructed from alleles showing significant association with schizophrenia (with GWAS P <  5 × 10–8) were 
converted to quintiles (1 =  lowest PRS1, 5 =  highest PRS1), and the ORs were estimated for affected status for each quintile with reference to the lowest risk 
quintile, in the whole sample (gray square) and in the absence (blue triangles) and presence (orange dots) of ELCs. Bars correspond to 95% confidence 
intervals. The numbers within brackets on the x axis refer to the individuals within each quintile, in the whole sample, in the absence of ELCs and in the 
presence of ELCs, in controls (first row) and in patients with schizophrenia (second row). b, Change of variance explained by genomic risk in the presence 
of ELCs compared with the absence of ELCs: proportion of variance (Nagelkerke R2) of schizophrenia risk was calculated, by comparison of a full model 
(covariates +  PRS) with a reduced model (covariates only), in the presence and absence of ELC history, for each of the ten different PRSs constructed from 
alleles showing association with schizophrenia at different threshold of significance (GWAS P value threshold and number of SNPs contributing to each 
PRS are reported in the grayscale legend). Shown is the difference (y axis) between Nagelkerke R2 in the presence of ELCs and Nagelkerke R2 in the absence 
of ELC history, for each PRS (x axis). c, Proportion of variance of schizophrenia by PRS1 and PRS2, and ELC history: shown is variance of case–control 
status (Nagelkerke R2, y axis) explained by PRS1 and PRS2, in the whole sample (gray bars), in the absence of ELCs (blue bars), and in the presence of ELCs 
(orange bars). All of the statistics were generated using multiple logistic regression, adjusting for population stratification (ten PCs). Results in the other 
clinical samples are shown in Supplementary Figs. 3 and 4.
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higher in individuals with a history of ELCs, compared with those 
without (Fig. 2b,c and Supplementary Figs. 1 and 2). The other 
scores, PRS3–10, do not show any interaction with ELCs, and the 
variance explained by them is not influenced by a history of ELCs 
(Fig. 2b and Supplementary Figs. 1 and 2). This is consistent with 
the possibility that the latter scores, involving a greater number of 
putative susceptibility genes, capture a greater number of genetic 
risk variants acting in a simply cumulative way, whereas the aggre-
gate effect of the GWAS significant SNPs (PRS1) and the almost 
GWAS significant SNPs (PRS2) is more conditioned on the history 
of ELCs. These results raise the possibility that the reason PRS1 and 
PRS2 loci achieve their privileged statistical significance status in 
this heterogeneous clinical sample is because of this interaction. 
From another perspective, the data show that patients with a history 
of ELCs have greater PRS1 than patients without ELCs (N = 234, 
t = 2.21, P = 0.028), whereas this relationship is not seen in healthy 
subjects (N = 267, t = − 0.68, P = 0.50). Maternal PRSs were avail-
able on a subsample of healthy mothers (N = 160) of schizophrenic 
offspring and were not associated with ELCs in their offspring 
(t = 0.08, P = 0.94; Supplementary Table 5). Similarly, paternal PRSs 
were available only for a subsample of fathers (N = 136) and were 
also not significantly associated with ELCs in the offspring (t = 1.40, 
P = 0.16; Supplementary Table 5). These results suggest that the 
interaction between genomic risk and ELCs is mainly driven by the 
fetal genome and is relatively independent of gene–environment 
interactions related to parental genomes per se.
We sought to replicate our findings in several additional, inde-
pendent samples. We first analyzed two case–control samples: an 
Italian sample of 273 subjects (scz_bari_eur) and a German sample 
of 919 subjects (scz_munc_eur) (see Table 1 and Supplementary 
Table 2 for sample information). As in the discovery sample, PRS1 
was positively associated with case–control status in both samples 
(scz_bari_eur: N = 273, R2 = 0.02, t = 2.11, P = 0.036; scz_munc_eur: 
N = 919, R2 = 0.04, t = 5.51, P = 5 × 10–8; Supplementary Table 3). 
ELCs were not differentially distributed between healthy subjects and 
patients with schizophrenia in the scz_bari_eur sample (z = − 0.51, 
P = 0.61), but there was a significant association of ELC history 
with schizophrenia in the larger scz_munc_eur sample (z = 3.54, 
P = 0.0004, OR = 1.85, 95% CI: 1.32–2.61). In both case–control sam-
ples, PRS again showed a significant interaction with ELCs in pre-
dicting case–control status (scz_bari_eur: t = 2.17, Pone-sided = 0.015; 
scz_munc_eur: t = 2.12, Pone-sided = 0.017; Table 1 and Supplementary 
Fig. 3a,b). When analyzing the relationship between PRS1 and 
case–control status in the context of ELCs, this PRS was once again 
associated with schizophrenia only in the presence of ELCs in the 
scz_bari_eur sample (N = 135, t = 3.38, P = 0.001), and not in their 
absence (N = 138, t = − 0.11, P = 0.91), whereas in the scz_munc_eur 
sample, the association between PRS1 and case–control status was 
significant both in the absence (N = 733, t = 3.88, P = 0.0001) and 
in the presence of ELCs (N = 186, t = 4.45, P = 2 × 10–5; Table 1 and 
Supplementary Fig. 3a,b). However, in both samples the variance of 
case− control status explained by PRS1 was much higher in individ-
uals with a history of ELCs (scz_bari_eur: R2 = 0.09; scz_munc_eur: 
R2 = 0.11) than in those without such history (scz_bari_eur: 
R2 = 0.0001; scz_munc_eur: R2 = 0.02; Supplementary Fig. 3c,d), and 
again subjects who experienced ELCs who were in the upper quin-
tile for PRS1 had the highest OR (scz_bari_eur: OR = 6.67, 95% CI: 
1.6–27.6, P = 0.005; scz_munc_eur: OR = 14.17, 95% CI: 4.0–49.9, 
P = 5.03 × 10–6; Supplementary Fig. 3e,f). These replication analy-
ses also confirmed that PRS1 was positively associated with ELCs 
only in cases (scz_bari_eur: N = 91, t = 2.88, Pone-sided = 0.003; 
scz_munc_eur: N = 521, t = 1.60, Pone-sided = 0.0547), but not in con-
trols (scz_bari_eur: N = 182, t = − 0.57, P = 0.57; scz_munc_eur: 
N = 398, t = − 1.64, P = 0.10; Table 1 and Supplementary Fig. 3a,b).
We further tested the relationship between genomic risk for schizo-
phrenia and ELC history in two more samples of only patients (total 
N = 1,192): another independent German sample of 1,020 patients 
with schizophrenia, namely, the Göttingen Research Association 
for Schizophrenia (GRAS) data collection (scz_gras_eur), and a 
Japanese sample of 172 patients with schizophrenia (scz_osak_asi) 
(Table 1 and Supplementary Table 2). In regard to the latter, it should 
be noted that the PRS derived from the European Caucasian sample 
of the recent GWAS study of schizophrenia has much less associa-
tion with schizophrenia in Asian samples16, as would be expected 
because the correlation between genotypes at nearby markers (that 
is, the linkage disequilibrium structure) is different across popula-
tions26. However, because many of the alleles comprising the score 
likely monitor ancient haplotypes, an association with ELCs might 
still be expected. As in the three other samples, we again found that 
PRS1 was associated with ELCs in both samples of patients with 
schizophrenia (scz_gras_eur: N = 1,020, t = 1.70, Pone-sided = 0.044; 
scz_osak_asi: N = 172, t = 1.79, Pone-sided = 0.047; Supplementary 
Fig. 4), so that patients with a history of complications had higher 
PRSs than patients who did not experience ELCs.
We also performed analyses in merged samples of cases and con-
trols (scz_lie_eur, scz_bari_eur, scz_munc_eur) and of only cases 
(scz_lie_eur, scz_bari_eur, scz_munc_eur, scz_osak_asi, scz_gras_
eur), after normalization of PRSs in each population. In these merged 
samples, we confirmed the interaction of PRS1 and ELCs on case–
control status (N = 1,693, t = 4.02, P = 6.18 × 10–5; Supplementary 
Fig. 5) and the relationship between PRS1 and ELCs in patients 
with schizophrenia (N = 2,038, t = 3.86, P = 0.0001; Supplementary 
Figs. 5 and 6). Also, in the merged samples, only PRS1 and PRS2 
interact with ELCs on case–control status, and only PRS1 and PRS2 
are positively associated with ELCs in patients with schizophre-
nia (Supplementary Figs. 5 and 6). Again, the positive association 
between genomic risk and ELCs was not present in controls, where 
the trend was actually negative (P = 0.10; Table 1), which is compat-
ible with a pattern of a gene–environment interaction. Sensitivity 
analyses with sex, age, paternal and maternal ages, maternal 
stress, socioeconomic status, and substance use as covariates and 
related interaction terms (in addition to genetic principal compo-
nents) confirmed the same results (Supplementary Tables 6–8). 
These consistent results in five independent samples support the 
hypothesis that these top PRSs are relevant for the etiopathogen-
esis of schizophrenia, particularly in the context of ELCs, whereas 
other PRSs (that is, PRS3–10) may capture polygenic mechanisms 
of schizophrenia not directly related to ELCs.
Expression of schizophrenia risk-associated genes in placenta. 
Even though several recent studies show preferential regulation 
of many schizophrenia risk genes in fetal brain27–29, the relation-
ship between the PRSs and ELCs that we found in five independent 
clinical samples from diverse ancestries points to the intra-uterine 
context as a likely place where some risk genes for schizophrenia 
and environmental adversity intersect, with implications not lim-
ited to the brain. Because PRS1 and PRS2 risk SNPs are associ-
ated with expression of nearby genes across many different tissues 
(Supplementary information, see “Screening of PRS1 and PRS2 
SNPs for eQTLs across different tissues” note), we tested whether 
the genes mapping to the loci showing the strongest association 
with schizophrenia and interacting with ELCs (that is, PRS1 and 
PRS2 genes; Fig. 2b and Supplementary Table 9) were more highly 
expressed in the placenta, compared with randomly selected genes 
contributing to PRSs constructed from alleles showing association 
with schizophrenia at lesser thresholds of significance (P > 1 × 10–6), 
which do not show an interaction with ELCs (that is, PRS3–10). 
We analyzed RNA sequencing data from placental tissue, gener-
ated in the Epigenome Roadmap Project (GSE16368), and found 
relatively greater expression of the PRS1 and PRS2 genes (N = 1,643 
genes), compared with same size set of genes randomly selected 
from PRS3–10 genes (N = 18,029 genes), in multiple placental tissue 
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compartments: amnion (N = 4 samples, P = 1 × 10–4), basal plate 
(N = 4, P = 1 × 10–4), chorion (N = 4, P = 3 × 10–4), villi (N = 4, P = 1 × 
10–5), trophoblast (N = 4, P = 1 × 10–5; second trimester: N = 2, 
P = 3 × 10–5; third trimester: N = 2, P = 1.6 × 10–6; Supplementary 
Table 10). These results indicate that, as predicted, genes mapping 
to GWAS significant loci that interact with ELCs are more abun-
dantly expressed in placenta than are genes in the other GWAS loci, 
which do not interact with ELCs.
Differential expression of schizophrenia risk-associated genes 
in placentae from complicated pregnancies. To elaborate on a 
specific role for the placenta in mediating the interaction between 
schizophrenia risk genes and ELCs, we next analyzed whether the 
PRS1 and PRS2 genes were differentially expressed in placentae 
from pregnancies complicated with pre-eclampsia and/or intra-
uterine growth restriction (IUGR) compared with normal placen-
tal controls, and in contrast with the PRS3–10 genes. The ELCs 
interacting with genomic risk for schizophrenia represent hetero-
geneous conditions, spanning pregnancy, labor, delivery, and early 
neonatal life; however, ischemic disease processes, with impaired 
trophoblast invasion and deficient remodeling of the maternal spi-
ral arteries, as well as an altered inflammatory response, may repre-
sent common denominators in the mechanisms underlying many 
ELCs30–32 (also including perinatal complications that are often the 
result of pathological processes starting during pregnancy30,33). 
We therefore analyzed gene expression data from placentae with 
pre-eclampsia and IUGR, because they represent two paradig-
matic placental diseases, characterized by ischemic processes, with 
impaired migration of extravillous trophoblasts and impaired spi-
ral artery remodeling32,34,35, and often associated with an altered 
inflammatory response of the placenta31,36,37. Pre-eclampsia and 
IUGR are multifactorial syndromes and indeed are frequently 
linked with many other ELCs detected in our samples, includ-
ing diabetes, obesity, alcohol use, vaginal bleeding, maternal 
smoking, preterm birth and other adverse birth outcomes, and 
perinatal morbidity38–41. They are themselves classic severe ELCs 
(severity level ≥ 4 in the McNeil–Sjöström scale) that have been 
linked with increased risk for schizophrenia, and also where the 
primary affected cells have been isolated and studied ex vivo13,42,43. 
In analyzing eight publicly available datasets, we consistently 
detected enrichment of the PRS1 and PRS2 genes (Table 2 and 
Supplementary Table 9) among the genes differentially expressed 
in the fetal portion of placentae from pregnancies complicated with 
pre-eclampsia and IUGR, specifically in pre-eclamptic (GSE24129: 
P = 3.5 × 10–4; GSE35574: 0.04; GSE10588: 0.003; GSE25906: 0.02) 
and IUGR (GSE24129: P = 0.019; GSE35574: 0.007; GSE12216: 
0.01) chorionic tissue from term placentae, in pre-eclamptic cyto-
trophoblast (GSE40182: P = 0.009) and first trimester chorionic 
villi (GSE12767: P = 0.003), and in microvascular endothelium 
from IUGR/pre-eclamptic pregnancies (GSE25861: P = 0.006). We 
observed that PRS1 and PRS2 genes tend to be upregulated (posi-
tive t-statistics) in multiple placental samples from pre-eclampsia 
and IUGR, compared with placental controls (Supplementary 
information, see “Differential expression of schizophrenia risk 
genes in placenta” note). Because the PRS1 and PRS2 genes were 
among the highly expressed placental genes, we then performed a 
Table 2 | Differential expression of schizophrenia risk genes in placentae from complicated pregnancies
Dataset Condition tissue N P value of 
gene set test
χ 2 test
P value χ 2
GSE24129 Pre-eclampsia Chorionic villi 16 3.5e−04 0.002 7.93
GSE24129 IUGR Chorionic villi 16 0.019 0.0007 10.21
GSE35574 Pre-eclampsia Chorionic tissue 59 0.04 0.062 2.36
GSE35574 IUGR Chorionic tissue 75 0.007 0.03 3.56
GSE10588 Pre-eclampsia Chorionic tissue 43 0.003 0.002 8.46
GSE25906 Pre-eclampsia Chorionic tissue 60 0.02 0.03 3.40
GSE12216 Pre-eclampsia Chorionic tissue 16 0.01 0.01 4.82
GSE40182 Pre-eclampsia CTB 20 0.009 0.04 3.04
GSE12767 Pre-eclampsia First trimester chorionic villi 12 0.003 0.005 6.78
GSE25861 Pre-eclampsia/IUGR Microvascular endothelium 8 0.006 0.04 3.002
GSE65271 CTB invasiveness CTB 7 0.005 0.002 8.30
GSE28619 Hepatitis (liver) Liver 22 0.136 0.10 1.70
GSE41804 Hepatitis (liver) Liver 40 0.285 0.20 (opposite direction) 0.69
GSE27411 HP gastritis (corpus) Stomach corpus 9 0.377 0.45 0.01
GSE27411 HP gastritis (antrum) Stomach antrum 9 0.453 0.34 0.17
GSE42955 Dilatative cardiomyopathy Heart 17 0.172 0.40 0.07
GSE3586 Dilatative cardiomyopathy Heart 28 0.283 0.10 (opposite direction) 1.63
GSE4172 Dilatative cardiomyopathy Heart 12 0.246 0.42 0.04
GSE4483 Hypoxia Second trimester astrocytes 6 0.470 0.18 0.85
GSE26420 MIBP1 overexpression HEK293 cells 6 0.263 0.002 (opposite direction) 8.01
GSE64699 IUGR Adipocytes from UC-MSC lines 28 0.109 0.37 0.12
Genes mapping to loci showing the strongest association with schizophrenia (GWAS P <  5 x 10–8e− 08: PRS1; P <  1 x 10–6: PRS2) and interacting with ELCs were tested for enrichment among the 
differentially expressed genes in pre-eclamptic and IUGR placental samples compared with controls, and in non-invasive cytotrophoblasts (CTBs), in nine independent datasets (11 differential expression 
analyses: rows 1–11), and in datasets from liver, stomach (HP: Helicobacter pylori), heart, and cells of embryonic origins (last 10 rows). Sample sizes are reported in the fourth column. The table shows the 
results of the gene set test (Wilcoxon test) analysis using the moderated t-statistics from each differential expression analysis, and the χ 2 test results from the gene set enrichment analyses  
(see also Supplementary information, “Differential expression of schizophrenia risk genes in placenta” and “Sensitivity analyses for placental enrichment” notes). Significant results (P <  0.05) with 
consistent directionality are highlighted in bold.
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sensitivity analysis controlling for average gene expression level, 
and the results were consistent (Supplementary Table 11).
We considered the possibility that differential expression 
of PRS1 and PRS2 genes in complicated placentae might be a 
nonspecific response to pathology or stress in adult or fetal tis-
sue. We therefore performed the same differential expression 
analyses on datasets from tissues with diseases likely unre-
lated to schizophrenia, such as hepatitis (GSE28619, GSE41804), 
Helicobacter pylori (HP) gastritis infection (GSE27411), and dila-
tative cardiomyopathy (GSE42955, GSE4172), as well as in data-
sets from embryonal cells (GSE4483, GSE26420, GSE64699). 
The PRS1 and PRS2 genes were not enriched among the genes 
differentially expressed in the pathological compared with 
normal condition in any of these datasets, from adult tissues 
and embryonic cells (Table 2; Supplementary Table 9; and 
Supplementary information, see “Sensitivity analyses for placen-
tal enrichment” note).
Taken together, these results converge on the conclusion that 
schizophrenia GWAS significant risk-associated genes that interact 
with ELCs are highly expressed in the placenta during early life and 
dynamically modulated in the placenta during biological stress, as 
reflected in their differential expression in placentae from compli-
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Fig. 3 | Placental and non-placental genomic risk for schizophrenia. a–d, Using GWAS SNPs marking loci containing genes highly and differentially 
expressed in pre-eclamptic/IUGR placental samples, we created new PRSs (PlacPRSs) and compared their interaction with ELCs with PRSs derived from 
the SNPs marking the remaining GWAS significant loci (NonPlacPRSs). The figure shows the interaction between PRSs and ELCs on case–control status 
in the US discovery sample (scz_lie_eur: N =  501): shown are PlacPRS1 (a), NonPlacPRS1 (b), PlacPRS2 (c), and NonPlacPRS2 (d) of controls (CONT) and 
patients with schizophrenia (SCZ), in the absence of ELCs (left side of each boxplot) and in the presence of ELC history (right). Results in the other clinical 
samples are shown in Supplementary Figs. 7–9. All the statistics were generated using multiple logistic regression, adjusting for population stratification 
(ten PCs); the P values refer to the significance of the interaction of ELCs with PlacPRSs (orange lines, a,c) and with NonPlacPRSs (blue lines, b,d); boxplot 
centers depict median; lower and upper hinges correspond to 25th and 75th percentiles; whiskers extend from hinges to smallest and larger values no 
further than 1.5*IQR from the 25th and 75th percentiles. e, Biological processes Gene Ontology terms enriched for PlacPRS1 genes (N =  130, orange bars) 
and NonPlacPRS1 genes (N =  707, blue bars) (see also Supplementary Tables 9, 15–18 and Supplementary Figs. 10–20): bars depict negative logarithm of 
the P values, and white numbers within bars correspond to fold enrichment.
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Genes highly and differentially expressed in placenta drive the 
interaction between polygenic risk scores and early-life compli-
cations on schizophrenia risk. The enrichment of expression in 
the placenta of genes in schizophrenia GWAS significant loci pro-
vides circumstantial evidence that the interaction of these loci with 
ELCs on risk for schizophrenia arises at least in part because of 
primary effects in the placenta. To achieve a more direct test of this 
possibility, we created new PRSs based on the GWAS SNPs mark-
ing loci-containing genes highly expressed in normal placentae 
and dynamically modulated in placentae from complicated preg-
nancies (Table 2 and Supplementary Table 9), and compared their 
interaction with ELCs with PRSs derived from the SNPs marking 
the remaining GWAS significant loci, first in our discovery sample 
(scz_lie_eur; Fig. 3a–d). The PRSs from the former group sig-
nificantly interact with ELCs in increasing risk for schizophrenia 
(PlacPRS1 (PRS1 “placental” subset based on 56 SNPs): t = 2.86, 
P = 0.004; PlacPRS2 (PRS2 “placental” subset based on 112 SNPs): 
t = 3.10, P = 0.002; Fig. 3a,c), whereas those from the latter do not 
(NonPlacPRS1 (PRS1 “non-placental” subset based on 49 SNPs): 
t = 0.78, P = 0.43; NonPlacPRS2 (PRS2 “non-placental” subset 
based on 125 SNPs): t = − 0.53, P = 0.60; Fig. 3b,d). Similar results 
were found in both other case–control samples (Supplementary 
Figs. 7 and 8). Analyses on the merged samples of cases and con-
trols (scz_lie_eur, scz_bari_eur, scz_munc_eur: N = 1,693) con-
firm these results; PlacPRS1 (t = 3.19, P = 0.0014) and PlacPRS2 
(t = 3.28, P = 0.0011) significantly interact with ELCs on case–
control status, whereas NonPlacPRS1 and NonPlacPRS2 do not 
(Supplementary Fig. 9).
To verify the specificity of these interactions to placenta gene 
expression, we calculated PRSs based on the genes highly expressed 
in various adult and fetal tissues/embryonic cells, and differentially 
expressed in these organs during pathological/stress compared with 
the normal condition, employing the same procedure that we used 
for the computation of PlacPRSs and NonPlacPRSs (Supplementary 
information, see “Sensitivity analyses for placental enrichment” 
note). We also calculated brain PRSs, based on SNPs in PRS1 and 
PRS2 loci associated with methylation quantitative trait loci in adult 
brain29 and with chromatin interaction in fetal brain27. In all of these 
sensitivity analyses, the PRSs comprising SNPs marking loci having 
genes highly expressed in these diverse adult and fetal tissues, and 
dynamically regulated in adult and fetal brain, as in the pathology 
of heart, liver, and stomach, and in pathological cells of embryonic 
origins, do not significantly interact with ELCs on risk for schizo-
phrenia (all P > 0.16 after false discovery rate correction; results are 
in Supplementary Tables 12–14), whereas only the SNPs mapping to 
the loci highly expressed and differentially expressed in placenta do.
Biological insights about placental-enriched genes associated 
with ELCs. Both PlacPRS1 and PlacPRS2 genes are significantly 
enriched for many pathways related to metabolic and cellular stress 
and hypoxia, particularly to “unfolded protein response”, “mito-
chondrial dysfunction”, and “HIF1α signaling” (Supplementary Figs. 
10 and 11; Supplementary Table 15), whereas not a single significant 
pathway enrichment could be obtained from the remaining PRS1 
and PRS2 genes (NonPlacPRS1 and NonPlacPRS2), as well as from 
the whole PRS1 and PRS2 gene sets, consistent with the analogously 
negative results of the original analysis of the GWAS significant 
loci16 (Supplementary information, see “Pathway, functional and co-
expression analyses” note). Notably, the pathways (Supplementary 
Figs. 10 and 11; Supplementary Table 15), biological functions and 
processes (Fig. 3e; Supplementary Figs. 12–14; Supplementary 
Tables 16, 17), and cellular compartments (Supplementary Figs. 
15 and 16; Supplementary Table 17) implicated in PlacPRS genes 
are virtually orthogonal to those highlighted in other analyses of 
schizophrenia loci, such as synaptic function, calcium signal-
ing, fragile X–associated proteins, and chromatin remodeling16. 
Interestingly, and in contrast, genes in the NonPlacPRSs do tend 
to implicate some of these brain-relevant functions. These results 
suggest that the loci containing the schizophrenia-associated genes 
dynamically modulated and most enriched in the placenta contrib-
ute to schizophrenia risk at least in part by influencing the fetal/
placental response to stress (Supplementary Figs. 17–19), as exem-
plified by the cellular stress response factor HSF144,45 being the main 
transcriptional regulator of genes in PlacPRS2 (Supplementary 
Fig. 18 and Supplementary Table 18). Moreover, co-expression 
analyses reveal that the PlacPRS1 and PlacPRS2 genes are sig-
nificantly co-expressed with immune response genes, in contrast 
with NonPlacPRS1 and NonPlacPRS2 genes, as well as similarly 
sized gene sets of non-schizophrenia-associated genes in the same 
datasets (Supplementary Tables 19 and 20; Supplementary Fig. 
20; Supplementary information, see “Pathway, functional and co-
expression analyses” note).
The suggestion of a distinct and orthogonal biology for the 
placental component of genomic risk raises the question whether 
genetic prediction might be enhanced by deconstructing genomic 
risk into discrete subcompartments that represent alternate risk 
biologies. An exploratory analysis revealed that the aggregate 
effect on prediction accuracy of the SNPs contributing to PRS3–10 
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Fig. 4 | Upregulation of schizophrenia risk genes in male compared with female placentae. a,b, PRS1 and PRS2 genes were tested for enrichment among 
the differentially expressed genes in placentae from male compared with female offspring in two placental datasets (a: GSE35574: N =  40, 17 females 
and 23 males; b: GSE25906: N =  37, 16 females and 21 males). Shown are the density plots of the t-statistics, from the differential expression analysis, of 
PRS1 and PRS2 genes (dark gray area), and of all of the other genes in PRSs (PRS3–10, ivory area) constructed from lesser statistical thresholds (negative 
t-statistics =  more expressed in females; positive t-statistics =  more expressed in males; Pone-sided from the Wilcoxon ‘geneSetTest’ statistics at the top of 
the graphic). Dotted lines depict 95% confidence intervals and median of the moderated t-statistics from the differential expression analysis (multiple 
regression) of PRS1 and PRS2 genes (red double-dotted lines) and of PRS3–10 genes (black dotted lines).
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(which include PRS1 loci) is higher when separating the contribu-
tion of PRS1 (Supplementary Fig. 21; Supplementary information, 
see “Variance of schizophrenia liability explained by ‘decomposed’ 
PRS’s” note for details). This is particularly true in the context of a 
history of ELCs, for each PRS. These results suggest that decom-
posing PRSs based on early environmental exposure and placental 
genetic risk may increase the prediction accuracy of genetic varia-
tion for schizophrenia.
Sex-specific analyses. The interaction between ELCs and genetic 
risk for schizophrenia is consistent with a body of literature point-
ing to the placenta as a mediator of stress effects on the develop-
ing brain7–9. Animal studies also have shown that the outcomes of 
altered placental functioning on neurodevelopment are substan-
tially sex-specific, with males more vulnerable than females to pre-
natal adversity8,9. Epidemiological studies of schizophrenia suggest 
that incidence is higher in males than in females2,46,47, despite the 
prevalence being similar across sexes1,2, likely because of higher 
mortality in males48. Consistently, most evidence suggests that 
males have an earlier age of onset of schizophrenia49,50, which is also 
a predictor of a worse prognosis49–51, and is plausibly linked with a 
higher sensitivity to early developmental risk factors. These obser-
vations raise the possibility that expression of schizophrenia risk-
associated genes may be different in placentae of male compared 
with female offspring, and this might relate to the greater incidence 
of developmental disorders like schizophrenia among males2,52. We 
therefore tested whether PRS1 and PRS2 genes, which interact with 
ELCs on case–control status, are differentially expressed in placen-
tae from male compared with female offspring. Analyses on pla-
cental samples from the two datasets with sex information revealed 
that PRS1 and PRS2 genes are highly significantly enriched among 
the genes differentially expressed, and specifically upregulated, in 
placentae from male compared with female offspring (GSE35574: 
N = 40, 17 females and 23 males, P = 4.9 × 10–8, Fig. 4a; GSE25906: 
N = 37, 16 females and 21 males, P = 2.3 × 10–10; Fig. 4b). In the same 
datasets, the relative upregulation was also present in male pre-
eclamptic placentae (GSE35574: P = 0.01; GSE25906: P = 0.001). 
Analogous analyses in a heart dataset (GSE4172) and a fetal lung 
dataset (GSE14334) with sex information did not reveal upregula-
tion of the PRS1 and PRS2 genes in males compared with females 
(P > 0.40; Supplementary information, see “Sensitivity analyses for 
placental enrichment” note). These data suggest a sex-biased role 
for the placenta in expressing genetic risk for schizophrenia.
Discussion
In this study, we show that exposure to ELCs represents an early 
environmental context that influences cumulative genomic risk for 
schizophrenia derived from GWAS significant loci. More to the 
point, the set of genes within these genomic loci that show inter-
action with intra-uterine and perinatal complications is highly 
expressed in placenta, and the same set of genes displays differen-
tial enrichment in this organ in abnormal invasive placental states. 
These results suggest that the most significant genetic variants 
detected by current GWASs16 contribute to risk for schizophrenia at 
least partly by converging on a developmental trajectory sensitive to 
intra-uterine and perinatal adversity, and linked with abnormal pla-
centation. Moreover, the strikingly relative enrichment of expres-
sion of schizophrenia risk genes in placentae from male compared 
with female offspring suggests that gene–environment interactions 
influencing placental biology may contribute to the higher inci-
dence of schizophrenia in males compared with females2.
Our results indicate a link between placental biology, ELCs, and 
schizophrenia, even as the syndrome is diagnosed during early 
adult life, which resonates with a broader evolutionary perspective 
and the developmental trajectory of schizophrenia. Schizophrenia 
is thought to be a condition on which the human species has a 
monopoly, and the delayed emergence of the clinical disorder 
has been posited to reflect the relatively late maturation of highly 
evolved neural functions, such as prefrontal cortical circuitry11. 
Interestingly, the evolutionary complexity of the primate placenta 
shows parallels with the phylogenetically remarkable expan-
sion of the human brain, particularly prefrontal cortical regions 
that are among the most affected in schizophrenia53,54; both pla-
cental complexity and brain expansion come with higher rates of 
ELCs in humans than in other species53,55. Our results are consistent 
with the possibility that some of the common genes implicated in 
schizophrenia risk—through diverse biological mechanisms—regu-
late the physiology of the placenta, the risk of ELCs, and thereby 
secondarily the development of the brain, potentially interacting 
with other mechanisms of gene regulation acting primarily within 
fetal brain27,56.
Despite many studies that have stressed the role of prenatal devel-
opment and early-life events in affecting risk for brain disorders like 
schizophrenia5,12,13,57, as well as autism58,59, the mechanisms by which 
this may happen have been elusive. Genetic research has been suc-
cessfully focused on detecting GWAS significant variants, but the 
difficulty of collecting environmental data has hindered defining 
the developmental context in which these common variants may 
have their critical effects. Our results underscore the importance of 
assessing early environmental factors such as obstetrical complica-
tions, in addition to genetic risk, to fully investigate their joint effect 
on susceptibility to neurodevelopmental disorders. Our results also 
point to the placenta as a crucial mediator of this interaction in rela-
tion to schizophrenia in particular, but likely to other neurodevel-
opmental disorders in general, underscoring the need for further 
research on placenta physiology in the context of brain develop-
ment and genomic risk. Pursuing this path should advance the role 
of prenatal care for reducing the burden of psychiatric illness and 
may identify new strategies60 for placental health as a form of pri-
mary prevention of schizophrenia, perhaps particularly in males 
with high genetic risk.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41591-018-0021-y.
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Methods
Compliance with ethical requirements All procedures performed in the clinical 
samples were in accordance with the ethical standards of the institutional research 
committees and with the 1964 Declaration of Helsinki and its later amendments or 
comparable ethical standards. Informed consent was obtained from all individual 
participants included in this study.
Samples and genotyping. 
•	 Discovery sample (USA): scz_lie_eur. A total of 501 Caucasian unrelated adult 
subjects, with good-quality genetics data and ELC history information (as 
described later), were selected from participants in the Clinical Brain Disor-
ders Branch Sibling Study of Schizophrenia at the National Institute of Men-
tal Health (NIMH; Clinical Brain Disorders Branch, protocol 95-M-0150, 
NCT00001486, Annual Report number: ZIA MH002942-05). The sample 
included 234 patients who met Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) criteria for schizophrenia and 267 healthy 
subjects (see Supplementary Table 2 for details). The Institutional Review Board 
of the NIMH Intramural Program approved the study, and written informed 
consent was obtained from the participants after complete description of the 
study. Exclusion and inclusion criteria have been previously reported61. Geno-
typing was done using Illumina BeadChips (510/610/660/2.5). 
•	 First replication sample (Italy): scz_bari_eur. A total number of 273 Italian 
Caucasian unrelated adult subjects from the Region of Puglia, Italy (91 schiz-
ophrenia cases and 182 controls; see Supplementary Table 2 for details) with 
availability of genetics data and ELC history information, similar to the discov-
ery sample, entered the study. The Institutional Review Board of University of 
Bari “Aldo Moro”, Bari (Italy), approved protocols and procedures, and written 
informed consent was obtained from the participants after complete descrip-
tion of the study. Exclusion and inclusion criteria were similar to the discovery 
sample, as reported elsewhere62. Genotyping was done using Illumina Bead-
Chips (510/610/660/2.5). 
•	 Second replication sample (Germany): scz_munc_eur. A total of 919 Caucasian 
unrelated adult subjects entered the study (521 schizophrenia cases and 298 
controls; see Supplementary Table 2 for details). Cases were ascertained from 
the Munich area of Germany, as described previously17. The controls were unre-
lated volunteers randomly selected from the general population of Munich. 
All were screened to exclude a history of psychosis/central neurological dis-
ease either personally or in a first-degree relative. All participants gave written 
informed consent, and the ethic committee of the Ludwig Maximilians Univer-
sity, Munich (Germany), approved the human subjects protocols. Genotyping 
was done with the Illumina 317 K array. 
•	 Third replication sample (Germany): scz_gras_eur. The GRAS collection 
included 1,020 unrelated adult patients with schizophrenia (see Supplemen-
tary Table 2 for details), recruited across 23 German hospitals. Cases com-
pleted a structured clinical interview and were diagnosed with DSM-IV 
schizophrenia or schizoaffective disorder63,64. The study was approved by the 
Georg-August-University ethics committee and Ethics Committee of the 
University of Göttingen, Göttingen (Germany). All participants gave written 
informed consent. Genotyping was done with a semicustom Axiom myDesign 
genotyping array (Affymetrix, Santa Clara, CA, USA), based on a CEU (Cau-
casian residents of European ancestry from Utah, USA) marker backbone and 
a custom marker set. 
•	 Fourth replication sample (Eastern Asia): scz_osak_asi. A total of 172 Japa-
nese unrelated adult patients who met DSM-IV criteria for schizophrenia 
(see Supplementary Table 2 for details) with availability of genetics data and 
ELC exposure information, similar to the discovery sample, entered the study. 
The Institutional Review Board of University of Osaka, Osaka (Japan), approved 
protocols and procedures, and written informed consent was obtained from the 
participants after complete description of the study. Exclusion and inclusion 
criteria were similar to the other samples65. Genotyping of this sample was done 
using the Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa 
Clara, CA, USA).
Quality control for genotyping. Quality control was performed using PLINK 
(version 1.07; http://pngu.mgh.harvard.edu/purcell/plink/)66, consistent with 
previous reference, for the scz_lie_eur, scz_bari_eur, scz_munc_eur, and  
scz_osak_asi samples16. Participants with missing rate higher than 2% and extreme 
heterozygosity values ( ± 3 s.d.) were removed. SNPs with missing rate higher 
than 2% and difference in missingness between cases and controls > 0.02 were 
also removed. In addition, SNPs were excluded if they failed Hardy–Weinberg 
equilibrium (P < 10−6 in controls or P < 10−10 in cases) and if they had minor allele 
frequency less than 1%. Prephasing was done before imputation using SHAPEIT, 
and imputation was done using IMPUTE2 with Phase I 1000 genome as the 
reference panel67,68. The quality-control procedure in the scz_gras_eur sample was 
consistent with the other samples, as described previously69.
Derivation of polygenic risk profile scores. Cumulative genetic risk profile scores 
(PRSs)21 were calculated for each individual, as described elsewhere20. In brief, 
PRSs are a measure of genomic risk21 calculated as the weighted sum of risk alleles 
for schizophrenia from the recent GWAS study16,20. We thus multiplied the natural 
log of the OR of each index SNP, from this recent schizophrenia GWAS16, by the 
imputation probability for the corresponding reference allele at each variant, and 
summed the products over all variants, so that each subject had whole genome 
PRSs as originally described for this measure20,21. The PGC provided ORs and 
index SNPs for each sample. For the scz_lie_eur sample, ORs and 102K index  
SNPs were derived from a meta-analysis of PGC GWAS datasets excluding our 
discovery sample (PGC 2014, non-scz_lie_eur PGC GWAS)16. Consistently, for the 
scz_munc_eur and the scz_gras_eur samples (also included in the PGC GWAS16), 
ORs and index SNPs were derived from a meta-analysis of PGC GWAS datasets, 
excluding, respectively, the scz_munc_eur and the scz_gras_eur samples. For the 
scz_bari_eur and scz_osak_asi samples, ORs and index SNPs were derived from 
the PGC GWAS datasets, because these samples are not included in the PGC 
GWAS dataset16. Consistent with the standard procedure for PRS calculation16,20, 
only autosomal SNPs were included in the analysis, to prevent any bias related to 
sex in the PRS calculation. We performed a linkage disequilibrium (LD) pruning 
and clumping of the SNPs, discarding variants within 500 kb of, and in r2 ≥ 0.1 
with, another (more significant) marker, as reported elsewhere16,20. Ten PRSs 
(PRS1–10) were calculated using subsets of SNPs selected according to the GWAS 
P value thresholds of association with schizophrenia: 5e− 08 (PRS1), 1e− 06 (PRS2), 
1e− 04 (PRS3), 0.001 (PRS4), 0.01 (PRS5), 0.05 (PRS6), 0.1 (PRS7), 0.2 (PRS8), 
0.5 (PRS9), and 1 (PRS10). SNPs in sets with lower P values are also in sets with 
higher P values (for example, SNPs in PRS1 are included in PRS2, SNPs in PRS2 
are included in PRS3, and so on). A detailed list of SNPs included in PRS1 and 
PRS2 is provided in Supplementary Table 1. We performed all of the analyses both 
including and excluding the top GWAS significant SNP in the extended MHC 
locus (hg19 coordinates: chr6: 25–34 Mb), with similar results (Supplementary 
Table 4). For additional analyses (Supplementary Fig. 21; Supplementary 
information, see “Variance of schizophrenia liability explained by ‘decomposed’ 
PRS’s” note), we also calculated PRSs from sets of SNPs with higher P values 
(PRS2–10) without including SNPs in sets with the lowest P values (PRS1).
Assessment of early-life complications. ELCs are here referred to as “somatic 
complications and conditions occurring during pregnancy, labor-delivery and the 
neonatal period” potentially harmful for the offspring, with special focus on the 
central nervous system22,23. These events are also referred to elsewhere as “obstetric 
complications”14,22,23 and, despite their potential frequent occurrence70, do not lead 
to negative outcomes in most cases. We assessed ELCs through medical records, 
when available, and personal interviews, described as follows:
•	 scz_lie_eur, and scz_bari_eur: We used mainly maternal recall based on an 
extensive personal interview, which has been repeatedly shown to represent a 
reliable method for obtaining ELC history, when used in a careful and detailed 
manner71,72. Specifically, we used a well-standardized and validated question-
naire14, based on all the items scored with the McNeil–Sjöström scale for 
obstetric complications22,23. It covers the entire duration of pregnancy and early 
neonatal life, and also contains indicators of reliability and an assessment of the 
seriousness of each complication.
•	 scz_osak_asi: We used mainly medical records. When medical records were not 
exhaustive, we interviewed the mothers of the patients; the histories were again 
scored directly based on the McNeil–Sjöström metrics23. 
•	 scz_munc_eur and scz_gras_eur: We used medical records, including all the 
discharge letters of patients, and personal interviews. Differently from the 
questionnaires used in the other samples, these interviews did not contain all 
the items included in the McNeil–Sjöström scale23, thus increasing the risk for 
incomplete information. History of ELCs from the available information was 
again scored using the McNeil–Sjöström scale22,23.
In the McNeil–Sjöström scale22,23 each ELC is assigned a severity level of 1–6, 
based on the degree of inferred potential harm to the offspring central nervous 
system. ELCs with severity weight ≥ 4 are considered potentially clearly harmful 
or relevant factors in fetal stress. The McNeil–Sjöström scale in the context 
of maternal recollection has been well validated in comparison with hospital 
records22. As in other reports22,24,25, we defined a positive history of ELCs based 
on the presence of at least one serious ELC (severity level ≥ 4), and we identified 
the severity level of each individual as the highest severity level of all of the ELCs 
occurring in that individual. GWAS-derived PRSs were unknown to both the 
individuals who provided the information about ELCs and to the researchers 
who collected and evaluated them. Individuals were excluded if the information 
provided was incomplete or inconsistent (for example, contradictory answers to 
related questions), or if the presence of a complication was certain but a severity 
weight could not be confidently determined. The frequency of ELCs in our 
samples may be not representative of the general populations (Supplementary 
information, see “Considerations about the assessment and the frequency of early 
life complications (ELCs)” note). Supplementary Table 21 contains a list of the 
ELCs detected in each sample.
Statistical analysis of the interaction between polygenic risk scores  
and early-life complications on case–control status. All statistical analyses  
were performed in the ‘R’ environment73. To test the central hypothesis  
of this study (that is, the interaction between PRS1 and ELCs on case–control status), 
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we used multiple logistic regression, with the following model: Diagnosis  
~ PRS + ELCs + PRS*ELCs + covariates. We also used multiple logistic regressions 
to confirm the association of each PRS with case–control status in our samples 
(Diagnosis ~ PRS + covariates) and to verify whether ELCs were associated with 
schizophrenia (Diagnosis ~ ELCs + covariates). In the presence of an interaction 
between PRS and ELCs, we performed post hoc analyses to evaluate the 
relationship between PRS and case–control status, in the presence and absence of 
ELC history (that is, stratifying the sample, based on ELC history), using the same 
model described earlier (Diagnosis ~ PRS + covariates). For all of these analyses, 
we report in the main text the P values and the t-statistics associated with our 
variable of interest (that is, PRS*ELCs, or PRS). To evaluate goodness of fit of these 
logistic models (Diagnosis ~ PRS + covariates) in the whole sample, in the absence 
and presence of ELC history, we calculated the Nagelkerke R2, by comparison of a 
full model (covariates + PRS) with a reduced model (covariates only). Similarly, in 
the presence of an interaction between PRS and ELCs on case–control status, we 
performed post hoc analyses to test the relation between PRS and ELCs, separately 
in controls and in patients with schizophrenia (that is, after stratifying the sample 
for diagnosis), using multiple logistic regression (ELC history ~ PRS + covariates). 
Consistently with the interaction between PRS and ELCs, we found a positive 
relation between PRS and ELCs only in patients with schizophrenia; we further 
explored this relationship in the two replication samples of only patients  
(scz_gras_eur, scz_osak_asi). In each analysis, we used 10 ancestry-based principal 
components as covariates, to avoid potential confounding effects of population 
stratification, consistent with previous work16. We performed sensitivity analyses 
adding sex, age, maternal and paternal ages, maternal stress, history of substance 
use, and socioeconomic status, as covariates, and also their interaction with PRS 
and ELCs, as recommended to properly exclude the role of confounders74. We also 
performed sensitivity analyses, in each sample, by excluding the individuals with 
mothers with a history of substance use. Results were consistent and are reported 
in Supplementary Tables 6–8. For the analyses in the merged sample, PRS scores 
were normalized by subtracting the mean and dividing for the s.d. in each sample; 
for this analysis, we added the sample as a covariate.
Selection of PRS1 and PRS2 genes. To define genes mapping to the PRS1 and 
PRS2 loci for gene set analyses, we used two alternative criteria:
•	 PGC LD regions: We considered, as PRS1 and PRS2 genes, all of the University 
of California, Santa Cruz (UCSC) genes overlapping the LD regions associated 
with each SNP (R2 > 0.6), as reported in a previous reference16 and on the PGC 
website (http://www.med.unc.edu/pgc/downloads); 
•	 Distance: We considered, as PRS1 and PRS2 genes, all of the UCSC genes map-
ping 500 kb ± the index SNPs of each PRS in the discovery sample (scz_lie_eur). 
We use this criterion, in addition to the “traditional” LD criterion, on the grounds 
that LD differs among populations, as we analyzed multiple samples. Moreover, 
the LD regions associated with each SNP have a huge variability: for example, 
2 out of the 108 GWAS significant schizophrenia-risk SNPs have an LD region 
that spans only 1 bp (rs4766428, rs117074560)16. Further, it has been shown that 
GWAS SNPs are often associated with expression of genes that are not their near-
est genes and are outside the associated LD regions16,75. Finally, the distance of 
500 kb ± the index SNPs is within the range commonly used for detection of 
cis-expression quantitative trait loci (eQTL) 75 and is the same dimension used to 
calculate PGC loci eQTL in the original PGC report 16. This criterion allowed us 
to distribute 21,028 out of 23,056 UCSC genes among the 10 PRSs.
Differences between the two list of genes (reported in Supplementary Table 9a,b) 
are related not only to the criterion adopted for SNP selection (distance or LD), but 
also to the fact that the PGC loci associated with schizophrenia at P < 5 × 10–8  
are defined based on combining the primary GWAS and the supplementary 
deCODE data, whereas SNPs for PRS calculation are derived from the primary 
GWAS only16. Because only SNPs mapping to autosomal chromosomes are used 
for schizophrenia PRS construction16,20, we excluded from our analysis genes 
that were irrelevant to our question, that is, genes mapping to mitochondrial 
DNA, and X- and Y-chromosome genes or other genes mapping to loci not used 
for PRS calculation. After exclusion of the genes on sex chromosomes and on 
mitochondrial DNA, and genes undetected in the expression datasets analyzed, 
the final number of PRS1 and PRS2 genes was 1,643 in the list based on distance 
(matching 325 out of the 348 genes assigned to the 108 schizophrenia GWAS 
significant loci16), and 589 in the gene list based on LD (matching 334 out of the 
348 genes assigned to the 108 schizophrenia GWAS significant loci16). In both gene 
lists, PRS1 genes are a subset of PRS2 genes (therefore referred in the text as PRS1 
and PRS2 genes). We performed all of the gene set analyses, with PRS1 and PRS2 
genes defined with both criteria (LD and distance), and found consistent results 
(Supplementary Table 9). In the main text, we report results with the PRS1 and 
PRS2 genes defined based on the distance criterion (Table 2).
Expression of PRS1 and PRS2 genes in placenta. The proprietary placental tissue 
used for this analysis was collected at the University of California, San Francisco. 
Methods of collection were approved by the University of California, San Francisco 
Institutional Review Board, and informed consent was obtained from all donors. 
The RNA-sequencing datasets related to second trimester and term placental 
tissues (amnion, basal plate, chorion, villi) and isolated cells (trophoblasts) are 
publicly available (GSE16368) on the National Institutes of Health Roadmap 
Epigenomics Project website (http://www.roadmapepigenomics.org/). Expression 
levels of each gene were quantified by determining reads per kilobase of transcript 
per million values76. Based on our primary hypothesis and on the fact that PRS1 
and PRS2 risk SNPs are associated with expression of nearby genes across many 
different tissues (Supplementary information, see “Screening of PRS1 and PRS2 
SNPs for eQTLs across different tissues”), we tested whether the genes mapping 
to the loci showing the strongest association with schizophrenia and interacting 
with ELCs are more expressed in placenta compared with randomly selected genes 
contributing to the other PRSs constructed from alleles showing association with 
schizophrenia at lesser thresholds of significance, which do not show an interaction 
with ELCs. To perform this analysis, we used the function ‘geneSetTest’ in the 
R package ‘limma’77, using the gene expression data from the RNA-sequencing 
analysis in placenta. With this function, we calculated a P value from a Wilcoxon 
test to verify the hypothesis that the selected set of genes (PRS1 and PRS2) 
tends to be more highly ranked in expression compared with randomly selected 
sets of genes of the same size (from the PRS3–10 genes). Results are reported 
in Supplementary Table 10. We also performed a further analysis testing the 
enrichment of the genes overlapping the PRS1 and PRS2 loci using the function 
‘findOverlaps’ in the R package ‘GenomicRanges’78 (either including or excluding 
genes with reads per kilobase of transcript per million expression > 0.01) and, as 
predictable, we obtained similar results.
Differential expression of PRS1 and PRS2 genes in placentae from complicated 
pregnancies. We searched for enrichment of the PRS1 and PRS2 genes among 
genes differentially expressed in placental samples from complicated pregnancies 
compared with controls. We interrogated placental datasets from the Gene 
Expression Omnibus public repository. Datasets were chosen for analysis if they 
included all of the following: a comparison between placental samples from 
complicated pregnancies and controls, more than one sample per group (that is, 
comparisons between pooled RNA samples were discarded), and expression data 
for at least half of the PRS genes. We found eight datasets that met these criteria, 
comparing control versus diseased (pre-eclampsia and IUGR) placenta cells.  
A dataset on normal cultured cytotrophoblasts was also chosen as cells were 
induced into different states of invasiveness. Because two of these datasets contain 
a comparison of controls versus pre-eclamptic and controls versus IUGR placentae, 
we were able to perform 11 differential expression analyses. In each dataset, we 
dropped probes that map to multiple genes and, when more than one probe per 
gene was present, we selected the one with the highest mean expression. We used 
the function ‘eBayes’ in the R package ‘limma’77 to attribute a moderated t-statistic 
to each gene related to differential expression (using the covariates provided by 
each reporting group); then we applied the ‘geneSetTest’ function on the moderated 
t-statistics (results are reported in Table 2) testing whether the selected set of 
genes (that is, those related to PRS1 and PRS2) tends to be more highly ranked in 
differential expression compared with randomly selected genes of the same size 
from the other GWAS loci (PRS3–10). We also used a χ 2 test to confirm whether 
PRS1 and PRS2 genes were enriched for differentially expressed genes compared 
with the remaining genes (Table 2).
We chose different thresholds for gene expression to exclude that low-
expressed genes could affect the significance of the results. Also, because PRS1 and 
PRS2 genes are relatively highly expressed in placenta, we performed sensitivity 
analysis, adjusting for average gene expression: for this purpose, we assigned each 
gene a moderated t-statistic from the differential expression analyses, an ‘in-set’ 
value “1” to PRS1 and PRS2 genes, and an ‘inset’ value “0” to the remaining 
genes (PRS3–PRS10); we then analyzed the relationship between the t-statistics 
and the ‘in-set’ variable, after covarying for average gene expression (see results 
in Supplementary Table 11). Importantly, in addition to an enrichment analysis 
of PRS1 and PRS2 genes based on genes mapping 500 kb ± the index SNPs of 
PRS1 and PRS2, we also calculated the enrichment results for the PRS1 and PRS2 
genes, defined as the UCSC genes overlapping the LD regions associated with 
each SNP (R2 > 0.6), as reported on the PGC website (http://www.med.unc.edu/
pgc/downloads) (Supplementary Table 9). We finally tested whether the PRS1 
and PRS2 genes are enriched among the genes that are differentially expressed 
in placentae from male compared with female offspring. Among the placental 
datasets selected in our study, only three (“GSE25861”, “GSE35574”, “GSE25906”) 
contained sex information; one of them (“GSE25861”) included one female sample. 
Therefore, we limited this analysis to the remaining two datasets, “GSE35574” and 
“GSE25906” (Fig. 4). Also, in this case, we performed sensitivity analyses adjusting 
for average gene expression (Supplementary Table 11).
To confirm the specificity of our findings in the placentae from complicated 
pregnancies, we performed similar analyses in available datasets from normal/
affected organs and in embryonic cells under distress (results for all of these 
sensitivity analyses are reported in Table 2, Supplementary Tables 9 and 11, and 
Supplementary information, see “Sensitivity analyses for placental enrichment” note).
Placental-enriched risk profile scoring. We calculated PRSs based on the GWAS 
SNPs marking loci-containing genes highly expressed in placenta and differentially 
expressed in placentae from complicated pregnancies, and compared their 
interaction with ELCs to PRSs derived from the SNPs marking the remaining 
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GWAS significant loci. For this purpose, we selected the loci-containing genes 
differentially expressed (P < 0.05) in at least four of the eight datasets analyzed and 
the loci containing genes with expression in the upper decile both in trophoblast 
and in villi. This gave us a list of 56 SNPs for PRS1 and 112 SNPs for PRS2, as 
marking loci with genes dynamically modulated and enriched in placenta; we then 
calculated PRSs based on these SNPs (“Placental” risk profile scores, PlacPRS1 
and PlacPRS2) and on the remaining SNPs in these PRS1 and PRS2 loci that 
did not show high or differential expression in placental tissues (NonPlacPRS1 
and NonPlacPRS2), as described earlier (see earlier "Derivation of polygenic 
risk profile scores" section). In an analogous way and to address the organ 
specificity of the PlacPRS interaction with ELCs, we calculated “TissuePRSs” and 
“NonTissuePRSs” based on SNPs marking PRS1 and PRS2 loci-containing genes 
highly and differentially expressed in adult and fetal tissues, or associated with 
methylation quantitative trait loci in postmortem human dorsolateral prefrontal 
cortex29, or with chromatin interactions in fetal brain27. We then analyzed the 
interaction of these TissuePRSs and NonTissuePRSs with ELCs on case–control 
status. Results of these sensitivity analyses are reported in Supplementary Tables 
12–14 and in the Supplementary information (see “Sensitivity analyses for 
placental enrichment” note).
Pathway and functional analyses. We investigated whether the placenta-enriched 
genes mapping to the loci of PlacPRS1 and PlacPRS2 are enriched for particular 
biological features, compared with the remaining genes mapping to the PRS1 
and PRS2 loci (NonPlacPRS1 and NonPlacPRS2). Data were analyzed through 
QIAGEN’s Ingenuity Pathway Analysis (QIAGEN, Redwood City, CA, USA;  
http://www.qiagen.com/ingenuity). The software determines the pathways and 
biological processes enriched for a given set of genes by considering the number 
of focus genes that participate in each process and the total number of genes that 
are known to be associated with that process in the selected reference set. We 
performed the Ingenuity Pathway Analysis “core” analysis, using default parameters 
(reference set: Ingenuity Knowledge Base; relationships: direct and indirect; node 
types: all; data sources: all; confidence: experimentally observed and high; species: 
human, mouse, and rat; tissues and cell lines: all; mutations: all). We chose a  
P value calculation based on the Benjamini–Hochberg method of accounting for 
multiple testing in the canonical pathway and functional analyses. In addition, we 
used the Panther tool79 on the Gene Ontology database (http://geneontology.org)  
for statistical overrepresentation testing, to further explore whether PlacPRS1 and 
PlacPRS2 genes and NonPlacPRS1 and NonPlacPRS2 genes show differences in 
enrichment among Gene Ontology terms associated with molecular functions, 
biological processes, and cellular components. In this analysis, the P value calculation 
is based by default on the Bonferroni method of accounting for multiple testing.
Reporting Summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this article.
Data and code availability. To protect the privacy of the study participants, the 
genetic and ELC data generated and analyzed during this study are available 
from the corresponding author on reasonable request, together with the codes 
used for the analyses. The placental datasets and the other gene expression 
datasets analyzed in this study are available on the Gene Expression Omnibus 
repository (https://www.ncbi.nlm.nih.gov/geo/) under the accession codes 
provided in this article.
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Abstract
Autoantibodies of the IgG class against N-methyl-D-aspartate-receptor subunit-NR1 (NMDAR1-AB) were considered
pathognomonic for anti-NMDAR encephalitis. This view has been challenged by the age-dependent seroprevalence (up to
>20%) of functional NMDAR1-AB of all immunoglobulin classes found in >5000 individuals, healthy or affected by
different diseases. These findings question a merely encephalitogenic role of NMDAR1-AB. Here, we show that NMDAR1-
AB belong to the normal autoimmune repertoire of dogs, cats, rats, mice, baboons, and rhesus macaques, and are functional
in the NMDAR1 internalization assay based on human IPSC-derived cortical neurons. The age dependence of
seroprevalence is lost in nonhuman primates in captivity and in human migrants, raising the intriguing possibility that
chronic life stress may be related to NMDAR1-AB formation, predominantly of the IgA class. Active immunization of
ApoE−/− and ApoE+/+ mice against four peptides of the extracellular NMDAR1 domain or ovalbumin (control) leads to high
circulating levels of specific AB. After 4 weeks, the endogenously formed NMDAR1-AB (IgG) induce psychosis-like
symptoms upon MK-801 challenge in ApoE−/− mice, characterized by an open blood–brain barrier, but not in their ApoE+/+
littermates, which are indistinguishable from ovalbumin controls. Importantly, NMDAR1-AB do not induce any sign of
inflammation in the brain. Immunohistochemical staining for microglial activation markers and T lymphocytes in the
hippocampus yields comparable results in ApoE−/− and ApoE+/+ mice, irrespective of immunization against NMDAR1 or
ovalbumin. These data suggest that NMDAR1-AB of the IgG class shape behavioral phenotypes upon access to the brain but
do not cause brain inflammation on their own.
Introduction
Autoantibodies (AB) of the immunoglobulin G (IgG) class
against the N-methyl-D-aspartate-receptor subunit-NR1
(NMDAR1) were originally interpreted as pathognomonic
for a condition called “anti-NMDAR encephalitis”, char-
acterized by high serum and cerebrospinal fluid (CSF) titers
of these AB, as well as a variably favorable response to
immunosuppressive therapy. The reported syndrome,
reflecting typical NMDAR1 antagonistic actions, consisted of
psychosis, epileptic seizures, dyskinesia, cognitive decline,
reduced consciousness, and autonomic dysregulation [1–4].
However, work on >5000 individuals, healthy or affected by
different diseases, consistently revealed overall comparable
age-dependent seroprevalence of functional NMDAR1-AB
of all Ig classes, nurturing serious doubts regarding a purely
pathological role of NMDAR1-AB of any Ig class [5–10].
NMDAR1-AB apparently belong to a pre-existing
autoimmune repertoire [11–17], where Ig isotypes are
determined by extracellular vs. intracellular antigen location
[6]. This may explain the rarity of the IgG class among AB
directed against extracellular epitopes, e.g., NMDAR1,










MOG, and CASPR2. In contrast, AB that recognize intra-
cellular antigens, e.g., amphiphysin, ARHGAP26, or
GAD65, show predominance of IgG [6]. Despite this
apparent “physiological autoimmunity”, no report exists that
systematically screened mammals other than humans for the
presence of NMDAR1-AB. In recent work, we found that
all naturally occurring NMDAR1-AB are functional and
thus have pathogenic potential irrespective of epitope and Ig
class [10]. Pathophysiological significance may emerge in
conditions of compromised blood–brain barrier (BBB), for
instance, upon injury, infection, inflammation, or genetic
predisposition (APOE4 haplotype), which then allows
substantial access of circulating NMDAR1-AB to the brain
where they act as NMDAR antagonists [5, 9, 18–20].
Alternatively, AB-specific plasma cells may reside or settle
in the brain and produce large amounts of AB intrathecally
[14, 21]. The question whether abundant endogenously
produced NMDAR1-AB of the IgG class can—upon access
to the brain—induce inflammation and thus “anti-NMDAR1
encephalitis” has never been experimentally addressed.
The present paper has therefore been designed to (i) sys-
tematically screen mammals other than humans for ser-
oprevalence of functional NMDAR1-AB and (ii) study mice
with open BBB behavioral and morphological consequences
of high circulating levels of endogenous NMDAR1-AB of
the IgG class formed in response to immunization.
Materials and methods
Ethical approvals
Ethics committees of Georg-August University, Göttingen,
and collaborating centers approved the Göttingen Research
Association for Schizophrenia (GRAS) data collection and
other studies “extended GRAS” acquiring human data,
serum samples, and IPSC [5, 6, 8, 9, 22, 23]. Hannover
Medical School Ethics Committee approved the neuro-
surgical specimen collection. Studies comply with Helsinki
Declaration. Patients gave written informed consent. Mouse
studies were approved by Animal Ethics (LAVES,
Oldenburg) following German Animal Protection Law.
Notes: All experiments were performed by researchers
unaware of group assignment. The new nomenclature
GluN1 for NMDAR1 is mostly disregarded here for con-
sistency with the respective literature.
Human samples
GRAS and “extended GRAS”
The GRAS [22, 23] subsample used here consists of deep-
phenotyped patients (N= 970; age 39.29± 0.40 years; 66.3%
men), diagnosed with schizophrenia or schizoaffective disorder
according to DSM-IV-TR [24]. Subjects of “extended GRAS”
(N= 4933; age 43.29± 0.24 years; 56.9% men) comprise
healthy individuals and patients with different neuropsychiatric
diagnoses, including schizophrenia, affective disorders, multi-
ple sclerosis, Parkinson, ALS, stroke, and personality disorders
(detailed description in [5, 6, 8, 9]). For this study, subjects are
dichotomously classified as nonmigrants or migrants compris-
ing first (patient migrated) and second generation (parents
migrated). Identified migrants (N= 301/N= 4933) are from
Europe (49.8%), Asia (36.9%), Africa (9%), North America
(2%), South America (0.7%), or mixed (1.6%).
Neurosurgical patients
A total of N= 72 paired samples of serum and ventricular CSF
were available from patients (N= 45 women; age 55.9± 2.2
years; N= 27 men; age 60.2± 2.7 years) undergoing neuro-
surgery for various reasons: meningiomas, metastases, and
other brain tumors (N= 25); intracerebral/subarachnoid
hemorrhages (N= 20); hydrocephalus (N= 12); arterial
aneurysms (N= 7); trigeminal neuralgia (N= 4); and others
(N= 4). Most pairs were taken simultaneously at the time point
of surgery, i.e., <5min (N= 64) or <30min (N= 8) apart.
Other mammals
Dogs and cats
Serum samples from dogs and cats of different breeds were
prospectively collected during routine (health check/vacci-
nation) or diagnostic (spectrum of different disorders)
workup of outpatients in the Small Animal Clinic, Uni-
versity of Veterinary Medicine, Hannover.
Monkeys
Serum samples from healthy baboons and rhesus macaques
were obtained through routine checkups at the Leibniz
Institute for Primate Research, Göttingen.
Rodents
Serum samples from healthy rats and mice were obtained at
the Max Planck Institute of Experimental Medicine and the
Institute for Multiple Sclerosis Research, Göttingen.
Serological analyses
NMDAR1-AB determination by clinical standard procedures
Human serum and ventricular CSF were tested for
NMDAR1-AB positivity using commercially available kits,
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based on HEK293T cells transfected with NMDAR1 and
secondary AB against human IgG, IgM, or IgA (Euro-
immun, Lübeck, Germany) [2, 25]. Mouse serum was
analyzed using the same assay with secondary AB against
mouse IgG, IgM, or IgA (M31001, A-31570, A-21042;
Thermo Fisher, Rockford, USA).
NMDAR1-AB IgM screening in monkey samples
HEK293T cells (50,000) cultured at 37 °C/8% CO2 in
DMEM (high glucose, Life Technologies, Carlsbad, USA)
were seeded on a 35 -mm dish, grown for 3 days, and
transfected with 3 µg of myc-His-tagged GluN1-1b cloned
into pcDNA4/TO/myc-His A (Invitrogen, Carlsbad, USA)
using Metafectene-Pro (Biontex, Munich, Germany) [10].
One day post transfection, cells were split onto five poly-D-
lysine-coated coverslips in a 35 -mm dish and 1 day later,
they were fixed with 5% paraformaldehyde (PFA) for 20
min, washed 5× (PBS), permeabilized with 0.1% Triton X-
100 for 5 min, again washed 5× (PBS), and blocked with
5% normal goat serum (NGS; Sigma-Aldrich, Munich,
Germany) for 1 h. After five PBS washes, cells were incu-
bated with serum and monoclonal mouse anti-myc IgG
(clone 9E10, Hollmann-Lab, Bochum) for 1 h, washed
with 10× (PBS), incubated for 1 h with fluorescein-labeled
goat anti-monkey IgM (072-11-031; KPL, Gaithersburg,
USA) and AlexaFluor®594-labeled goat anti-mouse
IgG (A11005; Thermo Fisher) secondary AB, and PBS
washed 5×. Cells were mounted in Fluoromount-G
(Southern Biotech, Birmingham, USA) and analyzed
via TCS-SP2-AOBS confocal microscope (63× oil
immersion objective; Leica-Microsystems, Wetzlar,
Germany). The results were independently assessed by
three investigators.
Protein-A assay
Human serum (for cross-validating clinical standard pro-
cedure and protein-A method), as well as dog, cat, rat, and
monkey serum were labeled with protein-A from Staphy-
lococcus aureus, binding the Fc portion of immunoglobu-
lins of different species [26]. Plasma (50 μl) and 25 μg of
FITC-conjugated protein-A (Sigma-Aldrich) were incu-
bated for 2 h in the dark at room temperature (RT). The
mixture was then diluted to 250 μl (PBS) and unbound
FITC–Protein-A was removed using 100- kDa Amicon filter
units (Sartorius, Göttingen, Germany), reconcentrating to
~50 μl [27]. NMDAR1-AB seropositivity was determined
using Euroimmun assay combined with commercial
monoclonal mouse NMDAR1-AB (114011; M68, SYSY,
Göttingen, Germany). Samples showing distinct double
labeling were rated “positive” (>98% consensus of three
investigators).
Endocytosis assay
Functional studies were conducted with sera following
ammonium-sulfate precipitation of immunoglobulins [28]
and dialysis (Slide-A-Lyzer® Mini Dialysis Units, 10,000
MWCO Plus Float, Thermo Fisher). To assess AB func-
tionality, human IPSC-derived neurons were exposed to
dialyzed serum [10]. For each species, arbitrarily selected
seronegative (N= 1) and seropositive samples (N= 2–3)
were analyzed. Briefly, cells were precooled on ice and
washed prior to incubation in cold HBSS with 1:50 diluted
dialyzed sera, control NMDAR1-AB (M68-SYSY), or
HBSS alone (negative control) for 30 min/4 oC. After
washing to remove unbound AB, neurons were returned to
their media and incubated for 20 min at 37 oC (three cov-
erslips/sample, endocytosis) or 4 °C (one coverslip/sample,
endocytosis control). The remaining surface NMDAR1 was
exposed to mouse anti-human NMDAR1-AB (N-terminal;
ab134308; Abcam, Cambridge, UK, 1:100), followed by
labeling with secondary donkey anti-mouse IgG (A10036;
Life Technologies, AlexaFluor®546, 1:100). Neurons were
fixed with ice-cold 4% PFA and double stained with
chicken anti-NeuN-AB (266006; SYSY, 1:500) and sec-
ondary donkey anti-chicken AB (703-546-155; Life Tech-
nologies, AlexaFluor®488, 1:250). Nuclei were visualized
using DAPI (Sigma-Aldrich, 0.01 µg/ml). After PBS wash,
coverslips were mounted on SuperFrost®-Plus slides with
Mowiol mounting media (Sigma-Aldrich). Confocal laser-
scanning microscopy was used to quantify NMDAR1
density at the membrane (63× glycerol objective; TCS-SP5
Leica-Microsystems, Mannheim, Germany). From each
coverslip, Z series of optical sections (0.5 μm apart) cov-
ering the three-dimensional extension of neurons were
acquired (sequential scanning mode, identical acquisition
parameters). FIJI-ImageJ software [29] was used to ran-
domly select NeuN+ cells and determine soma profile.
Fluorescence intensity/cell surface area (AlexaFluor546)
was automatically measured as readout of
NMDAR1 surface expression. After background subtrac-
tion, the mean intensity for each coverslip was determined
and fluorescence intensity ratio (37/4 °C) was calculated.
BBB-integrity testing
BBB integrity of 12-month-old ApoE−/− (N= 5) and
ApoE+/+ (N= 5) mice was determined using two different
fluorescent tracers, Evans blue (50 mg/g body weight) [30]
and sodium fluorescein (200 mg/g body weight). A detailed
description of this method will be published elsewhere [31].
Briefly, for tracer quantification in the brain at 4 h after
intravenous injection in the tail vein, animals were PBS
perfused to remove the circulating tracer. Brains were dis-
sected, immediately frozen on dry ice, weighed, and stored
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at −80 °C. Tissue was lyophilized at −56 °C for 24 h under
vacuum of 0.2 mBar (Christ LMC-1-BETA-1-16, Osterode,
Germany). For tracer extraction, hemispheres were incu-
bated with shaking in 10 ml formamide/mg brain at 57 °C
for 24 h. Integrated density of tracer fluorescence was
determined in triplicates on a fluorescent microscope
(Observer Z2, Zeiss, Germany), equipped with Axio-
CamMRc3, 1×Camera-Adapter, and ZEN2012 blue-edition
software, recorded at 10× magnification (Plan-Apochromat
10×/0.45M27). Tracer concentration was calculated using a
standard curve and normalized to controls (set to 1).
Mouse immunization
Mice (12-month-old C57BL/6 littermates: ApoE−/−N= 20
and ApoE+/+N= 23; genders balanced) were immunized
with a mixture of GluN1 extracellular peptides and/or
chicken ovalbumin (Sigma-Aldrich), and emulsified in
equal volume of complete Freund’s Adjuvant (Myco-
bacterium tuberculosis H37RA plus incomplete Freund’s
Adjuvant; Becton-Dickinson, Sparks, USA) at a final con-
centration of 1 mg/ml [32]. At the tail base, 50 μg of GluN1
peptides and/or 20 μg of ovalbumin were injected sub-
cutaneously (each side one).
Enzyme-linked immunosorbent assay (ELISA)
Orbital sinus blood of immunized mice was stored as EDTA
plasma at −80 °C. ELISA plates (96 well) were coated with
0.5 μg of GluN1 peptide mixture or 0.2 μg of chicken
ovalbumin in 50 μl PBS/well overnight at 4 °C and blocked
with 5% BSA/PBS (Carl Roth, Karlsruhe, Germany).
Mouse plasma (1:1000 or 1:50,000 5% BSA/PBS
50 μl/well) was added for 2 h at RT. The signal was
amplified with horseradish peroxidase-linked anti-IgG
(Sigma-Aldrich), and 3,3′,5,5′-Tetramethylbenzidine as
colorimetric substrate (BD Biosciences, San Jose, USA).
Absorbance at 450 nm was measured by microplate reader
(Tecan-Trading AG, Männedorf, Switzerland).
Basic behavioral screening
The behavioral test battery was performed as described
previously [33–36]. Starting at age 5 months, experi-
mentally naïve ApoE−/− and ApoE+/+ littermates under-
went (during light phase) tests of anxiety, activity and
exploratory behavior (elevated plus-maze, open field,
hole-board), motor (rotarod, grip strength) and sensory
function (visual cliff, olfaction, hearing, hot plate),
sensorimotor gating (prepulse inhibition), pheromone-
based social preference, and cognitive performance
(IntelliCage place/reversal learning). Males and females
were tested separately.
Baseline and post MK-801 locomotion in the open
field
The open-field apparatus consisted of a gray circular
Perspex-arena (120 cm diameter; wall height 25 cm).
Indirect white light illumination ensured constant light
intensity of 120 lux in the center. Locomotion was mea-
sured using automated tracking software (Viewer2-Biob-
serve, Bonn, Germany). ApoE−/− and ApoE+/+ littermates
received four baseline measurements preimmunization and
post immunization (15 min each), the last followed by
intraperitoneal MK-801 (Dizocilpine-[5S,10R]-(+)-5-
methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-
imine hydrogen maleate; 0.3 μg/10 μl PBS/g Sigma-
Aldrich). MK-801 is a noncompetitive NMDAR antagonist,
acting as a use-dependent ion-channel blocker, and known
to induce psychosis-like hyperactivity in the open field (loss
of inhibition) [37]. Directly post injection, locomotor
activity in open field was analyzed (4 min intervals), with
the first 4 min defined as reference locomotion to express
changes over 120 min as % reference.
Immunohistochemistry
Mice were anesthetized with Avertin (2,2,2-
Tribromoethanol, Sigma-Aldrich), and transcardially per-
fused with 4% PFA/Ringer solution (Braun-Melsungen,
Germany). Brains were removed, postfixed in 4% PFA
overnight at 4 °C, and incubated in 30% sucrose/PBS for
2 days at 4 °C. Brains were cryosectioned coronally into
30 µm slices and stored in 25% ethylene glycol and 25%
glycerol/PBS at −20 °C. Frozen sections (three/mouse;
rostral hippocampus), mounted on SuperFrost®-Plus slides
(Thermo Fisher, Waltham, USA), were used for cell quan-
tification. For CD3 staining, sections were microwaved 3×
for 4 min in citrate buffer (1 mM, pH 6) and blocked with
5% normal horse serum (NHS), and 0.5% Triton X-100/
PBS for 1 h at RT. Incubation with rat anti-mouse CD3
(MCA1477; BioRad, Hercules, USA; 1:100) diluted in 5%
NHS, and 0.5% Triton X-100/PBS was performed for two
nights/4 °C, followed by incubation with goat anti-rat
AlexaFluor®647 (A-21247; Thermo Fisher, Schwerte,
Germany; 1:1000) diluted in 5% NHS, and 0.5% Triton X-
100/PBS for 2 h at RT. For Iba1, GFAP, CD68, and MHC-
II staining, sections were blocked with 5% NGS and/or 5%
NHS in 0.5% Triton X-100/PBS for 1 h at RT. Incubation
with rabbit anti-mouse Iba1 (019-19741; Wako-Chemicals
GmbH, Neuss, Germany; 1:1000), or mouse anti-mouse
GFAP (NCL-GFAP-GA5; Novocastra-Leica, Newcastle
upon Tyne, UK; 1:500), diluted in 3% NGS or 3% NHS,
and 0.5% Triton X-100/PBS, was performed overnight, and
incubation with rat anti-mouse CD68 (MCA1957GA;
BioRad GmbH, München, Germany, 1:400) and rat
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anti-mouse MHC-II (14-5321; eBioscience, San Diego,
USA, 1:100) diluted in 3% NGS and 3% NHS, and 0.5%
Triton X-100/PBS, was performed over two nights, all at 4 °
C. Incubation with secondary antibodies was performed
with goat anti-rabbit AlexaFluor®555 (A-21428; Thermo
Fisher; 1:500) diluted in 3% NGS, 0.5% Triton X-100/PBS,
or donkey anti-rabbit AlexaFluor®488 (A-21206; Thermo
Fisher, 1:500) or donkey anti-mouse AlexaFluor488
(A21202; Thermo Fisher, 1:500) or goat anti-rat Alexa-
Fluor®647 (A-21247; Thermo Fisher, 1:500), diluted in
3% NGS or 3% NHS, and 0.5% Triton X-100/PBS for
1.5 h at RT. Nuclei were counterstained with DAPI (Sigma-
Aldrich, 0.01 µg/ml) and sections were mounted using
Aqua-Poly/Mount (Polysciences, Warrington, USA).
Tile scans of hippocampus were acquired using Leica-
DMI6000 epifluorescence microscope (20× objective;
Leica) and Iba1+ and CD3+ cells were counted using
cell counter plug-in of FIJI-ImageJ software [29].
GFAP+ cells in the hippocampus were quantified densito-
metrically upon uniform thresholding (expressed as %
respective area).
Statistical analyses
Statistical analyses were performed using SPSSv.17 (IBM-
Deutschland-GmbH, Munich, Germany) or Prism4
(GraphPad Software, San Diego, California, USA). Group
differences in categorical and continuous variables were
assessed using χ2, Mann–Whitney U, or Student's t-tests
depending on data distribution/variance homogeneity.
ANOVA was employed as indicated in display item
legends. All p-values are two tailed; significance is set to p
< 0.05; data are presented as mean ± S.E.M.
Results
Cross-validation of NMDAR1-AB detection methods
To determine NMDAR1-AB seropositivity in mammals
other than humans, we had to validate the protein-A
detection method [27]. For that, N= 72 paired human
serum and ventricular CSF samples, prospectively collected
from random neurosurgical patients, were analyzed by the
usual cell-based assay, employing specific secondary AB
for all Ig classes. A total of N= 5 sera turned out
NMDAR1-AB positive (titers ≤ 1:100; 3× IgM; 2× IgA;
0× IgG). Ventricular CSF samples were all negative. For
cross-validation of NMDAR1-AB of the IgG class, we used
serum of a seropositive stroke patient [8]. Application of
protein-A method combined with double labeling for
NMDAR1-AB M68 confirmed positive and negative
results (Fig. 1a).
High seroprevalence of NMDAR1-AB across
mammalian species
We next analyzed by protein-A method serum samples of
dogs, cats, rats, baboons, and rhesus macaques. Strikingly,
all mammalian species, independent of their respective life
expectancy, show high NMDAR1-AB seropositivity
(Fig. 1b). Mouse samples were analyzed using specific AB
against murine IgA, IgM, and IgG. As known for humans
[6], NMDAR1-AB of the IgG class were the rarest. For
another cross-validation, all monkey samples (N= 100)
were analyzed in blinded fashion by an independent lab
(Bochum; using specific anti-monkey IgM). IgM-positive
results coincided with the protein-A positivity by >97%
(76 of 78). The fraction of protein-A positive but IgM-
negative monkey samples (total 22%) likely presents
NMDAR1-AB of IgA class and IgG class where specific
AB were not available.
Age-dependent NMDAR1-AB seroprevalence except
for nonhuman primates and human migrants
All species revealed age dependence of NMDAR1-AB
seroprevalence (χ2 test; dogs: χ2(1)= 11.5, p= 0.01; cats:
χ2(1)= 4.8, p= 0.03; rats: χ2(1)= 9.5, p= 0.002; and mice:
Fisher’s exact test p= 0.032) as for humans [5, 8] with the
exception of baboons (χ2(1)= 1.0, p= 0.3), where already
>50% of young animals were seropositive. This surprising
result made us investigate another monkey species, rhesus
macaques, showing again high seroprevalence in old and
young animals (χ2(1)= 0.2, p= 0.6) (Fig. 1b). We won-
dered what the difference between humans, dogs, cats,
mice, and rats, on one hand, and monkeys, on the other
hand, could be, leading to loss of the usual age pattern
regarding seroprevalence. Postulating that captivity/non-
domestication of young monkeys might induce chronic life
stress due to maladaptation to the environment, we inves-
tigated in a hypothesis-driven way whether young human
migrants would display a similar increase in NMDAR1-AB
seropositivity. Of the GRAS data collection, detailed
information on migration was available in a subsample of N
= 970 individuals. While nonmigrants show the typical age
association of NMDAR1-AB seroprevalence (χ2(1)= 10.7,
p= 0.001), migrants do not (χ2(1)= 0.6, p= 0.4) (Fig. 1c).
Seroprevalence in young migrants is significantly higher as
compared to young nonmigrants (χ2(1)= 5.381, p= 0.020).
In both monkey species and migrants, the IgM fraction still
follows the expected age trend, while IgA seems to account
for the early increase in NMDAR1-AB seroprevalence
(Fig. 1c). Presentation of NMDAR1-AB by Ig class in the
extended GRAS sample (N= 4933), with
N= 4632 of likely nonmigrants (available information less
detailed) and N= 301 known migrants, illustrates the
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abnormal course of IgA vs. IgM/IgG seroprevalence over
age in migrants (Fig. 1d).
Functionality of NMDAR1-AB from different
mammalian species
To assess whether NMDAR1-AB of the tested species are
functional, our endocytosis assay using IPSC-derived
human cortical neurons [10] was employed. All positive
sera provoked NMDAR1 internalization, verifying func-
tionality (Mann–Whitney U; all p< 0.001) (Fig. 1e).
BBB dysfunction but normal behavior of
ApoE−/− mice
We next induced endogenous NMDAR1-AB formation in a
mouse model of BBB dysfunction, ApoE−/− mice vs. WT
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Fig. 1 NMDAR1-AB seropositivity and functionality across mam-
malian species. a Cross-validation of assays: paired serum and intra-
ventricular CSF samples from neurosurgical patients were tested using
a HEK293T cell-based clinical standard assay for NMDAR1-AB
seropositivity (Euroimmun biochip). For step 1, fluorescently labeled
IgA-specific, IgM-specific, and IgG-specific secondary AB were used;
for method cross-validation (step 2), NMDAR1-AB seropositive and
seronegative samples of each Ig class from step 1 were labeled with
protein-A–FITC conjugate and tested for colocalization (yellow) of
protein-A–FITC+ (green) and M68+ (monoclonal mouse NMDAR1-
AB followed by Alexa555 donkey anti-mouse IgG red). Representa-
tive pictures of both methods using the same seropositive samples
(IgA, IgM, and IgG) are displayed on the right: upper row step 1/lower
row step 2. b NMDAR-AB seropositivity (%) of young and old
mammals for all Ig classes combined (#protein-A–FITC/Euroimmun)
or for individual classes (+Euroimmun; *protein-A–FITC/Euroimmun
and cross-validation with Euroimmun/monkey IgM) presented in the
bars; color codes used for consistency and kept also in c and d; age
given in months (m) or years (y); χ2 or Fisher’s exact test. c NMDAR-
AB seropositivity of subjects with migration (first and second gen-
eration) vs. nonmigration history (GRAS data collection); all Ig classes
presented; age split at 35 years; χ2 test. d NMDAR1-AB course by Ig
classes in serum over age groups in migrants vs. nonmigrants of the
extended GRAS data collection. Note the different course particularly
for IgA. eFunctionality testing of NMDAR1-AB in human IPSC-
derived cortical neurons: degree of internalization expressed as a ratio
of fluorescence intensity measured at 37 and 4 °C; number of neurons
and sera (N) given; Mann–Whitney U test
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e INFLAMMATION READOUTS
d OPEN FIELD ACTIVITY OF ApoE+/+ AND ApoE-/- MICE UPON MK-801 INJECTION
Ovalbumin immunizaon (IgG)
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Fig. 2 Behavioral and morphological effects of endogenous NMDAR1-
AB of the IgG class in a mouse model with open BBB. a Demonstration
of BBB leakiness in ApoE−/− mice using an intravenously injected
mixture of Evans blue (EB) and sodium fluorescein (NaFl): After brain
cryopreservation/lyophilization, tracers were extracted with formamide
and quantified; Student’s t-test; b Experimental outline; c Immunization:
Left: GluN1 peptides (P1–P4) located in the extracellular part of the
receptor were used for immunization (compare Fig. 3); middle and right:
Time course of anti-ovalbumin and anti-GluN1-AB (IgG) upon
immunization in ApoE−/− and ApoE+/+ mice; optical density at dilution
1:1000 shown; titers after day 10 reach up to 1:50,000; d Effect of MK-
801 injection on activity in the open field; results presented as % change
from baseline (first 4 min post MK-801 set to 100%); no difference in
MK-801-induced hyperactivity between genotypes after ovalbumin
immunization (one-way repeated measures ANOVA: treatment× group
interaction: F(1,17)= 0.2; p= 0.7); increase in hyperactivity (during rise,
plateau, decline, and after-effect phases) upon MK-801 in ApoE−/− but
not ApoE+/+ mice immunized against GluN1 (one-way repeated mea-
sures ANOVA: treatment× group interaction: F(1,22)= 5.6; p= 0.028).
e Quantification of Iba1+ and CD3+ cells in the hippocampus to assess
inflammation in the brain; one-way ANOVA; representative pictures of
Iba1 (left) and CD3 (right) stainings in the middle
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month-old mice (age of immunization) BBB leakiness using
two fluorescent tracers. While brain water content was
similar in both genotypes, pointing against inflammation,
ApoE−/− mice showed increased tracer extravasation, con-
firming BBB dysfunction (Student’s t-test: EB: t(8)=
−10.66, p< 0.001; NaFl: t(8)=−8.97, p< 0.001)
(Fig. 2a). We wondered whether this compromised
BBB would by itself lead to behavioral abnormalities in
ApoE−/− mice. A comprehensive behavioral battery,
including tests for anxiety, activity, exploratory behavior,
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aas previously described in Netrakanti et al. 2015
Note: All data in the table are mean± S.E.M.
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motor and sensory function, sensorimotor gating,
pheromone-based social preference, and cognitive perfor-
mance did not reveal any differences between genotypes
(Table 1).
Immunization of ApoE−/− and ApoE+/+ mice against
NMDAR1-peptides
To explore whether endogenously formed NMDAR1-AB
would lead to measurable behavioral and morphological
effects, we immunized 12-month-old ApoE−/− and ApoE+/+
littermates against four peptides of the extracellular
NMDAR1/GluN1-domain (including NTD-G7; N368/
G369) and ovalbumin or against ovalbumin alone as
immunization control (Fig. 2b–c). GluN1 shows >99%
sequence homology among all here-tested mammalian
species, with immunizing peptides being 100% homologous
(Fig. 3). Immunization led to high circulating levels of
specific IgG (titers up to 1:50,000). Efficacy of immuniza-
tion and time course of IgG appearance as determined by
ELISA were comparable for NMDAR1-peptides and oval-
bumin across genotypes, making a simple boosting effect of
NMDAR1-peptides on pre-existing NMDAR1-specific B
cell clones rather improbable (Fig. 2c).
Psychosis-related behavior of ApoE−/− mice upon
MK-801 challenge
Open-field tests measuring baseline preimmunization and
postimmunization locomotion did not reveal any differences
between genotypes and/or immunization groups (Fig. 2b;
not shown). After 4 weeks, the endogenously formed
NMDAR1-AB of the IgG class induced strong hyper-
activity (psychosis-like symptoms [37]) upon MK-801
challenge in ApoE−/− mice only. In contrast, ApoE+/+
mice behaved comparably to ovalbumin-only immunized
mice of both genotypes (Fig. 2d; all p> 0.5). Thus, an open
BBB together with sufficiently high titers of AB (to reach a
threshold loss of NMDAR1 surface expression) is a pre-
requisite for the observed behavioral perturbation upon
MK-801.
No inflammation in hippocampus of immunized
ApoE−/− and ApoE+/+ mice
Immunohistochemistry did not show any evidence of
inflammation in either genotype and/or immunization
group. Numbers of Iba1+ and CD3+ cells as markers of
microglia and T cells, respectively, were comparable for
total hippocampus (one-way ANOVA: Iba1: F(3,18)= 0.3;
p= 0.8; CD3: F(3,18)= 0.4; p= 0.8) (Fig. 2e) and for all
hippocampal subfields separately (all p-values > 0.2; not
shown). Also, staining for microglial activity markers,
CD68 and MHCII, was essentially negative and identical
across groups. Moreover, staining for GFAP did not
reveal any appreciable density increase in the
hippocampus, and thus no sign of astrogliosis (data not
shown).
Discussion
The present work demonstrates high seroprevalence of
functional NMDAR1-AB of all Ig classes across mammals,
indicating that these AB are part of a pre-existing auto-
immune repertoire [11–17]. As in humans, NMDAR1-AB
of the IgG class are the least frequent [6, 20]. The age
related up to >50% NMDAR1-AB seropositivity is inde-
pendent of the respective species’ life expectancy, indicating
that the aging process itself rather than years of exposure to
a certain environment triggers NMDAR1-AB formation.
However, our knowledge on predisposing factors and
inducing mechanisms is limited. Specific autoimmune-
reactive B cells may get repeatedly boosted by, e.g.,
infections, neoplasms, or the microbiome, and less effi-
ciently suppressed over a lifespan likely owing to a gradual
loss of immune tolerance upon aging [14].
Unexpectedly, we find the age-dependence lost in non-
human primates and in human migrants that all display an
early-life rise in NMDAR1-AB seropositivity, mainly of
IgA. The intriguing possibility that chronic life stress,
known to be present in human migrants [38] and animals in
captivity [39], acts as a trigger of early NMDAR1-AB
formation is worth pursuing experimentally in the future. A
large proportion of migrants in our human samples are
suffering from neuropsychiatric illness. This may addi-
tionally support our chronic stress hypothesis since migra-
tion is recognized as an environmental stressor predisposing
to mental disease [40]. Further studies should screen wild-
life monkeys and species in zoos for NMDAR1-AB.
Experimental confirmation of our findings provided,
NMDAR1-AB (IgA) may even serve as stress markers. In
fact, earlier reports show that total serum-Ig of all classes,
most prominently IgA, respond to psychological stress [41].
NMDAR1-AB might thus belong to a set of stress-boosted
AB. Interestingly, we also find accumulated seroprevalence
of 23 other brain-directed AB [6] in young migrants vs.
nonmigrants increased (data not shown), suggesting a glo-
bal inducer role of chronic stress in humoral autoimmunity.
Earlier work has shown that AB against brain antigens in
general are common among mammals [42], but no study
has so far systematically screened nonhuman mammals for
NMDAR1-AB. As an exception, a recent report described
“anti-NMDAR1 encephalitis” in the young polar bear Knut
[27]. Based on the present findings, Knut may have
belonged to those nondomesticated species in captivity—
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Fig. 3 Alignment of GluN1-1b receptor amino acid sequence across all
mammalian species tested. Regions containing the four peptide
sequences (peptides 1–4: P1: AA35–53, P2: AA361–376, P3:
AA385–399, and P4: AA660–811) used in the immunization experi-
ment are highlighted in yellow and light brown (compare three-
dimensional presentation in Fig. 2c) and nonhomologous amino acids
in pink. SP signal peptide, S1, S2 segments of the ligand-binding
domain, TMD A transmembrane domain A, TMD B transmembrane
domain B, TMD C transmembrane domain C
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comparable to monkey species investigated here—that are
affected by chronic early-life stress, inducing NMDAR1-
AB seropositivity. Pre-existing NMDAR1-AB of this bear
may have ultimately shaped the clinical picture of an
encephalitis of unexplained origin (likely infectious
according to the zoo’s pathology reports) where an epileptic
seizure led to drowning [27].
This interpretation is supported by our novel auto-
immune model, namely, mice immunized against
NMDAR1-peptides. Even high titers of endogenously
formed NMDAR1-AB (IgG; up to 1:50,000) that induce
psychosis-like behavior upon MK-801 challenge in
ApoE−/− mice, with here-confirmed open BBB, do not lead
to any appreciable signs of encephalitis. This dissociation of
behavioral/symptomatic consequences and inflammation in
the brain is of major importance for clinicians [14]. For
instance, earlier studies reported an influence of NMDAR1-
AB infusions into the hippocampus on learning and mem-
ory in mice [43], and others found increased NMDAR1-AB
seroprevalence in patients with mild cognitive impairment
and Alzheimer's disease [44, 45]. However, while all natu-
rally occurring NMDAR1-AB that have pathogenic potential
irrespective of epitope and Ig class [10], and upon entry to
the brain (or via intrathecal production) can shape brain
functions in the sense of NMDAR antagonism, only a frac-
tion of individuals happens to have underlying encephalitis
of various etiologies, which is then called anti-NMDAR
encephalitis. The highly variable neuropathology and
response to immunosuppression of this condition [2, 3, 46]
may point to a broad range of possible encephalitogenic
mechanisms (from infection to oncology or genetics) which
need to be diagnosed and specifically treated [14].
Even though it is unclear how NMDAR1-AB are
generated by chronic stress, it should be considered that
NMDAR1 are not only expressed in the brain but also by
peripheral organs and tissues, including adrenal glands
and gut [47] which may be involved in triggering
NMDAR1-AB formation but may also be functionally
modulated by them. Since NMDAR antagonists are
increasingly recognized as antidepressant, anxiolytic, and
anti-inflammatory agents [48–52], we speculate that
stress-induced NMDAR1-AB could serve as endogenous
stress protectants. Remarkably, also in stroke, NMDAR1-
AB can be protective [8].
In conclusion, the widespread occurrence of NMDAR1-
AB across mammals, as well as the failure of even high
titers of endogenously formed NMDAR1-AB of the IgG
class to induce any signs of brain inflammation should lead
to rethinking current concepts that link NMDAR1-AB to
neuropsychiatric disease including encephalitis.
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